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1.1. Viruses 
1.1.1. Infectious laryngotracheitis virus 
Infectious laryngotracheitis virus (ILTV) is a contagious respiratory virus that 
primarily affects chickens. ILTV can also affect pheasants and peafowls (Crawshaw 
and Boycott, 1982). ILTV may cause severe production losses due to decreased egg 
production and/or mortality (Garcia et al., 2013). ILTV transmission commonly 
occurs by inhalation, direct bird-to-bird contact and indirect by fomites and people 
(Menendez et al., 2014). Ingestion is also a source of infection, but exposure to nasal 
epithelium is necessary following ingestion (Garcia et al., 2013; Robertson and 
Egerton, 1981).  
1.1.1.1. Background 
In 1925, a new disease was reported in chickens of the United States that was 
described as trachea-laryngitis (May and Tittsler, 1925). The disease was 
characterized by nasal exudate, swelling around eyes, dyspnea and expulsion of 
bloody mucus. However, laryngotracheitis was believed to have existed as early as 
1920s (Cover, 1996). Several different names have been used to describe this disease 
including laryngotracheitis, infectious laryngotracheitis (ILT), infectious bronchitis 
and avian diphtheria (Beach, 1930). In 1931, the special committee on poultry 
diseases of the American Veterinary Medical Association adopted the name infectious 
laryngotracheitis (Garcia et al., 2013). Beaudette was the first to show that ILT was 
caused by a filterable agent (= virus) (Beaudette, 1937). ILT was the first poultry viral 
disease for which an effective vaccine was developed (Garcia et al., 2013).  
1.1.1.2. Classification 
The International Committee on Taxonomy of Viruses (ICTV) has given a 
classification of herpesviruses (www.ictvonline.org) (Davison, 2010; Davison et al., 
2009). Herpesviruses belong to the order Herpesvirales, which contain three families, 
three subfamilies, seventeen genera and ninety species (Davison, 2010). 
Herpesviridae, Alloherpesviridae and Malacoherpesviridae are the three families 
within the Herpesvirales. The Herpesviridae contain viruses of mammals, birds and 
reptiles. Alloherpesviridae contain viruses of fish and frog, and Malacoherpesviridae 
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contain viruses of bivalves (Davison et al., 2009). Alphaherpesvirinae, 
Betaherpesvirinae and gammaherpesvirinae are three subfamilies of the 
Herpesviridae family.  
Alphaherpesvirinae 
Alphaherpesvirinae is an extensive subfamily that contains numerous mammalian and 
avian viruses (Thiry et al., 2005). Alphaherpesviruses have a short life cycle of 8 to 
12 hours, grow rapidly, lyse infected cells, and are capable to establish latency 
primarily in sensory ganglia (Davison et al., 2009; Fuchs et al., 2000; Thiry et al., 
2005). Some alphaherpesviruses are found to have a broad host range (Davison et al., 
2009). The alphaherpesvirinae contains four genera, namely Simplexvirus, 
Varicellovirus, Mardivirus and Iltovirus (Roizman and Baines, 1991). Herpes simplex 
virus 1 (HSV1), herpes simplex virus 2 (HSV2) and bovine herpes virus 2 (BHV2) 
are species under the genus Simplexvirus. The best-known species in the genus 
Varicellovirus are swine herpesvirus 1 (SHV1), bovine herpesvirus 1 (BHV1), bovine 
herpesvirus 2 (BHV2), equine herpesvirus 1 (EHV1), equine herpesvirus 4 (EHV4), 
canine herpesvirus 1 (CHV1) and feline herpesvirus 1 (FHV1) (Davison, 2010; 
Davison et al., 2009). Gallid herpesvirus type 2 and 3 (GaHV2 and 3), Anatid 
herpesvirus 1, Columbid herpesvirus 1 and Meleagrid herpesvirus 1 are avian 
alphaherpesviruses under genus Mardivirus (Gailbreath and Oaks, 2008; Gennart et 
al., 2015; Guo et al., 2009; Hunt and Dunn, 2015; Mahony et al., 2015; Petherbridge 
et al., 2009; Wozniakowski et al., 2013). Gallid herpesvirus type 1 (GaHV1) and 
Psittacid herpesvirus 1 (PsHV1) are another group of avian alphaherpesviruses that 
belong to the genus Iltovirus (Fuchs et al., 2007; Horner et al., 1992; Luppi et al., 
2016). An overview of the different avian alphaherpesviruses is represented in Table 
1. Here, we will focus on Gallid herpesvirus 1 (ILTV) as this avian herpesvirus was 
used in the present study. 
Betaherpesvirinae 
Betaherpesvirinae mainly comprise mammalian viruses. The viruses of this family 
have a restricted host range. The replication cycle of betaherpesviruses takes 36 hours, 
which is much longer than for alphaherpesviruses. The viruses go to latency in 
secretory glands, kidneys and lymphoreticular tissues. The betaherpesvirinae contain 
four genera, namely Cytomegalovirus, Muromegalovirus, Roseolovirus and 
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Proboscivirus (Davison et al., 2009; Roizman and Baines, 1991). Human herpesvirus 
5 (HHV5) is the prototype of betaherpesviruses in the genus Cytomegalovirus, and is 
also called human cytomegalovirus (CMV). 
Table 1. Overview of avian alphaherpesviruses. 
Genus Virus species Acronym Natural host Clinical signs 
Iltovirus Gallid 
herpesvirus 1 GaHV1 Chickens Respiratory disease (ILT) 
Psittacid 
herpesvirus 1 PsHV1 Psittacine birds Pacheco’s Disease (PD) 
Mardivirus Anatid 
herpesvirus 1 AnHV1 Ducks 
Duck virus enteritis 
(DVE)/Duck plague 
Columbid 
herpesvirus 1 CoHV-1 
Pigeons, owls 
and falcons 
Respiratory and digestive 
disease 
Gallid 
herpesvirus 2 GaHV2 Chickens 
Lymphoproliferative disease 
(MDV) 
Gallid 
herpesvirus 3 GaHV3 Chickens 
Nonpathogenic MDV 
serotype 2 
Meleagrid 
herpesvirus 1 MeHV1 Turkey 
Nonpathogenic herpesvirus 
of turkeys (HVT) 
 
Gammaherpesvirinae 
Gammaherpesviruses are generally lymphotropic and establishes latency in 
lymphocytes. The gammaherpesvirinae contains four genera, namely Macavirus, 
Percavirus, Lymphocryptovirus and Rhadinovirus (Ackermann, 2006; Davison et al., 
2009; Roizman and Baines, 1991). Human herpesvirus 4 (HHV4) or Epstein-Barr 
virus (EBV) is the prototype of gammaherpesvirus under the genus 
Lymphocryptovirus. Bovine herpesvirus 4 (BHV4), murine herpesvirus 4 (MuHV4) 
and human herpesvirus 8 (HHV8 or Kaposi’s sarcoma-associated herpesvirus) are 
species under the genus Rhadinovirus (Andrei and Snoeck, 2015; O'Connor and 
Kedes, 2007). The species under genus Percavirus are equine herpesvirus 2 and 5 
(EHV2 and EHV5). Alcelaphine herpesvirus 1 (AlHV1) and ovine herpesvirus 2 
(OvHV2) are under Macavirus genus (Davison et al., 2009; Ziak et al., 2014). 
Macaviruses cause malignant catarrhal fever (MCF), a fatal disease of artiodactyla 
species (Farquharson, 1946; Ricer, 2015). 
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1.1.1.3. Structure 
Based on electronmicrographs, ILTV demonstrated to have hexagonal nucleocapsid 
with icosahedral symmetry, a typical morphology of herpesvirions (Garcia et al., 
2013; Granzow et al., 2001; Portz et al., 2008). The four distinct structures of ILTV 
are genome, capsid, tegument and envelope (Figure 1). 
 
Figure 1. Structure of an ILTV virion. (A) Transmission electron microscopy image 
of an ILTV particle [adapted from Portz et al. (2008)]. (B) Schematic structure of a 
virion. Distinct structures of ILTV are genome, capsid, tegument and envelope. 
ILTV has a double stranded DNA genome of approximately 150 kilo base pairs (kbp). 
It consists of long and short unique regions (UL and US) interspersed with inverted 
repeat sequences, such as internal repeat (IR) and terminal repeat (TR) sequences 
(Figure 2) (Fuchs et al., 2007). 
 
Figure 2. Double-stranded DNA genome of ILTV. Genome of 150 kbp in size 
consists of long and short unique regions (UL, US), and of inverted repeats (IR, TR) 
flanking the US region [adapted from Fuchs et al. (2007)].  
Capsid 
Genome 
Tegument 
Envelope 
Envelope 
glycoproteins 
 A  B 
UL US TR IR 
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Table 2. Identified gene products of ILTV [adapted from Fuchs et al. (2007)]. 
Gene Protein Amino acids Expected masses (kDa) 
UL0 ILTV-specific-nuclear protein 506 57.0 
UL(-1) Iltovirus-specific-nuclear protein 501 57.6 
ORF A Iltovirus-specific protein 376 41.3 
ORF B Iltovirus-specific protein 340 38.1 
ORF C Iltovirus-specific protein 354 37.4 
ORF D Iltovirus-specific protein 374 41.5 
ORF E Iltovirus-specific protein 411 45.1 
UL10 gM homologue, envelope protein 393 43.1 
UL22 gH, envelope glycoprotein 804 89.4 
UL27 gB, envelope glycoprotein 883 100.2 
UL31 Nuclear protein 314 35.4 
UL37 Tegument protein 1022 113.0 
UL44 gC, envelope glycoprotein 414 46.4 
UL46 Tegument protein 557 62.7 
UL47 Tegument protein 623 70.0 
UL48 Tegument protein 396 44.6 
UL49 Tegument protein 266 30.4 
UL49.5 gN, envelope glycoprotein 117 12.7 
US4 gG, secreted glycoprotein 292 31.7 
US5 gJ, secreted glycoprotein 985, 611 106.5, 66.8 
 
The ILTV genome contains 79 open reading frames (ORFs), which have been 
predicted to encode proteins. The majority of ILTV ORFs are homologues to ORFs of 
other alphaherpesviruses, such as HSV1. ORFs A, B, C, D, E, F, UL-0 and UL-1 are 
specific to Iltovirus (Fuchs et al., 2007; Veits et al., 2003). Identified ORFs with gene 
products of ILTV are given in Table 2. The DNA is present in an icosahedral 
nucleocapsid of about 100 nm in diameter, which is made of elongated hollow 162 
capsomers-150 hexamers and 12 pentamers. Tegument is a layer of globular material 
that surrounds the capsid protein. ILTV is reported to have large amounts of tegument 
proteins (Granzow et al., 2001). A lipoprotein membrane envelope encloses the 
nucleocapsid with many glycoprotein spikes on its surface. Viral glycoproteins gB, 
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gC, gD, gE, gG, gH, gI, gJ, gK, gL, gM and gN are homologues of HSV1 (Thureen 
and Keeler, 2006). In addition to protein encoding genes, ILTV also encodes short 
RNAs (approximately 22 nt) known as micro RNAs. The micro RNAs role in 
silencing of viral/host transcription/translation is not known (Garcia et al., 2013; 
Rachamadugu et al., 2009). 
1.1.1.4. Replication cycle 
The replication cycle of ILTV is similar to other alphaherpesviruses, such as HSV1 
(Guo et al., 1993; Mettenleiter et al., 2009; Roizman and Taddeo, 2007). The 
replication of alphaherpesviruses usually starts with the initial attachment of envelope 
glycoproteins (gC) to cell surface heparan sulphate (Kingsley and Keeler, 1999). Viral 
glycoproteins gB, gD and gH-L complex are involved in enhancement of virus 
attachment to the host cell surface (Akhtar and Shukla, 2009; Eisenberg et al., 2012). 
In case of ILTV, the envelope gC lacks a positively charged heparan sulphate binding 
region that is conserved in other alphaherpesvirus homologues (Kingsley et al., 1994; 
Kingsley and Keeler, 1999; Pavlova et al., 2010). Thus, it seems that ILTV does not 
use heparan sulphate as its primary host cell receptor. After initial attachment, the 
nucleocapsid is released into the cytoplasm and transported to the nucleus. Upon 
injection of the viral genome in the nucleus via the nucleopore, viral DNA replication 
and transcription occur. All viral proteins are synthesized in the cytoplasm of the cell 
(Guo et al., 1993; Zaichick et al., 2011). In general, the alphaherpesvirus genome 
transcription strictly follows a regulated cascade. The viral genes are transcribed at 
different time points and are clustered into immediate early (IE), early (E) and late (L) 
genes (Honess and Roizman, 1974; Nicoll et al., 2012). Commonly, IE and E genes, 
and their products regulate transcription of L genes. The ILTV genes are not strictly 
regulated and found to be quite leaky (Mahmoudian et al., 2012). The ILTV genes are 
differentiated into IE, E, E/L and L genes. The cascade patterns of ILTV gene 
expression are as follows. First several enzymes and DNA binding proteins are 
expressed, which are required for DNA replication, e.g. DNA polymerase and 
thymidine kinase. After DNA replication, viral structural proteins like capsid, 
tegument and envelope glycoproteins are expressed (Mahmoudian et al., 2012; 
Prideaux et al., 1992). The newly synthesized DNA concatemers cleaves into 
monomeric units and assemble with capsids to form nucleocapsids (Ben-Porat and 
Tokazewski, 1977). The DNA encapsidation takes place in the nucleus. The 
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assembled nucleocapsids exploit an envelopment/de-envelopment mechanism for 
transport to the cytosol (Mettenleiter et al., 2006; Skepper et al., 2001). The 
nucleocapsids acquire an envelope by budding through the inner lamellae of the 
nuclear membrane. The primary enveloped nucleocapsids, undergo a fusion with the 
outer nuclear membrane, which leads to release of de-enveloped/naked nucleocapsids 
into the cytoplasm (Skepper et al., 2001). In cytoplasm, main tegument proteins added 
to the nucleocapsids, which obtain their final envelope by budding into glycoprotein-
containing Golgi derived vesicles (Mettenleiter et al., 2006). Enveloped mature 
virions released by cell lysis/exocytosis and vacuolar membrane fusion (Granzow et 
al., 2001; Guo et al., 1993; Mettenleiter, 2002; Mettenleiter et al., 2006; Mettenleiter 
and Minson, 2006). 
1.1.1.5. Pathogenesis 
ILTV enters its host through upper respiratory and ocular routes. After natural entry 
of virus through nostrils or eyes, it primarily replicates in the epithelium of larynx and 
tracheal mucosae (Garcia et al., 2013; Guy and Bagust, 2003). However, the exact 
replication characteristics and invasion mechanisms of ILTV at the respiratory 
mucosa are not clearly understood. ILTV also replicates in the conjunctiva, 
respiratory sinuses, air sacs and lungs (Figure 3). During the first week of infection, 
ILTV replication in the larynx and trachea, leads to epithelial damage and 
hemorrhages (Bagust and Johnson, 1995; Bagust et al., 2000; Garcia et al., 2013). 
Several studies have shown that active replication of ILTV slows down after 6 days 
post inoculation (dpi), and virus may remain at very low levels up to 10 dpi (Bagust 
and Johnson, 1995; Garcia et al., 2013). ILTV is reported to spread to trigeminal 
ganglion (TG) of chickens, after 4-7 days of tracheal infection (Bagust, 1986; Bagust 
et al., 1986). TG is the principal site of latency for ILTV. The establishment of 
latency is similar with that of other herpesviruses, and is the biological survival 
mechanism, which enables ILTV to evade host defense mechanisms (Bagust, 1986). 
The latent virus persists in the flock over generations, and act as source of ILTV 
infection during stress (Bagust et al., 2000). The onset of egg laying and mixing of 
chickens with unfamiliar birds are important stressors, which lead to reactivation of 
virus and spontaneous outbreaks of infection (Fuchs et al., 2007).  
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 9 
 
Figure 3. ILTV pathogenesis. Stars represent infectious virus. Star number and 
infectivity are directly proportional to each other. ILTV replicates in the epithelium of 
larynx, trachea, conjunctiva, respiratory sinuses, air sacs and lungs. Recently, ILTV 
was observed in kidneys, spleen, liver, heart, gizzard, small and large intestines, bursa 
Fabricious and Harderian gland. ILTV establishes a lifelong latency in trigeminal 
ganglion.  
Very recently, ILTV was reported in extra respiratory tissues like kidneys, spleen, 
liver, heart, stomach, intestines, bursa Fabricious and Harderian glands (Roy et al., 
2015; Zhao et al., 2013). Otherwise, still there is no clear information on viremic 
phase of ILTV infection (Garcia et al., 2013). 
1.1.1.6. Clinical signs and Pathology 
The clinical signs of ILT have been described into a mild and severe form. The mild 
form of the disease is characterized by nasal discharge, mild respiratory rales, mild 
conjunctivitis, reduced egg production and no mortality (Bagust et al., 2000). Clinical 
signs during a severe form are marked by dyspnea, open mouth breathing with 
expectoration of bloody mucoid material, severe conjunctivitis, high morbidity, and 
moderate to severe mortality (Fuchs et al., 2007; Garcia et al., 2013). The clinical 
signs were reported in chickens of all ages but the most characteristic signs observed 
Trigeminal ganglion (life long latency) 
Larynx 
Lung 
Conjunctiva 
Respiratory sinuses 
Trachea Kidney 
Duodenum 
Bursa of Fabricius 
Small intestine Gizzard 
Spleen 
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in adult birds (Garcia et al., 2013). The important pathological changes of ILT are 
hemorrhages and diphtheritic changes in larynx and trachea, and presence of mucoid 
plugs/casts in the trachea (Garcia et al., 2013). An overview of clinical signs and 
pathology following ILTV infection is shown in Figure 4. 
 
Figure 4. ILTV clinical signs and pathology. (A) Conjunctivitis, (B) open mouth 
breathing, (C) blood and mucus in larynx and trachea, and (D) mucoid plugs/casts in 
trachea (figures 4A and 4D adapted from a North Carolina State University fact Sheet 
entitled “Infectious Laryngotracheitis Virus (ILT)” by Donna K. Carver). 
1.1.2. Infectious bronchitis virus 
Infectious bronchitis virus (IBV) is the etiological agent of the disease infectious 
bronchitis (IB). IB is probably the most economically important viral respiratory 
disease of poultry industry, after avian influenza and Newcastle disease (Cook et al., 
2012). IBV is a highly contagious respiratory pathogen of chickens. Partridge, guinea 
fowl, geese, pigeon, duck and peafowl are also susceptible to IBV infection 
(Cavanagh, 2005, 2007). IBV affects both meat-type and egg-laying birds. Currently, 
several serotypes of IBV exist, and new variant types emerge due to increased point 
mutations and recombination events (Jackwood, 2012). 
C D 
A B 
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1.1.2.1. Background 
IB was reported in young chickens as a new respiratory disease in North Dakota, 
United States in 1931 (Fabricant, 1998; Schalk and Hawn, 1931). In 1936, the 
causative agent of IB was demonstrated to be a filterable agent (= virus) (Beach and 
Schalm, 1936). IBV was first cultivated in embryonated chicken eggs in 1937 
(Beaudette and Hudson, 1937). In the early 1950s, a first IBV variant was reported in 
the US, and found that vaccines did not cross protect or cross neutralize these variants 
(Fabricant, 1998; Jungherr et al., 1956). Later new variant strains and serotypes were 
reported all over the world. In the beginning of the 1950s, the well-known respiratory 
Massachusetts (Mass) type of IBV was reported in the US. Subsequently, Mass-type 
(prototype: M41) strains have been reported worldwide and new variants emerged 
(Hopkins, 1974). In the 1950s, an IBV type was reported to infects the reproductive 
tract, and which affects egg production and quality in laying chickens (Van Roeckel et 
al., 1942). In the 1960s, new emerging and fatal nephropathogenic IBV strains were 
described in the US, Australia, and later all over the world. In the last 15 years, 
nephropathogenic IBV strains have been emerging as most predominant IBV strains 
and remained as most feared disease in commercial poultry (Abdel-Moneim et al., 
2006; Bayry et al., 2005; De Wit et al., 2015; Lim et al., 2011; Liu and Kong, 2004; 
Mahmood et al., 2011; Meir et al., 2004; Seger et al., 2016; Toffan et al., 2013a; 
Zanaty et al., 2016; Ziegler et al., 2002). The B1648 strain was responsible for 
outbreaks of kidney disease in chicken farms in Belgium, The Netherlands and 
Northern France, and was first isolated in 1984 (Meulemans et al., 1987; Pensaert and 
Lambrechts, 1994). Currently, the B1648 strain or its variants are still circulating in 
Europe and North Africa (Bochkov et al., 2006; Ducatez et al., 2009; Krapež et al., 
2010; Toffan et al., 2013b). In the 1970s and 1990s, IBV was shown to infect the 
intestinal tract with no apparent effect on the gut function (Alexander and Gough, 
1977, 1978; Ambali and Jones, 1990). In Europe, currently, 4/91, D274, Mass 41, 
Italy 02 and QX are recognized as important circulating serotypes (Cavanagh, 2007; 
Cook et al., 2012). Here, we will focus on nephropathogenic B1648 and respiratory 
M41 strains as these IBV strains were used in the present PhD thesis work 
(Lambrechts et al., 1993; Pensaert and Lambrechts, 1994; Pensaert et al., 1981). 
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1.1.2.2. Classification 
Coronaviruses belong to the order Nidovirales, which contain four families, namely 
Coronaviridae, Arteriviridae, Roniviridae, and Mesoniviridae. Coronaviridae and 
Arteriviridae families represent economically important viruses of mammals and 
birds. Coronavirinae and Torovirinae are two subfamilies of the Coronaviridae 
family (Table 3). The coronavirinae contain four genera, namely Alphacoronavirus 
Betacoronavirus Gammacoronavirus and Deltacoronavirus (www.ictvonline.org) 
(Gorbalenya et al., 2006). An overview of the different viruses of the family 
Coronaviridae is represented in Table 3. 
Transmissible gastroenteritis virus (TGEV), canine coronaviruses (CCoV), feline 
coronaviruses and porcine respiratory coronavirus (PRCoV) are classified in the 
genus Alphacoronavirus and species Alphacoronavirus 1. Porcine epidemic diarrhea 
virus (PEDV), human coronaviruses 229E and NL63, and bat coronaviruses are other 
important coronaviruses in the genus Alphacoronavirus (Cavanagh, 2005). The well-
known species in the genus Betacoronavirus are murine hepatitis virus (MHV), 
porcine haemagglutinating encephalomyelitis virus (PHEV) and human coronavirus 
OC43. Recently reported, severe acute respiratory syndrome (SARS-CoV) 
coronavirus and Middle East respiratory syndrome coronavirus (MERS-CoV) are 
other important coronaviruses in the genus Betacoronavirus (Cavanagh, 2005; 
Drexler et al., 2014). 
The coronaviruses under the genera Gammacoronavirus and Deltacoronavirus infect 
birds (Woo et al., 2012). The better-known gammacoronaviruses are coronaviruses of 
domestic chickens (Gallus gallus), turkey (Meleagris gallopavo), pheasant (Phasianus 
colchicus), mallard duck (Anas platyrhynchos), greylag goose (Anser anser) and 
pigeon (Columbia livia) (Cavanagh, 2005, 2007). Deltacoronavirus genus contains 
viruses of pigs and wild birds. Recently, many important deltacoronaviruses were 
reported from free range and wild bird species (Woo et al., 2012).  
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Table 3. Overview of the family Coronaviridae (adapted from Desmarets Ph.D. 
dissertation, 2016). 
Subfamily Genus Species Subspecies 
Coronavirinae Alphacoronavirus Alphacoronavirus 1 Canine coronavirus type I and II 
   Feline coronavirus type I and II 
   Porcine respiratory coronavirus 
   Transmissible gastroenteritis virus 
  Alphacoronavirus 2 Ferret coronaviruses 
  Human coronavirus 229E  
  Human coronavirus NL63  
  Porcine epidemic diarrhea virus  
  Miniopterus bat coronavirus HKU8  
 Betacoroanvirus Betacoronavirus 1 Bovine coronavirus 
   Human coronavirus OC43 
   Equine coronavirus 
   Human enteric coronavirus 
   Porcine haemagglutinating encephalomyelitis virus 
   Canine respiratory coronavirus 
  Human coronavirus HKUI  
  Murine coronavirus Murine hepatitis virus 
   Puffinosis coronavirus 
  Severe acute respiratory syndrome virus Human SARS coronavirus 
  Middle East respiratory syndrome virus  
 Gammacoronavirus Avian coronavirus Infectious bronchitis virus 
   Turkey coronavirus  
   Duck coronavirus 
   Pigeon coronavirus 
   Goose coronavirus 
   Pheasant coronavirus 
  Cetacean coronavirus Beluga whale coronavirus SW1 
 Deltacoronavirus Bulbul coronavirus HKU11  
  Thrush coronavirus HKU12  
  Munia coronavirus HKU13  
  Sparrow coronavirus HKU17  
  Magpie robin coronavirus HKU18  
  Night heron coronavirus HKU19  
  Wigeon coronavirus HKU20  
Torovirinae Bafinivirus White bream virus  
 Torovirus Bovine torovirus  
  Equine torovirus  
  Porcine torovirus  
  Human torovirus  
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1.1.2.3. Structure 
IB viral particles are round to pleomorphic in shape with a mean diameter of 
approximately 120 nm (Figrue 5B) (Cavanagh, 2007). IBV is an enveloped virus with 
club shaped surface projections (spike proteins) (Cavanagh, 2007; Cavanagh and 
Naqi, 2003). 
 
Figure 5. Structure of an IBV virion. (A) Schematic structure of an IBV virion. The 
nucleocapsid (N) protein surrounds the RNA (+ss RNA). The N protein is surrounded 
by a lipid envelope in which three structural proteins are inserted, the spike (S), the 
envelope (E) and the membrane protein (M). (B) Electron micrograph of IBV virion 
negatively stained with phosphotungstic acid. [Adapted from Cook (1983)]. 
IBV has a positive-sense single-stranded RNA (+ss RNA) genome with the size of 
around 27.6 kilobases (kb) (Figure 5). The genome has a methylated cap and poly (A) 
tail at its 5’ and 3’ end, respectively. The positive-sense single stranded RNA directly 
acts as mRNA for the synthesis of viral replicative proteins through translation of 
open reading frames (ORFs). IBV genome contains at least ten ORFs in the order 5’ 
UTR-1a-1b-S-3a-3b-EM-5a-5b-N-3’UTR (Figure 6). 5’UTR and UTR3’ are 
untranslated regions of around 500 nucleotides, which mediate physical interactions 
with viral replicase proteins (Liu et al., 2007).  
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Figure 6. Genome of IBV (+ss RNA). Genome of 27.6 kilobases in size, and consists 
of a methylated cap and poly (A) tail at its 5’ and 3’ end. Open reading frame (ORF) 
1a and 1b accounts two-thirds of genome, and encode non-structural proteins (NSPs). 
S, E, M and N are structural protein genes. 3a, 3b, 4b, 4c, 5a, 5b and 6b are accessory 
genes (NSPs) (Cavanagh, 2005). 
Gene 1 (replicase transcriptase complex) contains two overlapping ORFs, namely 
ORF 1a and 1b, which make up two-thirds (20 kb) of the viral genome. A ribosomal 
frame shift mechanism mediates translation of ORF1b. ORF1a and 1b encodes 15 
non-structural proteins (NSPs), which are associated with RNA replication, 
transcription, aspects of pathogenesis and other still unknown functions. The known 
NSPs of ORF1a and 1b, are RNA-dependent RNA-polymerase, chymotrypsin like 
main protease, papain like protease 1 and 2, 3C-like protease, ADP-ribose binding 
protein, Helicase, exoribonuclease, and 2’-O-ribose methyltransferase and other NSPs 
(Gorbalenya et al., 2006; Hurst et al., 2010; Mielech et al., 2014; van Hemert et al., 
2008). The remaining 3’ one third of the genome contains ORFs 2, 3, 4 and 6, which 
encodes spike (S), envelope (E), membrane (M) and nucleocapsid (N) structural 
proteins, respectively. ORF 3 and ORF 5 encode accessory proteins 3a, 3b, 5a and 5b, 
which are interspersed between structural proteins. The exact roles of these accessory 
proteins are largely not known. 
The spike glycoprotein is assembles into trimers on the surface of virions to give the 
crown-like appearance or corona-like appearance (Belouzard et al., 2012). The spike 
protein is a leading mediator of viral entry. The spike protein (≈	 1160 amino acids) is 
cleaved into two subunits, namely N-terminal S1 subunit (≈	 520 amino acids) and C-
terminal S2 subunit (≈	 620 amino acids) (Belouzard et al., 2012; Cavanagh et al., 
1992). S1 is the most variable domain, and consists of virus neutralization and 
serotype specific determinants. S1 part is responsible for attachment of the virus to 
receptors on host cells (Casais et al., 2003).  S2 activates virus-cell fusion processes 
(Weiss and Navas-Martin, 2005). The envelope (E/3c) protein is a small membrane 
non-glycosylated protein. E protein has an important role in virus assembly. In 
addition, E protein was reported to play a role in ion channel activity, multiple 
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membrane topologies and virulence (Nieto-Torres et al., 2014; Ruch and Machamer, 
2012). The membrane (M) protein is a glycosylated, and most abundant envelope 
protein. Together with the E protein, the M protein plays crucial roles in virus 
morphogenesis, assembly and budding (Baudoux et al., 1998; Vennema et al., 1996). 
The nucleocapsid (N) protein is a highly phosphorylated structural protein. N protein 
has multiple functions, namely viral packaging, replication, transcription, translation, 
assembly, viral core formation and signal transduction (McBride et al., 2014).  
1.1.2.4. Replication cycle 
IBV replication takes place in the cytoplasm of the cell, and it is similar to other 
coronaviruses (Cavanagh and Naqi, 2003). The coronavirus replication cycle involves 
five steps: entry, genome replication, transcription, assembly and release. The viral 
spike protein and cell surface receptor interaction mediates the initial attachment and 
membrane fusion event of coronavirus entry. Coronaviruses have evolved with 
different cell surface receptors for virus entry. For example, many alphacoronaviruses 
use aminopeptidase N (APN), MHV utilize CEACAM1, SARS-CoV use angiotensin-
converting enzyme 2 (ACE2) and MERS-CoV use dipeptidyl-peptidase 4 (DPP4), to 
gain entry into cells (Cui et al., 2013; Fehr and Perlman, 2015; Li et al., 2003; 
Williams et al., 1991). Sialic acid is a cell surface receptor for IBV entry (Mork et al., 
2014; Winter et al., 2006). 
Following attachment and fusion, the viral nucleocapsid is released into the 
cytoplasm. The viral RNA genome directly synthesizes polyproteins pp 1a and pp 1ab 
by frame shift mechanism. Subsequently, pp 1a and pp 1ab cleave into individual 
NSPs (Ziebuhr et al., 2000). NSPs assemble into a replication transcription complex 
(RTC) where genome replication and transcription of subgenomic RNAs occur. Then, 
translation of S, E and M structural proteins occur, and these proteins embed into 
endoplasmic reticulum (ER) membrane. The structural proteins move through the 
endoplasmic reticulum-Golgi intermediate compartment (ERGIC) (de Haan and 
Rottier, 2005; Krijnse-Locker et al., 1994; Tooze et al., 1984). During this secretory 
pathway transport posttranslational modifications take place, and all proteins mature 
and assemble. The assembled virions are then transported to the plasma membrane 
surface in vesicles and are released by exocytosis (Fehr and Perlman, 2015).  
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1.1.2.5. Pathogenesis 
IBV primarily replicates in the epithelium of the upper respiratory tract (URT) 
(Cavanagh, 2007; Raj and Jones, 1997b). Virus was shown to replicate mainly in 
ciliated and mucus producing cells of the epithelium (Nakamura et al., 1996). 
However, the precise replication kinetics of IBV at the URT are unknown. 
 
Figure 7. IBV replicates at many epithelial surfaces. Stars represent infectious virus. 
Star number and infectivity are directly proportional to each other. IBV shows 
tropism to the trachea, lungs, kidneys, oviduct, oesophagus, duodenum, ileum, bursa 
of Fabricius, caecum and Harderian gland (Cavanagh, 2005). 
High viral titers are observed in the URT between 2 and 5 dpi (Nakamura et al., 1991; 
Otsuki et al., 1990; Raj and Jones, 1996). IBV also replicates in the lungs and airsacs 
(Janse et al., 1994; Nauwynck and Pensaert, 1988). In addition to the respiratory tract, 
IBV has a tropism for the epithelium of many other tissues, including kidneys, 
reproductive tract, gastrointestinal tract (oesophagus, proventriculus, duodenum, 
jejunum, bursa of Fabricius, caecal tonsils, rectum and cloaca) and testes (Figure 7) 
(Alexander and Gough, 1978; Ambali and Jones, 1990; Brown et al., 1987; Cook, 
1971, 1984; El-Houadfi et al., 1986; Gallardo et al., 2011; Jones and Jordan, 1971; 
Lucio and Fabricant, 1990; Raj and Jones, 1996; Villarreal et al., 2007). 
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Nephropathogenic IBV replicates in collecting ducts and tubules, Henle’s loops and 
distal convoluted tubules of kidneys (Chen et al., 1996; Chong and Apostolov, 1982; 
Owen et al., 1991). In some cases, IBV may persist in kidneys of chickens 
(Bhattacharjee et al., 1995; Jones and Ambali, 1987; Raj and Jones, 1997a). Up till 
now, there are poor reports on the viremic phase of IBV infection. 
1.1.2.6. Clinical signs and pathology 
The characteristic respiratory signs of IB are tracheal rales, coughing, gasping, nasal 
discharge, and huddling together (Jackwood and de Wit, 2013). The classical clinical 
signs of nephropathogenic IBV disease are increased water consumption, watery 
droppings, low body weight gain and increased mortality (Cook et al., 2012; 
Meulemans et al., 1987; Pensaert and Lambrechts, 1994). Decreased egg production 
and quality (thin shelled and misshapen), and cystic dilatation of the oviducts (IBV 
QX type) are shown in oviduct infected chickens (Awad et al., 2016; Benyeda et al., 
2009; Broadfoot et al., 1954; de Wit et al., 2011; Hewson et al., 2014; Maiti et al., 
1985). In general, QX type has been reported to be associated with cystic oviducts 
(false layers syndrome), nephritis and respiratory distress (Benyeda et al., 2009; de 
Wit et al., 2011). Presence of caseous or cloudy exudate in the tracheal and bronchi 
mucosa is pathological changes of respiratory IB. The important pathological changes 
of nephropathogenic IB are dehydrated carcasses, enlarged and pale kidneys with 
urates in the collecting tubules (Cook et al., 2012; Ignjatovic and Sapats, 2000; 
Meulemans et al., 1987). An overview of clinical signs and pathology following IBV 
infection is shown in Figure 8.  
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Figure 8. IB clinical signs and pathology. (A) Ephiphora, (B) cystic dilatation of the 
oviduct (IBV QX strain), (C) depression, (D) thin shelled eggs and (E) enlarged 
kidneys (figures 8A, 8C and 8D are adapted from atlas of avian diseases, Cornell 
University, figure 8B is adapted from de Wit et al. (2011) and figure 8E is from Dr. 
Kannan Ganapathy, University of Liverpool). 
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Avian respiratory viruses are an important cause of economic losses to the worldwide 
poultry industry. The main losses are due to decreased egg production and quality, 
reduced growth and mortality. The use of diagnostics, vaccines and antimicrobials to 
diagnose, prevent and treat secondary infections are other ancillary factors that cause 
additional losses. Infectious laryngotracheitis virus (ILTV) and infectious bronchitis 
virus (IBV) are economically the most important avian respiratory viruses. In general, 
ILTV and IBV show tropism primarily to the epithelium of the respiratory mucosa. 
However, the ILTV and IBV clinical features are different and evolved completely 
into different directions. Hence, in this thesis, the pathogenesis of ILTV and IBV were 
examined under in vitro and in vivo conditions, to elucidate the reasons for the 
differences in their clinical features. 
Infectious laryngotracheitis virus 
ILTV enters chickens through respiratory and ocular routes. After entry, initial virus 
replication takes place in the respiratory and conjunctival epithelial cells. Then, ILTV 
invades through the basement membrane (BM) to disseminate in the underlying 
lamina propria. However, the exact replication kinetics and invasion strategies of 
ILTV at the primary replication site are not well understood. In order to get an answer 
to this question in vitro tracheal and conjunctival mucosa explant models of chickens 
were established (Chapter 3.1.). 
During acute ILTV infection, the formation of mucoid plugs/casts in the trachea is the 
main cause for suffocation and mortality of chickens. Although it has been supposed 
that the trachea obstruction is due to mucus hypersecretion, there are no published 
reports to support this assumption. This lacuna will be addressed in Chapter 3.2. 
Infectious bronchitis virus 
Massachusetts (Mass) type IBV (prototype: M41) is a well-known respiratory IBV 
strain. Some IBV strains are nephropathogenic (NIBV), i.e. they cause additionally 
severe kidney infection. The virulent NIBV infection is characterized by wet 
droppings, increased water consumption, loss of body weight gain and increased 
mortality. In the last 15 years, diverse new variants of NIBV emerged as predominant 
IBV strains. 
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The NIBV strain B1648 was first isolated in 1984, in Flanders, Belgium. Despite 
intensive vaccination, B1648 and its variants are still circulating in Europe and North 
Africa.  
In the present thesis the complete genome of Belgian nephropathogenic IBV reference 
strain was identified to understand its evolutionary relationship with other IBV 
strains, and to determine possible genetic factors that may be associated with the 
nephropathogenic nature of this strain (Chapter 4.1.). Further, it is unknown why 
NIBV has a strong tropism for the kidneys. This was addressed in Chapter 4.2. 
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3.1.1. Abstract 
Avian infectious laryngotracheitis virus (ILTV) is an alphaherpesvirus of poultry that 
is spread worldwide. ILTV enters its host via respiratory tract and eyes. Although it is 
known for a long time, the replication characteristics of ILTV in the respiratory and 
conjunctival mucosa are still poorly studied. To study the replication characteristics of 
ILTV in chicken tracheal and conjunctival mucosa, two in vitro explant models were 
developed. Light microscopy and a fluorescent terminal deoxynucleotidyl transferase 
mediated dUTP nick end labeling (TUNEL) staining were used to evaluate the 
viability of mucosal explants. The mucosal explants were viable up to the end of the 
experiment at 96h of cultivation. The tracheal and conjunctival mucosal explants were 
inoculated with ILTV and collected at 0, 24, 48 and 72h post inoculation (pi). ILTV 
spread in a plaquewise manner in both mucosae. A reproducible quantitative analysis 
of this mucosal spread was evaluated by measuring plaque numbers, plaque latitude 
and invasion depth underneath the basement membrane (BM). No major differences 
in the plaque numbers were observed over time. Plaque latitude progressively 
increased over time up to 70.4 ± 12.9 µm in trachea and 97.8 ± 9.5 µm in conjunctiva 
at 72h pi. The virus had difficulties to cross the BM. Only from 48h pi BM crossing 
was found and at 72h pi it was observed in 56% (trachea) and 74% (conjunctiva) of 
the plaques. Viability analysis of infected explants indicated that ILTV blocks 
apoptosis in infected cells of both mucosae but activates apoptosis in bystander cells.  
3.1.2. Introduction 
Infectious laryngotracheitis virus (ILTV) is an avian herpesvirus, classified within the 
order Herpesvirales, family Herpesviridae, subfamily Alphaherpesvirinae and genus 
Iltovirus. ILTV is taxonomically designated as Gallid herpesvirus 1 (GaHV1) 
(Davison, 2010). ILTV is a contagious respiratory virus of chickens with an active 
cytolytic replication that takes place in the epithelium of trachea, larynx and 
conjunctiva, which may lead to severe mucosal epithelial damage and hemorrhages. 
These pathological changes lead to “infectious laryngotracheitis” (ILT) (Bang and 
Bang, 1967; Guy and Bagust, 2003). During ILTV infection, it is not clear if a 
viremia occurs (Bagust, 1986; Guy and Bagust, 2003; Zhao et al., 2013). After an 
acute phase of infection, ILTV, like other alphaherpesviruses, establishes a lifelong 
latency within the trigeminal ganglion of the central nervous system (CNS). During 
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stress, reactivation of the virus may occur, leading to the spread of ILTV to 
susceptible contact animals (Fuchs et al., 2007). The characteristic clinical signs of 
ILT during a mild form are nasal discharge, conjunctivitis and drop in egg production. 
During a severe form, additional signs are gasping, bloody mucus expectoration, 
dyspnea and death due to asphyxia (Fuchs et al., 2007). ILT has an economic impact 
by causing severe production losses due to a high morbidity and mortality and by 
mass vaccination (Jones, 2010). 
ILTV enters its host via respiratory and ocular routes. After its entry, initial virus 
replication takes place in the epithelium of the respiratory and conjunctival mucosa 
(Guy and Bagust, 2003). Afterwards, ILTV may invade through the basement 
membrane (BM). During evolution of all animal species, most alphaherpesviruses 
have acquired intriguing tools to invade through the BM of the mucosa and to 
disseminate in the underlying lamina propria (Glorieux et al., 2009; Steukers et al., 
2012). The precise replication characteristics and invasion mechanism of ILTV at the 
primary replication site, i.e. in the respiratory and conjunctival mucosa are unknown. 
Replication characteristics of ILTV in the respiratory and conjunctival mucosa may 
be investigated by performing animal experiments (Bang and Bang, 1967; Kirkpatrick 
et al., 2006). However, in vivo studies are more and more contested due to ethical 
reasons. Furthermore, animal experiments are prone to large inter-animal variation. 
Hence, a fully standardized in vitro model, which mimics the in vivo situation, is 
useful to study host-virus interactions during the early stages of infection.  
The tracheal organ culture (TOC) system is commonly used to study host-pathogen 
interactions (Reemers et al., 2009). Generally, tracheal rings from chicks or 19-day-
old chicken embryos are used for tracheal organ cultures (Jones and Hennion, 2008; 
Zhang et al., 2012). TOC has already been used for a long time for diagnosis and 
pathogenesis studies of ILTV (Bagust, 1986; Ide, 1978). The viability of TOCs has 
generally been analysed by two methods: one based on the cilial beating and another 
based on the ciliary removal of latex beads (Anderton et al., 2004). However, these 
two methods evaluate only the epithelium viability and do not control the viability of 
the lamina propria of the tracheal mucosa and the underlying submucosa. The chicken 
conjuctival organ culture (COC) has also been used to study host-virus interactions 
(Darbyshire et al., 1976) but viability analysis was not performed. To study 
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replication characteristics and invasion mechanism of ILTV through the BM towards 
the lamina propria and the underlying submucosa, it is crucial to keep these layers 
viable.  
The aims of the present study were (i) to evaluate quantitatively the replication 
characteristics of ILTV in in vitro models of chicken tracheal and conjunctival 
mucosa explants and (ii) to analyse cell viability of infected mucosal explants. Hence, 
an in vitro tracheal and conjunctival organ cultures were established. The tracheal and 
conjunctival mucosa explants (organs) were placed on fine-meshed gauze and 
maintained for 96h at an air-liquid interface. A viability analysis was performed using 
light microscopy (cilial beating) and fluorescence microscopy (TUNEL-positive cells). 
The mucosal explants were inoculated with ILTV. ILTV replication kinetics was 
quantitatively evaluated by measuring plaque number, plaque latitude and invasion 
depth underneath the BM in tracheal and conjunctival mucosa explants (organs). A 
viability analysis of infected mucosal explants was performed to examine the outcome 
of an ILTV infection in these mucosae.  
3.1.3. Materials and Methods 
3.1.3.1. Virus 
A pathogenic Belgian isolate of ILTV (U76/1035) was used in this study (Meulemans 
and Halen, 1978). Stock virus was propagated in primary chicken embryo kidney cells 
that were collected from 19-day-old embryonated specific pathogen free (SPF) eggs 
by trypsin digestion. Cells were grown in minimum essential medium (Gibco) 
supplemented with 2% fetal calf serum (Gibco). Virus titration was performed on the 
chorioallantoic membrane of 10-day-old chicken embryos to determine EID50/ml. The 
ILTV strain obtained was from unknown passages. From which a second passage was 
produced and utilized for inoculation of explants. 
3.1.3.2. Isolation and cultivation of chicken tracheal and conjunctival explants 
This study was in agreement with the guidelines of the Local Ethical and Animal 
Welfare Committee of the Faculty of Veterinary Medicine of Ghent University. SPF 
chickens were euthanized by intravenous injection of sodium pentobarbital (100 
mg/kg body weight) in the brachial wing vein. Tracheas and conjunctivas were 
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collected from three four to eight week old chickens. Tracheas were carefully split 
into two equal halves with sharp surgical blades (Swann-Morton). Conjunctival 
mucosa folds were carefully dissected from the underlying layers. Tracheal and 
conjunctival mucosal explants covering a total area of 10 mm2 were made and placed 
on fine-meshed gauze in six-well culture plates (Nunc), epithelium upwards. The 
explants were maintained in serum-free medium (50% Ham’s F12 (Gibco)/50% 
DMEM (Gibco)) supplemented with 100 U/mL penicillin (Continental Pharma), 0.1 
mg/mL streptomycin (Certa), 1	   µg/mL gentamycin (Gibco) and 25 mM HEPES 
(Gibco). The epithelium of the explants was slightly immersed in the fluid to achieve 
an air liquid interface, i.e. with just a thin film of fluid covering the epithelium. 
During the entire cultivation period, medium was not replaced. Explants were 
maintained up to 96 hours at 37°C and 5% CO2.  
3.1.3.3. Ciliary beating 
Ciliary beating of the tracheal explants was checked on a daily basis with a light 
microscope (Olympus CKX 31) at objective magnification x20.  
3.1.3.4. Viability analysis by TUNEL assay 
A viability analysis was performed in three independent experiments. Tracheal and 
conjunctival mucosa explants were collected at 0, 24, 48, 72 and 96h of in vitro 
cultivation. The In Situ Cell Death Detection Kit (Fluorescein) based on terminal 
deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) (Roche 
diagnostics GmbH, Mannheim, Germany) was used to detect apoptotic cells. The test 
was performed according to the manufacturer’s guidelines. Hoechst 33342 (Molecular 
Probes) was used to visualize cell nuclei. The percentage of TUNEL-positive cells 
was determined in five randomly selected fields of 100 cells in both epithelium and 
lamina propria with a fluorescence microscope (Leica DM RBE microscope, Leica 
Microsystems).  
3.1.3.5. Inoculation of GaHV1 (ILTV) and evaluation of mucosal spread 
Tracheas and conjunctivas of three chickens were used. Explants were inoculated at 
24h of cultivation with ILTV (U76/1035). For the inoculation, explants were taken 
from their gauze and placed at the bottom of a 24-well plate with the epithelial surface 
upwards. Explants were washed twice with warm serum-free medium and inoculated 
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with 1 ml of a virus stock containing 106.0 EID50 (1h, 37°C, 5% CO2). After one hour, 
inoculated explants were washed three times with warm medium and placed back on 
the gauze. Explants were collected at 0, 24, 48 and 72h pi, embedded in Methocel® 
(Fluka) and frozen at -70°C. Inoculation was performed for three different chickens. 
For each chicken, one explant was collected at each time point post inoculation. As a 
parameter of productive replication, we have checked viral titers in the supernatant of 
inoculated explants in one replicate. 
3.1.3.6. Immunofluorescence staining 
At 0, 24, 48 and 72h pi, 150 consecutive cryosections of 15 µm were made from the 
frozen explants and the cryosections were fixed in methanol (25 min, -20°C). The 
cryosections were first stained for collagen IV, which is abundantly present in the BM 
and connective tissue, and next for ILTV antigens. The cryosections were incubated 
(1h, 37°C) with goat anti-collagen IV antibodies (Southern Biotech) (1:50 in PBS), 
after which cryosections were washed three times (PBS) and incubated (1h, 37°C) 
with biotinylated rabbit anti-goat IgG antibodies (1:100 in PBS) and washed three 
times after incubation. Then, cryosections were incubated (1h, 37°C) simultaneously 
with streptavidin-Texas Red (Molecular Probes) (1:50 in PBS) and mouse monoclonal 
anti-ILTV gC antibodies (1:50 in PBS) (The monoclonal antibody against ILTV gC 
was provided by the Institute of Molecular Biology, Friedrich-Loeffler-Institute, 
Federal Research Institute for Animal Health, Boddenblick 5A, 17493 Greifswald-
InselRiems, Germany). Subsequently, after washing, the sections were incubated (1h, 
37°C) with FITC-labelled goat anti-mouse IgG antibodies (Molecular Probes) (1:100 
in PBS). Finally, after washing, the sections were incubated (10min, RT) with 
Hoechst 33342 (1:100 in PBS), washed and mounted with glycerin-DABCO (Janssen 
Chimica).  
3.1.3.7. Evaluation of ILTV mucosal spread  
A confocal microscope (Leica TCS SPE confocal microscope) was used for the 
analysis of ILTV replication in mucosal explants. Solid-state lasers were used to 
excite Texas Red (561 nm) and FITC (488 nm) fluorophores. We have analysed 
replication characteristics of ILTV by a reproducible quantitative analysis system 
described by Glorieux et al. (2009). Briefly, at 24, 48 and 72h pi, the average number 
of plaques were counted in a surface area of 8 mm2 of the explants (150 consecutive 
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cryosections) derived from both trachea and conjunctiva. Using the Leica confocal 
software, plaque dimensions, latitude and invasion depth (distance covered by ILTV 
underneath the BM) were measured at the maximal size for at least 10 different 
plaques per chicken at 0, 24, 48 and 72h pi. Maximum intensity projection (MIP) or 
Extended focus image of the confocal microscope was used to display three-
dimensional information of the plaque. We have excluded borders and edges of the 
explant from analysis, i.e. only middle regions of the explant were considered for 
analysis.   
3.1.3.8. Cell viability in ILTV infected tracheal and conjunctival mucosa 
The TUNEL assay was performed to detect apoptotic cells in infected tracheal and 
conjunctival mucosa explants. Immunofluorescence stainings were performed to 
detect ILTV antigens. The protocol of both techniques is described above. TUNEL-
positive cells were counted at 0, 24, 48 and 72h pi. Two regions of interest were taken 
into account for calculation: (i) regions containing ILTV-negative cells and (ii) 
regions containing ILTV-positive cells (plaque). In an ILTV-negative region, 10 
randomly selected fields of 100 cells were evaluated in both epithelium and lamina 
propria. In ILTV-positive cells region, 10 randomly selected ILTV plaques were 
evaluated in both epithelium and lamina propria. The experiment was performed in 
triplicate. 
3.1.3.9. Statistical analysis 
Sigma Plot (Systat Software, Inc., San Jose, CA) software was used to analyse the 
data statistically for one-way analysis of variance (ANOVA). The results of three 
independent experiments are shown as means ± standard deviation (SD) and P values 
of < 0.05 were considered significant. 
3.1.4. Results 
3.1.4.1. Ciliary beating 
The ciliary beating of the tracheal explants was normal up till the end of the study 
(96h of cultivation).  
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3.1.4.2. Viability of tracheal and conjunctival mucosa explants 
The viability of the tracheal and conjunctival mucosa explants was assessed based on 
the percentage of TUNEL-positive cells. We did not observe a significant increase in 
the number of positive cells at 0, 24, 48, 72 and 96h of in vitro cultivation for both the 
epithelium and the lamina propria (Table 1). The percentage of TUNEL-positive cells 
in the epithelium of trachea and conjunctiva ranged from 0.0 ± 0.0% to 0.9 ± 0.1% at 
0 and 96h, respectively. In the lamina propria of trachea and conjunctiva, the 
percentage of TUNEL-positive cells ranged from 0.0 ± 0.0% to 1.4 ± 1.8% at 0 and 
96h respectively. Negligible TUNEL-positive cells were observed in the tracheal 
cartilage. 
Table 1. Apoptosis in the epithelium and lamina propria of chicken tracheal mucosa 
explants during in vitro cultivation. Values are given for three independent 
experiments as means ± SD. 
 
Tissue Layer % of TUNEL positive cells at … hours of in vitro cultivation 
  0 24 48 72 96 
Trachea Epithelium 0.0 ± 0.0 0.3 ± 0.2 0.3 ± 0.3 0.6 ± 0.2 0.7 ± 1.1 
 Lamina propria 0.0 ± 0.0 0.4 ± 0.2 0.8 ± 0.5 0.9 ± 0.3 1.4 ± 1.8 
Conjunctiva Epithelium 0.0 ± 0.0 0.4 ± 0.3 0.5 ± 0.2 0.7 ± 0.2 0.9 ± 0.1 
 Lamina propria 0.2 ± 0.1 0.7 ± 0.1 0.7 ± 0.2 1.0 ± 0.2 1.2 ± 0.1 
 
3.1.4.3. GaHV1 (ILTV) interactions with tracheal and conjunctival mucosa 
3.1.4.3.1. Evaluation of ILTV mucosal spread - Inoculation of chicken tracheal and 
conjunctival mucosa explants with ILTV led to the formation of viral antigen positive 
plaques (group of closely connected cells) in the mucosa. At 0h, no infection was 
observed. At 24, 48 and 72h pi clear ILTV infected plaques were found in the tracheal 
and conjunctival mucosa. Representative images of plaques at 24h pi are illustrated in 
Figure 1. We have observed ILTV infection only in the epithelial cells. We did not 
observe infection at the edges and ventral region of the cryosections. Dissemination 
kinetics of plaques in the mucosa was evaluated by measuring the plaque number, 
maximal plaque latitude and invasion depth underneath the BM at 0, 24, 48 and 72h 
pi. The viral titers in the supernatant of inoculated explants were increased from 102.7 
EID50/ml at 24h pi to 104.3 EID50/ml 72h pi. 
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Figure 1. Representative confocal photomicrographs illustrating three ILTV-positive 
plaques in the epithelium of tracheal mucosa at 24h pi. Images for individual channels 
are shown on top row from left to right (Cell nuclei is blue, ILTV antigen is green and 
Collagen IV is red fluorescence) and a larger merged image on a down row. 
Colocalization of viral antigen with collagen IV is visualised by yellow color. Scale 
bar represents 50 µm. 
3.1.4.3.2. Plaque Number - Mucosal explants covering a total area of 10 mm2 were 
evaluated using Leica confocal microscope. We have excluded borders and edges of 
the explant for analysis. Results of the average number of plaques are given per 8 
mm2 or per one explant (150 consecutive cryosections). Mean values ± SD are 
represented in Figure 2 for three independent experiments. The number of plaques 
slightly increased in time.  
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Figure 2. The number of plaques was determined at 0, 24, 48 and 72h pi. For each 
chicken, 150 consecutive cryosections were analysed at every time point to count 
plaques. Bars with different letters are significantly different from each other (P < 
0.05). 
3.1.4.3.3. Plaque latitude - Plaque latitudes were measured using Leica confocal 
software. Mean values ± SD are represented in Figure 3a for three independent 
experiments. The plaque latitude increased steadily over time from 0 to 72h pi. In the 
tracheal mucosa the latitude increased from 29.4 ± 9.0 µm (24h pi), to 55.4 ± 5.6 µm 
(48h pi) and 70.4 ± 12.9 µm (72h pi). In the conjunctiva increased from 17.2 ± 3.4 µm 
(24h pi), to 59.8 ± 5.3 µm (48h pi) and 97.8 ± 9.5 µm (72h pi).  
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Figure 3. Evolution of plaque latitude (a) and invasion depth (b) underneath the 
basement membrane at 0, 24, 48 and 72h pi. Data are represented as means of 10 
plaques at maximal size for three different independent experiments ± SD (error bars). 
Bars with different letters are significantly different from each other (P < 0.05). 
 
Chapter 3.1 
	   48 
3.1.4.3.4. Plaque invasion depth - Plaque invasion is the vertical spread of ILTV in 
mucosa. Plaque invasion depth is the distance covered by ILTV-infected tissue 
underneath the BM (Glorieux et al., 2009). Plaque invasion depths were measured 
using Leica confocal software. The evolution of ILTV plaque formation at 0, 24, 48 
and 72h pi in trachea and conjunctiva are illustrated in Figure 4. At 0 and 24h pi, 
infected plaques did not cross the BM. ILTV starts BM invasion slowly, as infected 
plaques only crossed the BM between 24h and 48h pi. At 48h pi, about 31% of the 
plaques showed invasion through the BM of trachea and about 43% of the plaques 
showed invasion through the BM of conjunctiva. At 72h pi, this percentage increased 
to 56% in trachea and 74% in conjunctiva. Mean values ± SD are represented in 
Figure 3b for three independent experiments. The average depths underneath the BM 
increased from 5.1 ± 2.9 µm at 48h pi to 10.3 ± 3.6 µm at 72h pi among all plaques of 
tracheal mucosa. In conjunctival mucosa, the average depths underneath the BM 
increased from 9.6 ± 3.1 µm at 48h pi to 17.6 ± 6 µm at 72h pi among all plaques. 
 
 
 
 
 
 
 
 
 
 
Figure 4. Representative confocal photomicrographs illustrating the evolution over 
time of ILTV induced plaques in tracheal (a) and conjunctival mucosa (b). Green 
fluorescence visualises ILTV antigens. Collagen IV is visualised by red fluorescence. 
Scale bar represents 50 µm.  
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3.1.4.4. Cell viability in ILTV infected tracheal and conjunctival mucosa 
After inoculation with ILTV, a large number of cells were ILTV infected. A small 
number of TUNEL-positive cells were observed in both regions of ILTV-infected and 
non-infected cells (Table 2). In ILTV-infected regions, TUNEL-positive cells were 
usually observed in the vicinity of ILTV-infected cells. ILTV-infected cells were 
mostly not TUNEL-positive. In tracheal and conjunctival epithelium, the percentage 
of ILTV-positive cells that were TUNEL-positive ranged from 0.4 % at 24h to 1.4% 
at 72h pi. A representative confocal image illustrating TUNEL-positive cells in the 
vicinity of ILTV-infected cells but not in the ILTV-infected plaque is given in Figure 
5. 
 
Figure 5. Representative confocal photomicrographs illustrating a small number of 
TUNEL-positive (apoptotic) cells in a region of ILTV-positive cells. Images for 
individual channels are shown on top row from left to right (Cell nuclei is blue, 
Apoptotic cell is green and Viral antigen is red fluorescence) and a larger merged 
image on a down row. TUNEL-positive cells were usually present in the vicinity of 
ILTV-infected cells. ILTV-infected cells were in general not apoptotic. Scale bar 
represents 50 µm. 
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Table 2. Percentage of TUNEL-positive cells in both epithelium and lamina propria 
of a region of ILTV-negative and of a region of ILTV-positive cells (plaque) at 0, 24, 
48 and 72 h post inoculation (pi). Values are given for three independent experiments 
as means ± SD. 
 
Tissue Layer % of TUNEL positive cells at … hours of in vitro cultivation 
  0 24 48 72 
Trachea ILTV− Epithelium 0.4 ± 0.1 0.8 ± 0.2 0.7 ± 0.1 1.3 ± 0.5 
 ILTV
− Lamina 
propria 0.7 ± 0.2 1.1 ± 0.3 1.3 ± 0.2 2.5 ± 1.0 
 ILTV+ Epithelium ND 1.1 ± 0.1 3.9 ± 1.2* 4.2 ± 1.1* 
 ILTV
+ Lamina 
propria ND 5.3 ± 1.2
* 7.1 ± 1.1* 6.4 ± 0.9* 
Conjunctiva ILTV− Epithelium 0.6 ± 0.1 1.0 ± 0.2 0.9 ± 0.3 1.4 ± 0.1 
 ILTV
− Lamina 
propria 1.0 ± 0.2 0.9 ± 0.1 1.6 ± 0.3 2.1 ± 0.4 
 ILTV+ Epithelium ND 1.6 ± 0.2* 4.9 ± 1.5* 3.2 ± 1.3 
 ILTV
+ Lamina 
propria ND 4.9 ± 1.3
* 9.0 ± 2.3 8.3 ± 1.4* 
      
ND = not determined; no ILTV-positive cells were found. 
* Significant differences compared with the control (ILTV negative tissue) at P < 0.05 level.	  
3.1.5. Discussion 
In the present study, (i) chicken tracheal and conjunctival mucosa explants were 
established, (ii) replication kinetics of ILTV were investigated in tracheal and 
conjunctival mucosa and (iii) cell viability was analysed in ILTV infected tracheal and 
conjunctival mucosa explants. 
Even though in vivo laboratory animals are the best system for studying host-pathogen 
interactions, physiological inter-individual differences and different environmental 
conditions are important drawbacks. The use of an in vitro culture offers the opportunity 
to study host-pathogen interactions under more controlled conditions. In cell cultures, 
cell-cell and cell-extracellular matrix interactions are reduced due to the lack of a three-
dimensional architecture of the culture (Freshney, 2005). In vitro explant (organ) 
cultures are excellent alternative models that mimic natural conditions. The in vitro 
explant (organ) cultures are in line with the three Rs principle, i.e. Reduction (reduction 
of number of animals), Replacement (no use of living animals) and Refinement 
(minimizing the pain) (Russell and Burch, 1959). A major advantage of the in vitro 
explant (organ) model is that explants of the same animals can be used to compare 
different viral strains. 
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The culture technique that was used in this study for chicken tracheal and conjunctival 
explants (organs) is similar to that of porcine (Glorieux et al., 2007), bovine (Steukers et 
al., 2012), equine (Vandekerckhove et al., 2009) and human (Glorieux et al., 2011) 
respiratory explants. To our knowledge, there are no reports on the viability of cells in 
the epithelial layers, lamina propria and underlying connective tissue of chicken TOC 
and COC. Hence, in this study the viability of epithelial cells and cells in the lamina 
propria of TOC and COC were evaluated by quantifying TUNEL-positive cells at 0, 24, 
48, 72 and 96h of in vitro cultivation. The TUNEL-positive cells remained below 1.5% 
up to 96h of cultivation in both epithelium and lamina propria of TOC and COC. Thus, 
we can state that TOC and COC were successfully maintained for at least 96h in culture 
at an air-liquid interface without significant changes in tissue viability. 
The chicken tracheal and conjunctival explants were susceptible to an ILTV infection. 
The infection pattern of ILTV in the mucosal explants is mimicking extremely well the 
in vivo observations made by the Bang and Bang (1967). The purpose of the present 
study was to analyse the behavior of ILTV in the mucosa by immunofluorescence and 
mathematical quantitative analysis using confocal microscopy and software Image J, as 
described for the first time by Glorieux et al. (2009). By doing this, a complete three-
dimensional picture of the horizontal and vertical spread of ILTV in the mucosa was 
obtained. This novel approach is an ideal tool for studying cellular and molecular 
aspects of the invasion mechanisms of pathogens (Glorieux et al., 2011; Glorieux et al., 
2009; Steukers et al., 2012; Vandekerckhove et al., 2010). It allows a thorough 
comparison of different alphaherpesvirus replication kinetics in their respective species. 
The ILTV induced plaques were present in the epithelial layer starting from 24h pi. The 
plaque latitude increased in time. The ILTV infected plaques started to cross the 
basement membrane from 48h pi.  
Mucosa explant models of porcine, equine, human and bovine origin were developed in 
our laboratory to study virus-host interactions and mucosal invasion. By using these 
explants, invasion processes of different alphaherpesviruses (EHV1, EHV4, BHV1, 
SHV1 and HSV1) have already been described. Based on their invasion mechanism, 
alphaherpesviruses can be classified into three types: (i) EHV4 shows replication in the 
respiratory epithelial cells without invasion through the BM, (ii) BHV1, SHV1 and 
HSV1 exhibit a plaquewise spread through the BM in the in vitro explant model and 
(iii) EHV1 spreads only laterally and does not breach through the BM (similar to 
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EHV4) but invades deeper tissues of the respiratory tract via infected leukocytes which 
function as Trojan horses (Glorieux et al., 2011; Glorieux et al., 2009; Steukers et al., 
2012; Vandekerckhove et al., 2010). 
When comparing replication kinetics of ILTV in trachea and conjunctiva, we observed 
some interesting findings. At 72h pi, the plaque latitude in the conjunctival mucosa was 
significantly larger compared to that in the tracheal mucosa. The percentage of the 
plaques that penetrated through the BM was larger in conjunctiva (48h pi: 43% and 72h 
pi: 74%) compared to the trachea (48h pi: 31% and 72h pi: 56%). Plaque latitude and 
invasion depth kinetics indicated that at later time points (48 and 72h pi) ILTV showed 
a more extensive replication in conjunctival mucosa compared to the tracheal mucosa. 
The differences in the replication kinetics of ILTV are likely due to variation in its 
tropism for trachea and conjunctiva. Kirkpatrick et al. (2006) observed that there is a 
variation in ILTV in its tropism for trachea or conjunctiva. In the future, the replication 
characteristics of different ILTV strains on mucosal explants may help to understand 
their tropism for trachea and conjunctiva. 
In BHV1, SHV1 and HSV1 infection, the lateral mucosal spread and vertical invasion 
depth evolved similarly with increasing time pi. In the case of ILTV, the invasion 
through the BM was very restricted. At 48h pi 30.9% of the plaques in trachea and 
43.3% of the plaques in conjunctiva were crossing the BM. This finding is in contrast 
with plaques induced by SHV1, HSV1 and BHV1. With SHV1 and HSV1, 100% of the 
plaques crossed the BM at 24h pi (Glorieux et al., 2011; Glorieux et al., 2009). With 
BHV1, 90% of the plaques went through the BM at 48h pi (Steukers et al., 2011). ILTV 
may not have developed enough tools to breach quickly through the BM like BHV1, 
SHV1 and HSV1. The restricted ILTV invasion through the BM agrees with the in vivo 
pathogenesis of ILTV, where no clear evidence exists for viremia (Bagust, 1986; Guy 
and Bagust, 2003). Otherwise, invasion of ILTV through the BM of trachea and 
conjunctiva is evidently corroborated. Indeed, (Zhao et al., 2013) detected ILTV in most 
of the internal organs of infected chickens. 
Although speculative, a hypothesis can be formed to explain the restricted ILTV 
invasion through the BM in chickens compared to the invasion of other 
alphaherpesviruses in their respective species. Viral structural components and BM 
composition should be considered. The structural glycoproteins present on the surface 
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of alphaherpesviruses and alphaherpesvirus-infected cells together with up-regulated 
cellular proteases are putative candidates for helping the virus to cross the BM. Several 
proteolytic enzymes, including trypsin-like proteases, have been shown to break down 
the BM and extracellular matrix and trypsin-like serine protease was found to be 
involved in the SHV1 invasion through the BM (Barrett et al., 2003; Glorieux et al., 
2011). A rapid breakdown of BM components is most probably facilitating the SHV1 
invasion. Alphaherpesviruses use the glycoprotein E/glycoprotein I (gE/gI) complex to 
spread directly from cell to cell through cell junctions (Devlin et al., 2006). In case of 
BHV1, the gE/gI complex also efficiently mediates invasion through the BM (Steukers, 
2013). The involvement of trypsin-like serine proteases and/or gE/gI complex in the 
ILTV invasion needs to be addressed. Characteristics of the BM may also play a role in 
the restricted ILTV invasion. The heterogeneous components in the BM interact and 
form a sheet of fibers. These intermolecular interactions in the BM might be stronger in 
chickens compared to mammals and prevent better the entry of pathogens (Fitch et al., 
1982; LeBleu et al., 2007; Mayne et al., 1982; Mayne and Zettergren, 1980). Several 
questions on why ILTV has problems to cross the BM are still not answered. Do certain 
components or total thickness of the BM play a role in its barrier function against ILTV 
invasion (Steukers et al., 2012)? Or did ILTV not develop a mechanism during 
evolution to invade quickly through the BM? Tracheal and conjunctival mucosal 
explants are ideal tools to address these questions. 
The effect of ILTV on the cell viability of tracheal and conjunctival mucosa was 
analysed by a TUNEL assay. A large number of epithelial cells were ILTV-positive. 
But, only a few ILTV-infected cells were TUNEL-positive, even at 72h pi. Our studies 
are consistent with previous reports demonstrating that low levels of apoptosis were 
observed in cells infected with other alphaherpesviruses HSV2-, SHV1- and HSV1 
(Aleman et al., 2001; Asano et al., 1999; Glorieux et al., 2011). Further, TUNEL-
positive cells were predominantly restricted to the vicinity of ILTV-infected cells. These 
TUNEL-positive cells might be local leukocytes that respond to the productive ILTV 
infection, as seen in SHV1 and HSV2 (Aleman et al., 2001; Asano et al., 1999). Or 
these apoptotic cells may be uninfected bystander cells present in the vicinity of 
infected cells (Aleman et al., 2001). ILTV-infected cells may release some pro-
apoptotic components or cytokines to induce apoptosis. This could be an ILTV strategy 
to sustain the infection in the mucosa. Several publications have shown that 
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alphaherpesviruses (HSV1, HSV2, SHV1 and BHV1) evade the immune system by 
inhibiting apoptosis of infected cells (Aleman et al., 2001; Asano et al., 1999; Galvan 
and Roizman, 1998; Jerome et al., 1999; Winkler et al., 1999). More specifically, 
alphaherpesviruses usually evades natural killer (NK) cell- and T-lymphocyte-
dependent antiviral pathways and maintain the viability of infected cells (Aleman et al., 
2001; Favoreel et al., 2000; Han et al., 2007; Murugin et al., 2011; Orange et al., 2002; 
Winkler et al., 1999). There are reports that ILTV suppresses apoptosis of infected 
primary cells (Burnside and Morgan, 2011; Lee et al., 2012). However, to our 
knowledge there are no reports on the effect of ILTV on apoptosis in infected cells of 
tracheal and conjunctival mucosae. Therefore, our current in vitro study indicates that 
ILTV blocks apoptosis in infected epithelial cells of tracheal and conjunctival mucosa. 
Furthermore, it may induce apoptosis of neighboring uninfected cells. Usually viruses 
alter host immune responses to their benefit. It may protect infected cells against an 
attack by the immune system. This allows infected epithelial cells to survive long 
enough to support replication. Further, surviving epithelial cells may ensure that virus 
could breach the BM, reach the lamina propria and finally enhance mucosal invasion in 
the infection process. By doing this ILTV may easily reach sensory nerves and the 
trigeminal ganglion, the site of latency. All these mechanisms help ILTV to sustain life-
long infection. The exact viral factors involved in the inhibition of apoptosis of infected 
cells and the activation of apoptosis in the surrounding cells will be identified in the 
near future. 
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Presence of DNA extracellular traps but not MUC5AC and MUC5B 
mucin in mucoid plugs/casts of infectious laryngotracheitis virus 
(ILTV) infected tracheas of chickens 
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3.2.1. Abstract 
Although it has been speculated that the tracheal obstructions and asphyxiation during 
acute infectious laryngotracheitis (ILT) are due to mucoid plugs/casts formed by 
mucus hypersecretion, there are no reports demonstrating this. Hence, in the present 
study, we first examined if the main respiratory mucins, MUC5AC and MUC5B, are 
expressed in the mucosae of larynx, trachea and bronchi of mock-inoculated and 
ILTV infected chickens. Second, the tracheas with plugs/casts were stained for 
mucins (MUC5AC and MUC5B) and nuclear material (traps). MUC5AC and 
MUC5B were produced by the mucosae of larynx, trachea and bronchi of mock-
inoculated chickens. Interestingly, MUC5AC and MUC5B were exclusively present 
in the dorsal tracheal region of the cranial and middle part of trachea of mock-
inoculated chickens. In ILTV infected chickens, the tracheal lumen diameter was 
almost 40% reduced and was associated with a strongly increased tracheal mucosal 
thickness. MUC5AC and MUC5B were scarcely observed in larynx, trachea and 
bronchi, and in tracheal plugs/casts of ILTV infected birds. Surprisingly, DNA 
fibrous structures were observed in connection with nuclei of 10.0 ± 7.3% cells, 
present in tracheal plugs/casts. Upon inoculation of isolated blood heterophils with 
ILTV, DNA fibrous structures were observed in 2.0 ± 0.1% nuclei of ILTV 
inoculated blood heterophils at 24 hours post inoculation (hpi). In conclusion, the 
tracheal obstructions and suffocation of ILTV infected chickens are due to a strong 
thickening of the mucosa (inflammation) resulting in a reduced tracheal lumen 
diameter and the presence of mucoid plugs/casts containing stretched long DNA-
fibrous structures (traps) but not MUC5AC and MUC5B mucins. 
3.2.2. Introduction  
Avian infectious laryngotracheitis virus remains a threat to the worldwide commercial 
poultry industry by decreased egg production, delayed growth and mortality (Fuchs et 
al., 2007). ILTV belongs to the order Herpesvirales, family Herpesviridae, subfamily 
Alphaherpesvirinae and genus Iltovirus (Davison, 2010). ILTV replicates in the 
epithelial cell of the larynx, trachea, and conjunctiva mucosae, and invades 
underlying layers in a restricted manner (Garcia et al., 2013; Reddy et al., 2014). 
ILTV is usually highly cytolytic in the larynx and trachea mucosae, which may lead 
to severe mucosal epithelial damage and hemorrhages. The above pathological 
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changes cause the typical ILT clinical signs: coughing, nasal discharge, and 
conjunctivitis during a mild form and marked dyspnea, gasping, open mouth 
breathing and expectoration of bloody mucoid material during a severe form (Bagust 
et al., 2000; Garcia et al., 2013). Mucoid casts/plugs in the trachea obstruct airways 
and predispose chickens to die due to asphyxiation (Bagust et al., 2000; Linares et al., 
1994).  
After an acute laryngotracheitis infection, ILTV can establish a lifelong latency in the 
trigeminal ganglion of the central nervous system (Garcia et al., 2013). Stress during 
rehousing with unfamiliar birds and onset of egg production cause sporadic 
reactivation followed by active replication of ILTV and horizontal transmission of 
ILTV to susceptible contact animals (Bagust et al., 2000; Fuchs et al., 2007). 
Mucus is a viscoelastic and biopolymeric hydrogel, which coats the moist non-
keratinized surface of mucosa. Mucus serves as a major protective layer on the 
mucosa, by forming a semipermeable barrier that enables the exchange of nutrients, 
gases and water, while being impermeable to most pathogens/foreign particles 
(Vareille et al., 2011; Yang et al., 2012). The mucus layer thickness differs among the 
species, location in the respiratory tract and health status. The major components of 
respiratory mucus are mucins. Up till now, at least 9 mucin genes have been reported 
in human airway mucus, with MUC5AC and MUC5B being the major gel forming 
mucins (Corfield, 2015). Mucin types may changeduring disease (Rose and Voynow, 
2006) and many respiratory viruses stimulate mucus production in respiratory mucosa 
(Vareille et al., 2011). During an acute ILTV infection, mucoid plugs/casts are 
formed in the trachea and obstruction may lead to chicken mortality (Linares et al., 
1994). It has been postulated that the mucoid plugs/casts are formed due to mucus 
hypersecretion, however there are no hard data proving this (Garcia et al., 2013; 
Linares et al., 1994). 
In the present study, first we examined the expression of MUC5AC and MUC5B in 
the mucosae of larynx, trachea and bronchi of the mock-inoculated and ILTV infected 
chickens by immunofluorescence staining. Second, the tracheal lumen diameter and 
mucosal thickness were compared between the mock-inoculated and ILTV infected 
chickens to understand their role in obstruction of the trachea. Third, tracheas with 
mucoid plugs/casts from euthanized ILTV infected chickens showing respiratory 
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distress were stained for MUC5AC and MUC5B and for DNA fibrous structures 
(extracellular network). Finally, the effect of ILTV on the formation of DNA fibrous-
like structures from nuclei of blood heterophils was analyzed (Chuammitri et al., 
2009; Cortjens et al., 2016; Funchal et al., 2015; Goldmann and Medina, 2012; 
Raftery et al., 2014; Zawrotniak and Rapala-Kozik, 2013). 
3.2.3. Materials and Methods 
3.2.3.1. ILTV (U76/1035) inoculation 
Six 12 weeks specific pathogen free (SPF) White Leghorn chickens were individually 
tagged and housed in two experimental rooms. Drinking water and feed were 
provided ad libitum. A pathogenic Belgian isolate of ILTV (U76/1035) was used in 
this study (Meulemans and Halen, 1978; Reddy et al., 2014). Before the start of the 
experiment, an acclimatization period of one-week was respected. At the age of 13 
weeks, three chickens (group 1) were inoculated with the virulent ILTV (U76/1035) 
via intratracheal (300 µl), nasal (50 µl each nostril) and ocular routes (50 µl each eye) 
with 104 EID50/500 µl. The second group of three animals was mock-inoculated with 
PBS and served as non-infected control. This study was in agreement with the 
guidelines of the Local Ethical and Animal Welfare Committee of the Faculty of 
Veterinary Medicine of Ghent University (EC 2015/81). 
3.2.3.2. Clinical signs  
Clinical signs were recorded daily until 5 days post inoculation (dpi), with special 
emphasis on bird breathing. 
3.2.3.3. Euthanasia and collection of mock-inoculated and ILTV infected larynx, 
trachea and bronchi, and ILTV infected trachea with mucoid plugs/casts 
Larynx, trachea and bronchi were collected from three mock-inoculated (5 dpi) and 
three ILTV infected chickens (5 dpi). Equal sized tissues were prepared, embedded in 
Methocel® (Fluka) and frozen at -70°C. 
In order to have a good yield of mucoid plugs/casts in ILTV infected tracheal mucosa, 
chickens were humanely euthanized when they showed marked gasping and open 
mouth breathing with an extended neck (5 dpi). During necropsy, tracheas with 
mucoid plugs/casts were collected in a gelatin capsule (size 000, Nova, Belgica 
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T.O.P. nv). The schematic procedure for collecting tracheas with mucoid plugs/casts 
from ILTV infected chickens is illustrated in Figure 1. Briefly, a trachea containing a 
mucoid plug/cast was placed vertically in a gelatin capsule. The gelatin capsule with 
trachea containing a mucoid plug/cast was immediately embedded in Methocel® in 
plastic tubes (Fluka) and were snap frozen for immunofluorescence staining. 
 
Figure 1. Schematic procedure of the collection of ILTV infected trachea with 
mucoid plug/cast in a gelatin capsule and of the evaluation of the results. A trachea 
containing a mucoid plug/cast was placed vertically in a gelatin capsule. The gelatin 
capsule with a trachea containing a mucoid plug/cast was immediately embedded in 
Methocel® and snap frozen. Cross-cryosections were made and processed for the 
detection of MUC5AC/MUC5B and ILTV antigens by immunofluorescence and for 
the detection of DNA fibrous structures by Hoechst staining. 
3.2.3.4. Immunofluorescence staining for MUC5AC and MUC5B in laryngeal, 
tracheal and bronchial mucosae of mock-inoculated chickens 
Immunofluorescence staining was performed to determine MUC5AC and MUC5B 
secretion in the mucosae of larynx, trachea and bronchi of mock-inoculated chickens. 
Cryosections of 10 µm were made from larynx, trachea and bronchi, fixed in 4% 
paraformaldehyde for 20 min at 4°C and permeabilized in 0.1% Triton® X-100 for 10 
min at room temperature. For MUC5AC staining, the sections were incubated with 
mouse anti-MUC5AC monoclonal IgG1 antibodies as primary antibody (45M1, 
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LifeSpan Biosciences, 1:100) and FITC labeled goat anti-mouse IgG polyclonal 
antibodies as secondary antibody (Molecular Probes, 1:200). For MUC5B staining, 
the sections were incubated with rabbit anti-MUC5B polyclonal antibodies as primary 
antibody (H-300, Santa Cruz Biotechnology, 1:100) and FITC labeled goat anti-rabbit 
IgG polyclonal antibodies as secondary antibody (Molecular Probes, 1:200). All 
antibodies were diluted in 10 mM phosphate buffer saline (PBS) and incubated for 1 h 
at 37°C. Two washings with PBS (10 min/each) were performed after each incubation 
step. The nuclei were counterstained with Hoechst 33342 (Molecular Probes, 1:100) 
for 10 min at room temperature. The sections were then washed twice and mounted 
with glycerin-DABCO (Sigma). 
3.2.3.5. Immunofluorescence staining for MUC5AC/MUC5B and ILTV in 
laryngeal, tracheal and bronchial mucosae, and trachea with mucoid plugs/casts 
of ILTV infected chickens  
Cryosections of 10 µm were made from ILTV infected larynx, trachea and bronchi, 
and trachea filled with mucoid plugs/casts. ILTV infected laryngeal, tracheal and 
bronchial mucosae and trachea with mucoid plugs/casts were visualized for 
MUC5AC, MUC5B and ILTV using the same technique as for the cryosections of 
laryngeal, tracheal and bronchial mucosae of mock-inoculated chickens. To visualize 
ILTV infection in laryngeal, tracheal and bronchial mucosae and trachea with mucoid 
plugs/casts, cryosections were incubated with mouse monoclonal anti-ILTV gC 
antibodies as primary antibody (1:50) (kindly provided by Walter Fuchs, Institute of 
Molecular Biology, Friedrich-Loeffler-Institute, Federal Research Institute for Animal 
Health, Greifswald-Insel Riems, Germany) and FITC labeled goat anti-mouse IgG 
polyclonal antibodies as secondary antibody (Molecular Probes, 1:100). To determine 
if mucin-producing cells were infected with ILTV, double immunofluorescence 
stainings were performed for MUC5B and ILTV. Hoechst was used to visualize cell 
nuclei. A confocal microscope (Leica TCS SPE confocal microscope) was used for 
the analysis of the presence of mucin and ILTV infected cells in laryngeal, tracheal 
and bronchial mucosae and trachea with mucoid plugs/casts.  
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3.2.3.5.1. Measurement of the diameter of tracheal lumen and the thickness of 
tracheal mucosa 
The tracheal lumen diameter and mucosal thickness were evaluated in the mock-
inoculated and ILTV infected chickens by using a confocal microscope. The epithelial 
layer and lamina propria layer were measured as mucosal thickness (Nunoya et al., 
1987). Ten randomly selected regions were considered for measurement in each 
chicken. The measurement was performed in tracheal rings of three mock-inoculated 
and three ILTV infected chickens. Student’s t-test was used to compare the diameter 
of the tracheal lumen and the tracheal mucosal thickness between ILTV infected and 
control groups (M ± SD, n=3). 
3.2.3.6. Isolation of blood heterophils, inoculation of ILTV and immunostaining 
Five ml blood was collected on heparin (15 IU/ml) (Leo) from the brachial wing vein 
of chickens. Heterophils were isolated from chicken whole blood by 
PolymorphprepTM gradient centrifugation as described by the manufacturer (Nycomed 
pharma). Polymorphonuclear cells were resuspended in RPMI-1640 (Gibco) medium 
containing 10% fetal calf serum (FCS, Gibco), 100 U/ml penicillin (Continental 
Pharma), 0.1 mg/ml streptomycin (Certa), 1 µg/ml gentamycin (Gibco), and 1% non-
essential amino acids (Gibco). Heterophil’s viability was determined with 0.1% 
trypan blue and heterophil’s morphology was analysed using Diff-Quick stained 
cytospin preparations of cell suspensions. Mean viability of the isolated heterophils 
was 98.0 ± 1.7% (range between 96 and 99%, n=3). Mean purity of the heterophils 
was 95.7 ± 1.5% (range between 94 and 97%, n=3). Afterwards, 2×106 cells/ml were 
seeded in a 24-well plate (Nunc) and cultivated at 37°C with 5% CO2. After one hour 
of cultivation, polymorphonuclear cells were inoculated with ILTV at a multiplicity 
of infection (m.o.i.) of 0.5. After 1 h of incubation (37°C, 5% CO2), cells were 
washed two times with warm RPMI-1640 medium. Cells were collected at 0, 12 and 
24 hpi to make cytospins, and were visualized for ILTV using the same technique as 
for the cryosections of tracheas with mucoid plugs/casts. The nuclei were 
counterstained with Hoechst. All experiments were performed in triplicate. 
Immunostainings were analysed by confocal microscopy.  
Chapter 3.2 
 66 
3.2.4. Results 
3.2.4.1. Clinical signs and euthanasia 
After ILTV inoculation, one chicken showed coughing at 2 dpi, and two chickens 
showed mild gasping at 3 dpi. At 4 dpi, all three chickens showed mild gasping and 
open mouth breathing. At 3 and 4 dpi, chickens were still active. Appetite of the 
ILTV infected chickens was normal until 4 dpi. Only at 5 dpi, severe gasping, marked 
dyspnea, expectoration of mucus and open mouth breathing with an extended neck 
were observed in all three ILTV inoculated chickens. Chickens were euthanized at 5 
dpi. At necropsy, intraluminal mucoid plugs/casts were observed that completely 
filled the trachea of ILTV infected chickens (Figure 2C). None of the mock-
inoculated chickens showed clinical signs during the whole experiment. Mucoid 
plugs/casts were not observed in tracheal lumen of mock-inoculated chickens (Figure 
2A). 
 
Figure 2. Representative macroscopic picture and confocal photomicrographs of a 
mock-inoculated trachea (A and B) and an ILTV infected trachea with an intraluminal 
mucoid plug/cast (C and D) after euthanasia (5 dpi). (A) Tracheal ring from a mock-
inoculated chicken, free of plugs. (B) MUC5AC was exclusively distributed (arrows) 
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in the dorsal region of the trachea. (C) Tracheal ring from a chicken at 5 days post 
ILTV inoculation; note the obstruction with a jelly plug. (D) Epithelial cell layer was 
almost completely destroyed, submucosa was swollen and mucins were hardly 
observed in ILTV infected tracheal mucosa and mucoid plugs/casts. Green 
fluorescence visualises MUC5AC (arrows). Cell nuclei were stained with Hoechst 
(blue). 
3.2.4.2. MUC5AC and MUC5B production in laryngeal, tracheal and bronchial 
mucosae of mock-inoculated chickens 
MUC5AC and MUC5B were produced by the epithelial cells of laryngeal, tracheal 
and bronchial mucosae of mock-inoculated chickens. More MUC5B was produced 
compared to MUC5AC in laryngeal, tracheal and bronchial mucosae of mock-
inoculated chickens (Table 1). The MUC5AC and MUC5B protein domain 
organization is similar between humans and chickens and therefore the affinity is 
predicted to be similar (Lang et al., 2006). In our laboratory, MUC5AC and MUC5B 
immunofluorescence staining was compared simultaneously with respiratory mucosae 
of chickens, humans and pigs (Yang, 2015). MUC5AC production was higher than 
that of MUC5B in the respiratory tract of humans and pigs whereas the situation was 
reversed in chickens (Kirkham et al., 2002; Rose and Voynow, 2006; Yang, 2015).  
Table 1. MUC5AC and MUC5B expression in the normal and ILTV infected 
respiratory mucosa, and ILTV infected mucoid plugs/casts. 
Infection status Tissue/casts 
Immunofluorescence score* 
MUC5AC MUC5B 
Mock-infected 
Larynx (dorsal mucosa) ++ +++ 
Trachea (dorsal mucosa) ++ +++ 
Bronchi +/- ++ 
ILTV 
Larynx +/- +/- 
Trachea +/- +/- 
Bronchi +/- +/- 
Mucoid plugs/casts +/- +/- 
    
Score for Positive cells *: +/- <1% of the cells; + 1-5%; ++ 6-15%; +++ 16-30%; 
++++ >30% 
In general, MUC5AC and MUC5B production was higher in larynx and trachea than 
in bronchi (Table 1). Representative confocal images of the production of MUC5AC 
and MUC5B in tracheal mucosa of mock-inoculated chickens are illustrated in Figure 
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3. Interestingly, MUC5AC and MUC5B were exclusively distributed in the dorsal 
tracheal region of the tracheal mucosa. The dorsal distribution of MUC5AC and 
MUC5B was predominantly observed in the cranial and middle part of the trachea. In 
the caudal part of the trachea, MUC5AC and MUC5B were distributed in lateral and 
ventral sides along with dorsal distribution. A representative confocal image of 
MUC5AC distribution in the dorsal region of the cranial tracheal ring is presented in 
Figure 2B. 
 
Figure 3. Confocal photomicrographs illustrating the production of MUC5AC and 
MUC5B in tracheal mucosa of mock-inoculated chicken. MUC5B production was 
higher compared to MUC5AC. Green fluorescence visualises MUC5AC and 
MUC5B. Cell nuclei were stained with Hoechst (blue). 
3.2.4.3. Immunofluorescence staining for MUC5AC/MUC5B and ILTV in 
laryngeal, tracheal and bronchial mucosae, and trachea with mucoid plugs/casts 
of ILTV infected chickens 
ILTV infected laryngeal, tracheal and bronchial mucosae, and trachea with mucoid 
plugs/casts were stained for MUC5AC, MUC5B and ILTV. Immunofluorescence 
staining showed that the epithelial cell layer was desquamated (Figure 2D). The 
epithelial and lamina propria layers were observed to be swollen in ILTV infected 
tracheal mucosa, and that was suggestive of marked tracheal edema, congestion and 
thickened tracheal mucosa (Figure 2B and 2D). Thus, the tracheal lumen diameter and 
mucosal thickness were measured to address differences between control and ILTV 
infected groups.  
DNA extracellular traps but not MUC5AC and MUC5B in ILTV mucoid plugs/casts  
 69 
3.2.4.3.1. Measurement of the diameter of the tracheal lumen and the thickness 
of tracheal mucosa 
The tracheal lumen diameter and mucosal thickness were measured using Leica 
confocal software (Figure 4). The mean diameter for the ILTV infected group was 
1318.8 ± 24.3 µm, while for the control group the diameter was 2010.2 ± 62.9 µm. 
The mean tracheal mucosal thickness on top of the cartilaginous layer for the ILTV 
infected group was 685.5 ± 55.5 µm, whereas that for the control group thickness was 
105.1 ± 4.0 µm. The tracheal lumen diameter and the mucosal thickness were 
significantly different between the infected and control groups (P < 0.05). 
 
Figure 4. The diameter of the tracheal lumen and the mucosal thickness. The 
diameter of tracheal lumen and the tracheal mucosal thickness were evaluated from 
ILTV infected and control chickens. Mean and standard deviation (SD) are shown for 
each group. An asterisk (*) indicates statistically significant difference (P < 0.05) 
between ILTV infected and control groups. 
3.2.4.3.2. MUC5AC and MUC5B were scarce in ILTV infected laryngeal, 
tracheal and bronchial mucosae, and trachea with mucoid plugs/casts 
MUC5AC and MUC5B were sparsely observed in the ILTV infected laryngeal, 
tracheal and bronchial mucosae, and trachea containing mucoid plugs/casts (Table 1, 
and Figure 2D and 5). Further, ILTV infected cells were hardly observed in laryngeal, 
tracheal and bronchial mucosae, and were not observed in the trachea containing 
mucoid plugs/casts. Surprisingly, the nuclei of 10.0 ± 7.3% of the cells contained 
DNA fibrous-like structures linked with the nucleus in the mucoid plugs/casts. The 
DNA fibrous-like structures in the mucoid plugs/casts were identified as stretched 
long DNA fibrous threads of 17.8 ± 6.5 µm in length (Figure 6). These DNA fibrous 
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structures originated from nuclei and protruded beyond the cell margins in the 
environment. The DNA fibrous-like structures connected to nuclei of ILTV infected 
trachea with mucoid plugs/casts were very similar to extracellular networks of DNA 
as reported by Chuammitri et al. (2009), Goldmann and Medina, (2012), Zawrotniak 
and Rapala-Kozik (2013), Raftery (2014), Funchal (2015) and Cortjens (2016) in 
neutrophils and heterophils. The percentage of DNA fibrous-like structures was 
determined in 10 randomly selected fields of 300 cells that were present in mucoid 
plugs/casts. The DNA fibrous-like structures were mainly present at the periphery of 
the mucoid plugs/casts (in the area of desquamated epithelial layer). The DNA 
fibrous-like structures were not observed in mock-inoculated chickens. 
 
Figure 5. Immunofluorescence of MUC5AC and MUC5B in the trachea with mucoid 
plugs/casts of ILTV infected chickens. MUC5AC and MUC5B were scarcely present 
in the trachea with mucoid plugs/casts of ILTV infected chickens. Green fluorescence 
visualises MUC5AC and MUC5B. Cell nuclei were stained with Hoechst (blue). 
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Figure 6. . Fluorescent images taken by means of confocal microscopy from nuclei of 
trachea with mucoid plugs/casts of ILTV infected chickens at 5 dpi. DNA fibrous-like 
structures from nuclei of trachea with mucoid plugs/casts were present (arrows). Cell 
nuclei were stained with Hoechst (blue). 
We have hypothesized that cells showing these DNA fibrous-like structures in the 
mucoid plugs/casts could be immune cells, especially macrophages and heterophils. 
Hence, the KUL01 marker (marker for monocytes and macrophages) was used to 
check the cell type that shows DNA fibrous-like structures in the mucoid plugs/casts. 
These cells were not monocytes/macrophages. Further, ILTV interactions were 
evaluated in peripheral blood mononuclear cells (PBMCs). The DNA fibrous-like 
structures were not observed in ILTV inoculated PBMCs. Currently, there are no 
markers available specific for heterophils of chickens. Therefore, it was not possible 
to check whether the DNA fibrous-like structures were formed by heterophils in the 
trachea containing mucoid plugs/casts. As an alternative, an ILTV inoculation 
experiment with isolated blood heterophils was performed. 
3.2.4.4. DNA fibrous-like structures from nuclei of ILTV inoculated blood 
heterophils 
The percentage of heterophils with DNA fibrous-like structures was determined in 10 
randomly selected fields of ILTV inoculated blood heterophils. At 24 hpi, only 2.0 ± 
0.1 % nuclei of ILTV inoculated blood heterophils showed DNA fibrous-like 
structures, suggesting that heterophils are most probably not the only cells that have 
DNA fibrous structures in tracheas containing mucoid plugs/casts. These structures 
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were not observed at 0 and 12 hpi, and in the control heterophils (Figure 7). We have 
started to work on the role of other cell types in the formation of DNA fibrous-like 
structures in tracheas with mucoid plugs/casts. The results of that work will be 
published in a future paper. 
 
Figure 7. Confocal photomicrographs of mock-inoculated (A) and ILTV inoculated 
heterophils (B). Mock-inoculated blood heterophils with segmented nuclei. DNA 
fibrous-like structures from nuclei of ILTV inoculated blood heterophils were similar 
to neutrophil/heterophil extracellular networks (arrows). Green fluorescence 
visualises ILTV antigens taken up by the heterophils. Cell nuclei were stained with 
Hoechst (blue). 
3.2.5. Discussion 
During acute ILTV infection, the formation of mucoid plugs/casts in the trachea is the 
main cause for asphyxiation and mortality in chickens (Linares et al., 1994). Although 
it has been postulated that the trachea obstruction is due to mucus hypersecretion 
(Garcia et al., 2013; Linares et al., 1994), there are no published reports supporting 
this hypothesis. Thus, we wished to determine if there is any change of mucin 
secretion in ILTV infected animals leading to plugs/casts in the lumen of the trachea. 
MUC5AC and MUC5B mucins were extensively produced in the superficial 
epithelium of laryngeal, tracheal and bronchial mucosae of mock-inoculated chickens. 
This is in line with the respiratory mucosa of humans and pigs (Kirkham et al., 2002). 
MUC5B expression was more pronounced than that of MUC5AC in laryngeal, 
tracheal and bronchial mucosae of mock-inoculated chickens, which is opposite to the 
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situation in humans and pigs (Kirkham et al., 2002; Rose and Voynow, 2006; Yang, 
2015). The mucin MUC5AC and MUC5B production was higher in larynx and 
trachea compared to bronchi. In evolution, the innate defense mechanism of mucins at 
larynx and trachea, may be anatomically more relevant and necessary to protect 
against initial entry and interactions of pathogens/foreign substances than at bronchi. 
This could be the main reason for the higher expression of mucin secretory glands in 
larynx and trachea than in bronchi. 
An important observation of this study was that the MUC5AC and MUC5B mucins 
were only present at the dorsal tracheal region of the cranial and middle tracheal 
mucosa. This property may have been developed in evolution to restrict the entry of 
pathogens/foreign substances via dorsal surface, the area where the air has the largest 
impact on the mucosa. When the pathogens naturally enter through the respiratory 
route, they may directly hit the dorsal surface of the mucosa, where they can attach 
and invade. In evolution, to block the initial entry of pathogens, the mucosa may have 
developed mucus secretory goblet cells at the dorsal surface. ILTV may have infected 
mainly the areas without mucus secretory goblet cells (lateral and ventral areas). 
Earlier in our laboratory, Yang et al. (2012 and 2015) have reported that MUC5AC 
producing tracheal epithelial cells were resistant to alphaherpesvirus of pigs, and 
alphaherpesvirus mobility was fully blocked in porcine tracheal respiratory mucus. In 
addition, in chickens we have observed that MUC5B producing primary tracheal 
epithelial cells were not susceptible to ILTV infection (data not shown). Therefore, 
we have indicated that ILTV infection may have occurred mainly in non mucin 
secreting lateral and ventral areas of cranial and middle tracheal mucosa of chickens 
(Yang, 2015). 
In ILTV infected chickens, the tracheal mucosa thickness was nearly 6.5 times higher 
compared to the tracheal mucosa thickness of control chickens, and which is the main 
reason for almost 40% reduced diameter of the lumen in infected trachea. The 
important factors behind the increased tracheal mucosal thickness are most probably 
marked congestion, severe edema and massive infiltration of heterophils, 
macrophages, lymphocytes and plasma cells in the mucosa and submucosa (Devlin et 
al., 2006; Garcia et al., 2013; Hayashi et al., 1985). Thus, the present study strongly 
corroborates that the increased mucosal thickness and its associated reduced tracheal 
lumen is one of the important reason for the obstruction of the trachea at 5 dpi of 
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ILTV causing severe respiratory problems. In the past, many studies have reported 
that respiratory infection or inflammation is associated with increased mucosal 
thickness (Bowden et al., 1996; Kita et al., 2009; Nunoya et al., 1987; Sajjan et al., 
2004). The mucosal thickness measuring is an established system for determining the 
degree of tracheal infection in Mycoplasma gallisepticum infections of chickens 
(Gaunson et al., 2000; Nunoya et al., 1987; Sprygin et al., 2011; Zaki et al., 2004). 
Devlin et al. (2006) used the tracheal mucosal thickness to evaluate the virulence of 
ILTV. 
Mucin production was sparsely observed in the ILTV infected mucosa. The results 
presented here are somewhat in contrast with another study, where hypertrophic 
goblet cells were observed in the mucosa at 5 dpi with a low virulent ILTV strain 
(A4557-5) (Russell, 1983). The strain used, virulence of virus, experimental design 
and conditions, intercurrent infections and detection techniques may explain this 
discrepancy in mucin secretion. 
MUC5AC and MUC5B mucins were scarcely present in the trachea-mucoid 
plugs/casts, which does not fit with the assumption that the mucoid plugs/casts are 
associated with mucus hypersecretion (Garcia et al., 2013; Linares et al., 1994). The 
gel that was present in the ILTV infected tracheae may be explained by the release of 
a DNA network. Indeed, DNA fibrous-like structures were present in 10% of the cells 
in the trachea-mucoid plugs/casts. These structures were very similar to the 
extracellular networks of neutrophils/heterophils (Chuammitri et al., 2009; Cortjens et 
al., 2016; Funchal et al., 2015; Goldmann and Medina, 2012; Raftery et al., 2014; 
Zawrotniak and Rapala-Kozik, 2013). A network of DNA may form a jelly substance. 
The scarce presence of mucin in the trachea-mucoid plugs/casts, and presence of 
extracellular networks like DNA fibrous structures in the nuclei of the trachea-mucoid 
plugs/casts of ILT is in line with what has been shown with the sputum and mucus of 
cystic fibrosis patients (Henke et al., 2004; Lethem et al., 1990; Rubin, 2007). In this 
sputum and mucus, the DNA source has been reported to be from neutrophils. The 
extracellular DNA network was shown to be associated with bacterial colonization 
(Henke et al., 2004; Lundgren and Baraniuk, 1992; Rahman and Gadjeva, 2014). 
Further, the DNA was reported to give high adhesive and viscoelastic properties to 
sputum and mucus of cystic fibrosis patients (Lethem et al., 1990; Zawrotniak and 
Rapala-Kozik, 2013). Similarly, during ILT infection, we have observed that the 
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trachea-mucoid plugs/casts were highly adhesive and viscoelastic (data not shown), 
and the DNA fibrous-like structures may be at the basis of this property. 
Usually, an extracellular DNA network is a defense mechanism of host cells towards 
pathogenic microorganisms (Goldmann and Medina, 2012). The extracellular network 
during an acute ILTV infection may also be a strategy to control virus replication and 
eliminate the virus in the respiratory mucosa. The formation of an extracellular DNA 
network generally starts with the loss of the tight organization of the nuclei followed 
by chromatin decondensation. Then, the characteristic shape of nuclei disappears and 
chromatin leaks into the cytoplasm. Finally, antimicrobial proteins absorb to the 
decondensed chromatin, and becomes released DNA into the extracellular milieu 
(Chuammitri et al., 2009; Goldmann and Medina, 2012). Up till now, 
heterophils/neutrophils, mast cells and macrophages have been reported to release 
extracellular networks to trap and kill viruses, bacteria, fungi and parasites (Bruns et 
al., 2010; Chow et al., 2010; Goldmann and Medina, 2012; Linch et al., 2009; 
Lippolis et al., 2006; Saitoh et al., 2012; von Kockritz-Blickwede et al., 2008; 
Yousefi et al., 2008). During an acute ILTV infection, the decondensed DNA fibrous 
structures may be released either from infiltrated heterophils/other immune cells or 
from desquamated epithelial cells of the respiratory mucosa (Bagust et al., 2000; 
Linares et al., 1994). The decondensed DNA fibrous structures may trap cellular 
debris, proteins, lipids, cations and other non-mucin components, which may have 
been released due to hemorrhages and necrosis of the mucosa during acute ILT 
(Garcia et al., 2013; Lethem et al., 1990; Linares et al., 1994). A DNA network with 
these trapped substances form together a jelly plug in the trachea and obstruct normal 
airways of chickens, and may cause asphyxiation. 
In cystic fibrosis cases, aerosolized deoxyribonuclease I (DNase I, Dornase Alfa) has 
been effectively used to treat sputum/mucus casts containing DNA fibrous structures 
(Rogers, 2007; Shak, 1995; Shak et al., 1990). Thus, aerosol administration of DNase 
I could be helpful to alleviate the dyspnea, gasping, open mouth breathing and 
suffocation during an ILTV infection. Further, mucoactive agents such as mucolytics, 
expectorants and mucokinetics will not be useful to reduce clinical signs of acute ILT 
disease (Rogers, 2007).  
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Secretory mucins such as MUC5AC, MUC5B and MUC2 and membrane-tethered 
mucins such as MUC1 and MUC4 have been reported to contribute to the innate 
immune defense and mucociliary clearance in airways of healthy humans (Rose and 
Voynow, 2006). In chronic airway diseases of humans, MUC5AC, MUC5B, MUC8 
and MUC2 mucins have been identified in the sputum samples (Rose and Voynow, 
2006). There are fewer reports on the presence of other secretory and membrane-
tethered mucins in airways of healthy and diseased chickens, except for MUC5AC 
and MUC5B. In chickens, there are only a few reports available that demonstrate the 
presence of several mucin genes based on prediction with bioinformatics tools 
(MUC2, MUC4, MUC6, MUC13 and MUC16) and mRNA gene expression studies 
(MUC2) (Fan et al., 2015; Lang et al., 2006). However, the functional roles of these 
mucins were still unknown (Fan et al., 2015; Lang et al., 2006; Rose and Voynow, 
2006). Currently, there are antibodies available only against MUC5AC and MUC5B 
mucins but not against other secretory and membrane-tethered mucins of airways of 
chickens. Thus, the presence of other than MUC5AC and MUC5B mucin types 
cannot be excluded in laryngeal, tracheal and bronchial mucosae of healthy and ILTV 
infected chickens, and in tracheas containing mucoid plugs/casts of ILTV infected 
chickens. 
Mucoid plug/cast formation with asphyxiation is mainly associated with ILT, when 
compared with other avian respiratory diseases such as Infectious bronchitis, 
Newcastle disease, Influenza (H9N2 is an exception) and Mycoplasma gallisepticum 
(Bagust et al., 2000; Garcia et al., 2013; Linares et al., 1994; Nili and Asasi, 2002; 
Wu et al., 2008). The specific activation of DNA fibrous structure formation during 
ILT may be the main reason for this difference. In the future, the molecular 
mechanism will be unraveled. 
In summary, MUC5AC and MUC5B were the gel-forming mucins produced by the 
epithelium of laryngeal, tracheal and bronchial mucosae of mock-inoculated chickens. 
The presence of other mucin types in healthy airways of chickens cannot be excluded. 
MUC5AC and MUC5B were present only in the dorsal tracheal region of the cranial 
and middle part of the tracheal mucosa of mock-inoculated chickens. Tracheas with 
mucoid plugs/casts of ILTV infected chickens contained DNA fibrous structures 
connected with nuclei but not MUC5AC and MUC5B mucins. The absence of other 
mucin types cannot be stated in the airways and tracheas with mucoid plugs/casts of 
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ILTV infected chickens. Taken together, the tracheal obstructions and suffocation of 
ILTV infected chickens were associated with the presence of DNA fibrous structures 
connected with nuclei of cells in tracheas containing mucoid plugs/casts, which 
together with the swelling of the mucosa reduced the diameter of the tracheal lumen. 
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4.1.1. Abstract 
The virulent nephropathogenic infectious bronchitis virus (NIBV) strain B1648 was 
first isolated in 1984, in Flanders, Belgium. Despite intensive vaccination, B1648 and 
its variants are still circulating in Europe and North Africa. Here, the full-length 
genome of this Belgian NIBV reference strain was determined by next generation 
sequencing (NGS) to understand its evolutionary relationship with other IBV strains, 
and to identify possible genetic factors that may be associated with the 
nephropathogenicity. Thirteen open reading frames (ORFs) were predicted in the 
B1648 strain (5′UTR-1a-1b-S-3a-3b-E-M-4b-4c-5a-5b-N-6b-3′UTR). ORFs 4b, 4c 
and 6b, which have been rarely reported in literature, were present in B1648 and most 
of the other IBV complete genomes. According to phylogenetic analysis of the full-
length genome, replicase transcriptase complex, spike protein, partial S1 gene and M 
protein, B1648 strain clustered with the non-Massachusetts type strains 
NGA/A116E7/2006, UKr 27-11, QX-like ITA/90254/2005, QX-like 
CK/SWE/0658946/10, TN20/00, RF-27/99, RF/06/2007 and SLO/266/05. Based on 
the partial S1 fragment, B1648 clustered with the strains TN20/00, RF-27/99, 
RF/06/2007 and SLO/266/05 and, further designated as B1648 genotype. The full-
length genome of B1648 shared the highest sequence homology with UKr 27-11, 
Gray, JMK, and NGA/A116E7/2006 (91.2 to 91.6%) and was least related with the 
reference Beaudette and Massachusetts strains (89.7%). Nucleotide and amino acid 
sequence analyses indicated that B1648 strain may have played an important role in 
the evolution of IBV in Europe and North Africa. Further, the nephropathogenicity 
determinants might be located on the 1a, spike, M and accessory proteins (3a, 3b, 4b, 
4c, 5a, 5b and 6b). Overall, strain B1648 is distinct from all the strains reported so far 
in Europe and other parts of the world. However, the interpretations of this chapter 
should be further confirmed by reverse genetics system (RGS) and in vivo chicken 
experiments. 
4.1.2. Introduction 
Infectious bronchitis virus (IBV) belongs to the Nidovirales, family Coronaviridae, 
subfamily Coronavirinae and genus Gammacoronavirus. Coronaviruses of turkeys, 
ducks, pheasants, teal and geese, as well as Beluga whale and Bottlenose dolphin 
coronaviruses are other known members within this genus (Cavanagh, 2005; Woo et 
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al., 2014). IBV is an enveloped virus with a positive sense single stranded RNA 
genome.  
The genome has a size of approximately 27.6 kb and contains a methylated cap and 
poly (A) tail at its 5′ and 3′ end, respectively. IBV contains at least ten open reading 
frames (ORFs) in the order 5′ UTR-1a-1b-S-3a-3b-EM-5a-5b-N-3′UTR (Cavanagh, 
2007). Gene 1 or the replicase transcriptase complex gene is the largest gene (20 kb) 
among the ten ORFs. Gene 1 consists of two overlapping ORFs, namely ORF1a and 
ORF1b, of which the latter is translated in polyprotein 1ab by a ribosomal frameshift. 
Furthermore, ORF1a and ORF1b encode 15 non-structural proteins (NSPs), which are 
required for RNA replication, transcription and other aspects of viral replication and 
pathogenesis. ORFs 2, 3, 4 and 6 encode four major structural proteins: The spike (S) 
glycoprotein, the small envelope (E) protein, the membrane (M) glycoprotein and the 
nucleocapsid (N) protein, respectively. The S protein is cleaved into two subunits, 
namely S1 and S2, of which S1 is the most variable domain and a major serotype 
determinant. ORFs 3 and 5 are interspersed between ORFs encoding structural 
proteins, and encode small non-structural proteins (NSPs), known as 3a, 3b, 5a and 5b 
(Cavanagh, 2007). Overall, the IBV genome is genetically variable due to the frequent 
occurrence of point mutations, insertions, deletions and recombination events 
(Cavanagh, 2007; Kottier et al., 1995; Thor et al., 2011). 
IBV affects both broiler and layer chickens. Although chicken flocks are routinely 
vaccinated with live vaccines, outbreaks of infectious bronchitis have been observed 
in vaccinated flocks, as there is partial cross-protection between different IBV 
serotypes (Cook et al., 2001; Lambrechts et al., 1993; Pensaert and Lambrechts, 
1994). Hence, serological and molecular characterization of field isolates is very 
important to select appropriate vaccine strains. IBV has a tropism for the epithelial 
cells of the respiratory tract, kidney, oviduct and alimentary tract of chickens. In the 
beginning of the 1950s, the respiratory Massachusetts (Mass) type of IBV was 
identified in the United States (Hopkins, 1974). Later, Mass-type strains have been 
isolated all over the world and variants emerged (Cavanagh et al., 1992; Hopkins, 
1974; Johnson and Marquardt, 1975).  
In Europe, at present, Mass 41, 4/91, D274, Italy 02 and QX are recognized as 
important circulating serotypes (Cavanagh, 2007; Cook et al., 2012; Kottier et al., 
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1995; Thor et al., 2011). Some IBV strains were described as nephropathogenic since 
the respiratory infection was followed by a severe renal disease, which leads to 
clinical signs such as excessive water consumption and wet droppings and increased 
mortality. Post-mortem examination of birds that died after a nephropathogenic IBV 
(NIBV) infection reveals dehydrated carcasses and swollen and pale kidneys with 
urates in the tubules. 
The first nephropathogenic IBV strains were reported in the US (Winterfield and 
Hitchner, 1962) and Australia (Cumming, 1969), and later in other parts of the world 
(Meulemans et al., 1987; Song et al., 1998; Wang et al., 1996). Over the past 15 
years, the nephropathogenic IBV strains have been emerging as most predominant 
IBV strains in poultry industry, especially in Asian and Middle Eastern countries 
(Abdel-Moneim et al., 2006; Bayry et al., 2005; Lim et al., 2011; Mahmood et al., 
2011; Meir et al., 2004). Strain B1648 was responsible for outbreaks of kidney 
disease on chicken farms in Belgium, The Netherlands and Northern France, and was 
first isolated in 1984 (Cook et al., 2012; Meulemans et al., 1987; Pensaert and 
Lambrechts, 1994). At present, strain B1648 or its variants are still circulating in 
Europe and North Africa (Bochkov et al., 2006; Ducatez et al., 2009; Krapež et al., 
2010; Toffan et al., 2013b). Based on the spike gene analysis of B1648 strain, some of 
the European, American and West African non-Massachusetts type strains show close 
genetic relationship with strain B1648 (Ducatez et al., 2009; Shaw et al., 1996). 
However, conclusions based on the spike gene or partial spike gene segment analysis 
should be made cautiously, because the true evolutionary relationship of B1648 with 
other strains can only be evaluated by complete genome analysis (Ammayappan and 
Vakharia, 2009; Phillips et al., 2012; Zhao et al., 2013; Zhou et al., 2014). Hence, this 
paper aims to characterize the complete genome of strain B1648 by means of NGS 
(Illumina) and aimed to speculate the genetic factors, which might be associated with 
the nephropathogenic nature of this strain. 
4.1.3. Materials and Methods 
4.1.3.1. Virus propagation 
The virulent nephropathogenic IBV strain, B1648 has been isolated in 1984 (Pensaert 
and Lambrechts, 1994). Virus stocks were prepared in 10-day-old embryonated SPF 
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chicken eggs by allantoic route inoculation. Then, virus was propagated in embryos 
for 48 h at 37 °C. Finally, the allantoic fluid was harvested, cleared by low speed 
centrifugation and frozen at −70 °C until use. 
4.1.3.2. Preparation of RNA for illumina sequencing 
The virus infected allantoic fluid was filtered twice using 0.8 µm and 0.45 µm 
membrane filters. Free and bacterial DNA/RNA was destroyed by the addition of 2 
µL of Benzonase Nuclease (Novagen, San Diego, CA, USA), 1 µL of Micrococcal 
Nuclease (New England Biolabs, Ipswich, MA, USA) and 1 µL of NEBNext® RNase 
III RNA Fragmentation Module (Invitrogen, Carlsbad, CA, USA) in 7 µL of 
homemade buffer (1 M Tris, 100 mM CaCl2 and 30 mM MgCl2) that were added to 
140 µL of allantoic fluid, and incubated for 2 h at 37 °C. Next, 7 µL of EDTA were 
added to the sample for enzyme inactivation. Extraction of viral RNA was performed 
using the QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany) according to the 
manufacturer’s instructions, but without using carrier RNA. Total RNA was amplified 
using the Whole Transcriptome Amplification Kit (WTA 2, Sigma Aldrich, St. Louis, 
MO, USA). Therefore, 0.5 µL Library Synthesis Solution was added to 2.82 µL of 
RNA, followed by denaturation for 2 min at 95 °C. RNA was cooled to 18 °C and 0.5 
µL Library Synthesis Buffer, 0.4 µL Library Synthesis Enzyme and 0.78 µL of water 
was immediately added to the reaction. The mixture was treated with the following 
temperature conditions: 18 °C, 25 °C, 37 °C, 42 °C and 70 °C for 10, 10, 30, 10 and 
20 min, respectively. Samples were cooled down to 4 °C followed by a brief 
centrifugation step. A mastermix containing 60.2 µL of nuclease free water, 7.5 µL of 
Amplification Mix, 1.5 µL of WTA dNTP mix and 0.75 µL Amplification Enzyme 
was added to the sample and incubated as follows: 94 °C for 2 min and 30 cycles at 
94 °C for 30 s and 70 °C for 5 min. The resulting cDNA products were purified with 
the MSB® Spin PCRapace kit (STRATEC Molecular, Birkenfeld, Germany) 
according to the instructions of the manufacturer and prepared for Illumina 
sequencing using the KAPA Library Preparation Kit (Kapa Biosystems, Wilmington, 
NC, USA), according to the manufacturer’s instructions. 
4.1.3.3. Illumina sequencing and sequence assembly 
Fragments ranging from 350–600 bp were selected using the BluePippin (Sage 
Science, Beverly, MA, USA) according to the manufacturer’s instructions. 
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Sequencing of the samples was performed on a HiSeq 2500 platform (Illumina, San 
Diego, CA, USA) for 300 cycles (150 bp paired ends). Raw reads were trimmed for 
quality and adapters, and were de novo assembled into contigs using SPAdes 
(Bankevich et al., 2012). Scaffolds were classified using a tBLASTx search against all 
complete viral genomes in GenBank using an e-value cut-off of 10−10. Scaffolds with 
a significant tBLASTx hit were retained and used for a second tBlastx search against 
the GenBank nucleotide database using an E-value of 10−4 (Altschul et al., 1990). 
4.1.3.4. Genome sequence analysis 
Multiple sequence alignments were performed using the ClustalW plug-in in the 
MEGA software version 5.2.2, followed by manual editing. The B1648 genome, 
coding sequence and ORF prediction was carried out in 
http://covdb.microbiology.hku.hk and http://www.jcvi.org/vigor/ (Huang et al., 2008; 
Wang et al., 2010). Phylogenetic trees were constructed using the maximum-
likelihood method. Substitution models were determined for each gene separately. 
The bootstrap values were determined from 500 replicates of the original data. 
Nucleotide and amino acid identities were determined using the p-distance model. The 
complete genome of strain B1648 was compared to 55 relevant respiratory and 
nephropathogenic complete IBV genomes of North America (USA), Asia (China, 
Korea and Taiwan), Africa (Nigeria) and Europe (Sweden, Ukraine and Italy). Partial 
S1 gene sequences (727 nt) of 90 relevant respiratory and nephropathogenic IBV 
strains of North America (USA), South America (Argentina), Europe (Sweden, Italy, 
UK, Slovenia, Ukraine and Russia), Asia (China, India, Israel, Korea and Taiwan), 
Africa (Tunisia, Nigeria and Egypt) and Australia were compared to B1648 strain as 
well. During B1648 strain outbreak (1984), Mass type strains were other important 
IBV strains present in the field (Meulemans et al., 1987). Thus, Mass and non-Mass 
strains nomenclature has been used in this chapter to understand the phylogenetic and 
pairwise comparisons of B1648 genome in a better way. 
4.1.3.5. Recombination analysis 
Simplot analysis (SimPlot version 3.5.1) was performed to determine whether the 
B1648 strain has recombined with other strains during its evolution. Based on the 
phylogenetic analysis of the complete genome sequence, 10 relevant strains were 
selected and included in the recombination analysis. The 10 complete genome 
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sequences were aligned using the ClustalW plug-in in the MEGA software version 
5.2.2. The Kimura 2-parameter model was used as a distance model, the window size 
was 500 bp and step size was 60 bp. 
4.1.3.6. Genbank accession number 
The full-length genomic sequence of the B1648 strain that was described in this report 
has been deposited in the GenBank database with accession number KR231009.  
4.1.4. Results 
4.1.4.1. Genome organization of strain B1648 
The complete genome sequence of strain B1648 had a size of 27654 nucleotides (nt), 
excluding the poly(A)-tail. Thirteen ORFs (5′-1a-1b-S-3a-3b-E-M-4b-4c-5a-5b-N-6b-
3′) were predicted in the B1648 genome (Table 1). ORFs 4b, 4c and 6b were predicted 
in the B1648 genome and also in most of the GenBank IBV genomes (Table 2). 
Among the different regions of the genome, the 5′ end untranslated regions (UTR) 
(518 nt) and 3′ end UTR (292 nt) were most conserved (94.8 to 99.5%). On the other 
hand, the 6b protein was the most variable (15.9 to 96%), followed by 4c (46.4 to 
100%), 3b (51.2 to 96.4%) and the Spike protein (56.9 to 86.2%) (Table 2). Deletions, 
insertions and point mutations were distributed throughout the B1648 genome. 
Table 1. Genes, coding regions, nucleotide length and amino acids size of B1648 
strain. 
 
Open Reading Frame Frame Nucleotide Location Nucleotide Length (bp) Amino Acids Size 
5′ UTR - 1–518 518 - 
1a +3 519–12368 11,850 3949 
1b +2 12443–20401 7959 2652 
Spike +3 20352–23852 3501 1166 
3a +2 23852–24025 174 57 
3b +1 24025–24219 195 64 
Envelope +2 24200–24484 285 94 
Membrane +3 24477–25154 678 225 
4b +3 25155–25439 285 94 
4c +1 25360–25530 171 56 
5a +2 25514–25711 198 65 
5b +1 25708–25956 249 82 
Nucleocapsid +3 25899–27128 1230 409 
6b +2 27137–27361 225 74 
3′ UTR - 27362–27654 292 - 
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Table 2. Nucleotide and amino acid sequence identity (%) of B1648 genome with relevant genomes of Infectious Bronchitis Virus (IBV). 
Strain Genome 5′ 1a 1b Spike 3a 3b E (3c) M 4b 4c 5a 5b N 6b 3′ 
Beaudette 89.7 96.2 89.7/91.7 91.9/96.6 80.7/80.7 91.1/94.6 80.1/64.6 88.9/81.8 95.1/93 90.2/85.8 87.1/84.2 83.4/84.8 95.3/90.8 92.4/93.6 93.6/93.9 99.1 
California99 90.4 98.1 90.1/91.9 93/97.1 79.2/84.1 87.8/82.8 96.6/96.4 92.3/90.7 93.9/91.5 89.6/87.5 89.0/89.7 86.5/88.4 93.6/86.6 93.4/96 68.9/65.2 98.1 
Cal5572003 90.4 98.4 90.3/91.3 92.9/97.2 79.5/83 93.7/94.6 89.8/80.7 93.5/91.9 94.4/91.5 83.7/76.9 64.4/50.5 87.1/86.6 94.4/86.6 93.3/94.7 94.3/96 98.1 
Cal56b 90.6 97.8 90.7/92.1 92.9/97 77.8/82.8 89.2/85.9 94.8/92.7 91.5/88.2 95.1/93 85.5/82.4 66.0/50.5 88.3/88.4 94.5/90.8 94.1/96.2 93/93.9 98.6 
SAIBK 86.8 95.8 86.4/89.4 89.5/95.5 78/81.7 90.9/79.6 76.2/67.1 88.5/85.7 92/90.4 83/82.4 64.4/46.4 87.2/91.9 93.6/89.5 85.7/91.8 NA 97.6 
TW2575/98 86.0 95.5 84.8/87.9 88.9/95.7 79.2/81.7 94.8/97.3 87.3/80.7 90.5/87 92.7/90.4 83.7/80.6 85.1/81.3 86.3/88.4 92.6/85.2 88.4/92 68.3/65.2 97.1 
ArkDPI11 90.8 98.7 90.6/92.2 93/96.9 80.7/83.7 97.4/94.6 96.6/94.6 93/91.9 93.6/92 89.6/87.5 89.9/92.4 86.5/88.4 94.9/89.5 94.2/96.5 94.3/96 98.1 
H52 89.6 97.8 89.4/91.5 92.1/96.5 80.9/80.6 85.1/88.9 81.5/67.1 88.9/81.8 95.4/93 88.5/85.8 85.2/78.3 87.8/88.4 92.6/85.2 91.9/94.7 34.7/15.9 98.6 
H120 90.4 98.7 89.9/91.7 93.6/97.4 79/81.1 85.1/88.9 80.7/67.1 87.6/76.3 96.2/92.5 88.5/85.8 85.2/78.3 88.4/88.4 95.3/90.8 93.4/94.7 34.7/15.9 99.0 
Mass412006 90.8 98.7 91.1/92.6 92.5/97 83.1/82.3 87.8/82.8 96.6/96.4 93.5/93.1 93.7/92 89.6/87.5 89.9/92.4 86.5/88.4 94.4/88.1 94.4/96.7 93/93.9 98.6 
Mass411985 89.7 96.8 89.6/91.4 92.2/96.7 58.3/80.8 91.1/91.8 81.5/67.1 89.5/83.1 94.8/93 90.9/89.1 89.2/81.3 86.6/83 92.6/83.7 91.9/94.7 NA 98.1 
Conn461996 91.1 97.8 91.5/92.7 93.1/97 58.6/82.5 87.8/82.8 96.6/96.4 93.3/93.1 93.6/92 89.6/87.5 89.9/92.4 86.5/88.4 94.9/89.5 94.4/96.7 89.5/91.8 98.6 
ITA/90254/2005 90.2 97.1 92.2/94.2 90.8/96.3 80.5/81.8 85.7/79.6 64.1/54 89.2/84.4 95.6/94.6 93.4/92.4 92.7/89.7 90.1/91.9 92.6/86.6 91.3/94.9 97.5/96 99.0 
NGA/A116E7/2006 91.6 97.8 92.2/94 93/96.8 81.7/84.8 90/79.6 78.1/64.6 92/90.7 89.9/85.5 92.4/90.8 91.9/89.7 93.5/91.9 93.5/88.1 92.8/95.2 94.2/89.7 98.6 
Delaware072 88.1 98.4 89.1/90.5 91/94.2 81.4/57.5 92.8/82.8 96.6/96.4 92.9/90.7 94.7/93 88.5/85.8 85.1/78.3 85.3/88.4 94.9/89.5 92.9/94.4 92.9/93.9 98.6 
Gray 91.2 98.7 91.8/93.3 92.6/97.2 78.6/82.8 97.4/94.6 96.6/94.6 92.6/91.9 88.2/81.6 89.6/85.8 89.9/92.4 86.5/88.4 93.1/86.6 86.1/84.5 94.9/96 96.6 
Holte 90.7 98.7 91.5/92.8 92.2/97 79/80.2 91.9/88.9 94.2/88.9 91.4/89.5 94.9/92 87.9/82.4 89.1/84.2 83.3/86.6 95.8/92.2 91.2/93.4 NA NA 
Iowa97 90.6 98.4 91.3/92.4 92.2/97 77.7/82.7 91.9/88.9 94.2/88.9 91.4/89.5 94.5/91.5 87.9/82.4 89.1/84.2 83.3/86.6 95.8/92.2 91.5/93.9 91.5/89.7 96.6 
JMK 91.2 98.7 92/93.5 92.5/97 79.1/82.3 97.4/94.6 96/92.7 92.6/91.9 94.1/92 89.6/85.8 89.9/92.4 86.5/88.4 93.1/86.6 93.6/94.9 NA 98.1 
CK/CH/LDL/101212 90.4 98.4 89.8/91.6 93.6/97.3 78.8/81.2 85.1/88.9 80.7/67.1 87.6/76.3 96.2/92.5 88.5/85.8 85.2/78.3 87.8/86.6 95.3/90.8 93.2/94.4 34.7/15.9 98.1 
CK/SWE/0658946/10 89.5 96.8 90/91.1 91.3/95.8 80/80.8 83.6/76.4 64.9/51.2 93.7/88.2 96.1/95.6 91.3/92.4 92.0/81.3 94.7/98.4 91.2/85.2 89.2/90.4 97.5/96 99.0 
KM91 90.0 98.7 91.1/92.6 91.7/96.6 62.4/80.4 87.8/69.5 78.8/74.1 89.6/89.5 94.3/93.5 92.5/92.4 93.6/95.0 86/84.8 93.1/86.6 92.5/95.5 71.4/73.2 96.6 
CK/CH/LJL/111054 90.7 98.7 90.2/92.1 93.6/97.3 84.6/82.6 87.8/82.8 96.6/96.4 93.3/93.1 93.7/92 89.6/87.5 89.9/92.4 86.5/88.4 94.9/89.5 94.4/96.7 90.2/91.8 98.6 
Ukr27-11 91.2 96.5 89.8/91.7 93.6/97.2 80.8/86.2 98.3/97.3 93/92.7 92.3/91.9 96.9/96.6 97.6/97 96.9/100.0 94.7/93.5 94.4/89.5 93.2/95.2 97.5/96 99.0 
CK/CH/LDL/110931 90.6 98.7 89.9/91.7 93.6/97.3 80.7/82.4 87.8/82.8 96.6/96.4 93.3/93.1 93.7/92 89.6/87.5 89.9/92.4 86.5/88.4 94.9/89.5 94.4/96.7 90.2/91.8 98.6 
Boldface indicates the highest, and italic the lowest, nucleotide and amino acid sequence identity
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4.1.4.2. Phylogenetic analysis and comparison alignments of full genomes of IBV 
strains 
The general time reversible model with gamma distribution and invariant sites was 
used for the construction of a maximum likelihood phylogenetic tree of the 55 
relevant respiratory and nephropathogenic complete IBV genomes of North America 
(USA), Asia (China, Korea and Taiwan), Africa (Nigeria) and Europe (Sweden, 
Ukraine and Italy) (Figure 1). The phylogenetic analysis of 55 full-length nucleotide 
sequences of different IBV strains has demonstrated that NGA/A116E7/2006 (non-
Mass pathogenic variable type of Nigeria), UKr 27-11 (non-Mass recombinant type of 
Ukraine), QX-like ITA/90254/2005 (non-Mass type of Italy) and QX-like 
CK/SWE/0658946/10 (non-Mass type of Sweden) strains clustered most closely with 
B1648. The B1648 strain has the highest nucleotide sequence homology with strains 
UKr 27-11, Gray (non-Mass nephropathogen), JMK (non-Mass respiratory pathogen) 
and NGA/A116E7/2006 (91.2 to 91.6%) (Table 2). Strain B1648 was clustered 
distinctly from all the Mass type strains. The nucleotide sequence homology to Mass 
41 (M41, 1985) and reference (Beaudette) strain was 89.7%. 
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Figure 1. Maximum likelihood phylogenetic tree based on 55 full genome sequences. 
Bootstrap values (n = 500 replicates) of <50% are not shown. Strain B1648 cluster is 
shown in red.  
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4.1.4.3. Phylogenetic analysis and sequence comparison of spike protein (1166 aa) 
and partial S1 gene (727 nt) 
Maximum likelihood trees were constructed for the amino acid sequences of the spike 
protein and nucleotide sequences of the partial S1 gene using the general time 
reversible and Tamura 92 models with gamma distribution sites, respectively (Figure 
2). The phylogenetic analysis of the spike protein (1166 aa) clustered 
NGA/A116E7/2006 and Ukr27-11 with B1648 strain. The phylogenetic analysis of 90 
partial S1 genes (727 nt) of relevant respiratory and nephropathogenic IBV strains of 
North America (USA), South America (Argentina), Europe (Sweden, Italy, UK, 
Slovenia, Ukraine and Russia), Asia (China, India, Israel, Korea and Taiwan), Africa 
(Tunisia, Nigeria and Egypt) and Australia has clustered B1648 strain with TN20/00 
(Tunisian), RF-27/99 and RF/06/2007 (Russian) and SLO/266/05 (Slovenian) strains. 
The Spike protein of B1648 showed the highest amino acid identities to California99, 
NGA/A116E7/2006 and Ukr27-11 (84.1 to 86.2%). The partial S1 gene of B1648 
strain showed the highest nucleotide homology with strains SLO/266/05, RF/06/2007, 
RF-27/99 and TN20/00 (89.4 to 97.4%). According to amino acid sequence identity, 
the Spike protein (56.9 to 86.2%) was the fourth most variable region (Table 2). 
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Figure 2. Maximum likelihood phylogenetic trees based on amino acid sequences of 
spike protein and nucleotide sequences of partial S1 gene. Bootstrap values (n = 500 
replicates) of <50% are not shown. Strain B1648 cluster is shown in red. 
Spike Partial S1 
 
-.1&

-.1&	


-.1&
-.1&	


-.1&	
	


-.1&!	
*&7)*66*7423*

&55	
!	
-.1&$	

(/-.1&
&55	!	
-.1&	


211	!	
!!

	-.1&



206*!!
28&!!
&0.+241.&!$
		

4/!!	
4&9!!	
!!
&0

!	

&0
'!!

	
.,*4.&		

!/4!/4&.1*

#-.1&
 "

 &.8&1		

-.1&

-.1&!
	
-.1&$

!24*&
-.1&!	
$-.1&	

#$-.1&

	-.1&	
	
-.1&
	-.1&$	
24*&
#$
-.1&	
-.1&!

-.1&
	
"-.1&

%-.1&#

 
	
6&09			
"
	8*)*1
-.1&

-.1&#


$-.1&	

(:9-.1&
$#-.1&#		
#-.1&#
 %-.1&


*24,.&!
	
*0&8&4*!!






















	
	























57-)-60756)905/-4
57-)-60756)905/-4
014)&


&$014)	
!014)

'014)	

!+>=014)
'&014)&		

	312-57-)
!%
	!<-,-4
"
	
9)3=			
57-)-60756)905/-4
57-)

312-57-)	
	
312-57-)	
!57-)-60756)905/-4	
"014)'

!	014)'	
!
014)#
	
&014)
014)-60756)905/-4'

014)#

&'
014)	
!014)
014)
	
	014)	
	
&'014)

!014)#	
'014)	

%014)

#27#27)14-

	#
	
(014)&

"%

")1<)4		

014)
544	#!	

	014)



#!#

57-)-60756)905/-4	

	#!'


)88	
#!	
014)'	

014)
-):,-99-:756-

)88	#!	
014)	


014)


014)#	
!014)	

014)
014)	
	

014)	


1/-71)		

 :4-4,1)'


  :881)	


	
"":4181)


 :881)		
  :881)		
!
!35;-41)#	
  :881)

	
  :881)


 7/-4914)
 
7/-4914)
 
7/-4914)	
57-)-60756)905/-4
!#57-)
:897)31)-60756)905/-4#

	:897)31)-60756)905/-4#	

$1+!:897)31)-60756)905/-4#


:897)31)-60756)905/-4#

/=69	
!

87)-3'
  :881)

	
$#!-60756)905/-4
)3
*#!#
)3

#!	

)31.5741)#!'
		

72#!#	
  :881)


"":4181)
"
":4181)


7)=#!#	
#!#
539-#!#
5<)#!#
&014)&
"(014)


-57/1)#!
	
-3)<)7-#!#





	











	



















	



	





















Genetic characterization of the Belgian NIBV reference strain B1648 
 97 
4.1.4.4. Phylogenetic analysis and comparison alignments of the replicase 
transcriptase complex (polyprotein 1a (3949 aa) and 1b (2652 aa)) 
The replicase transcriptase complex (polyprotein 1a (3949 aa) and 1b (2652 aa)) 
maximum likelihood trees were constructed using the general time reversible model 
with gamma distribution and invariant sites (Figure 3). Based on the phylogenetic 
analysis of the replicase protein complex amino acid sequences, B1648 clustered with 
NGA/A116E7/2006 (1a, 1b), ITA/90254/2005 (1a) and UKr 27-11 (1b). 
Polyprotein 1a (3949 aa) had the highest amino acid homology with strains Gray, 
NGA/A116E7/2006 and ITA/90254/2005 (93.3 to 94.2%), while polyprotein 1b 
(2652 aa) was closest to CK/CH/LDL/101212, CK/CH/LHLJ/131216 and H120 (97.3 
to 97.4%). Overall, polyprotein 1b (95.3 to 97.4%) was more conserved than 1a (84.8 to 
94.6%) (Table 2). Among the 15 NSPs of polyprotein 1ab, NSP3 (80.6 to 92.4%), NSP9 
(69.1 to 99.1%) and NSP11 (69.8 to 86%) were most variable, whereas the other 
NSPs were generally more conserved (82.8 to 100%) (Supplementary Table S1). 
4.1.4.5. Phylogenetic analysis and sequence comparison of amino acid sequences of 
E, M and N proteins 
For construction of E or 3c (94 aa), M (225 aa) and N (409 aa) proteins maximum 
likelihood trees, the Jones Thornton Taylor model with gamma distribution sites was 
used (Figure 3). Based on the phylogenetic analysis of amino acid sequences of E 
protein, NGA/A116E7/2006, Ukr27-11, Cal5572003, Cal56b and many other Mass 
and non-Mass type strains were clustered together with B1648. Further, a sequence of 
12 amino acids (36 nucleotides) was discontinuously deleted in the  
C-terminal of the B1648 E protein. The same 12 amino acids were deleted in strains 
NGA/A116E7/2006, Ukr27-11, Cal5572003 and Cal56b (Figure 4). According to 
amino acid sequences of the M protein, B1648 strain was clustered with 
NGA/A116E7/2006, UKr 27-11, QX-like ITA/90254/2005, QX-like 
CK/SWE/0658946/10 and many other non-Mass type strains. Based on the amino acid 
sequences of N protein, NGA/A116E7/2006, UKr 27-11, QX-like ITA/90254/2005, 
Beaudette, Mass type (1985) and many other Mass type and non-Mass type strains 
were clustered together with B1648. 
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Figure 3. Maximum likelihood phylogenetic trees based on amino acid sequences of 
1a, 1b, E (3c), M and N proteins. Bootstrap values (n = 500 replicates) of <50% are 
not shown. Strain B1648 cluster is shown in red. 
1a 1b 
  
 
E (3c) M N 
 
 H120/China/FJ807652
 CK/CH/LDL/110931/China/KJ425485
 CK/CH/LDL/101212/China/JF828981
 Delaware072/USA/GU393332
 H52/China/EU817497
 CK/CH/LJL/111054/China/KC506155
 Cal5572003/USA/FJ904715
 ArkDPI11/USA/EU418976
 Georgia1998/USA/GQ504722
 California99/USA/AY514485
 CK/SWE/0658946/10/Sweden/JQ088078
 Ukr27-11/Ukraine/KJ135013
 Cal56b/USA/GU393331
 Mass41 2006/USA/FJ904713
 Conn461996/USA/FJ904716
 FL18288/USA/GU393333
 Holte/USA/GU393336
 Iowa97/USA/GU393337
 B1648/Belgium
 ITA/90254/2005/Italy/FN430414
 NGA/A116E7/2006/Nigeria/FN430415
 Gray/USA/GU393334
 JMK/USA/GU393338
 JSNU8067/Korea/JQ977697
 KM91/Korea/JQ977698
 Beaudette/Europe/M95169
 Mass41 1985/USA/FJ904723
 TW2575/98/Taiwan/DQ646405
 CK/CH/LSD/05I/China/EU637854
 SAIBK/China/DQ288927
 SC021202/China/EU714029
 BJ/China/AY319651
 A2/China/EU526388
 CK/CH/LGD/120723/China/KC013541
 CK/CH/LDL/091022/China/JX195175
 CK/CH/LZJ/111113/China/JX195176
100
100
100
100
100
100
100
100
100
100
100
100
100
98
99
86
100
98
80
99
76
78
52
91
99
100
100
73
0.1
 Conn461996/USA/FJ904716
 FL18288/USA/GU393333
 Cal56b/USA/GU393331
 California99/USA/AY514485
 CK/CH/LJL/111054/China/KC506155
 Cal5572003/USA/FJ904715
 ArkDPI11/USA/EU418976
 Georgia1998/USA/GQ504722
 Mass41 2006/USA/FJ904713
 Delaware072/USA/GU393332
 H120/China/FJ807652
 CK/CH/LDL/101212/China/JF828981
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 Gray/USA/GU393334
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 H52/China/EU817497
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100
100
100
100
100
100
100
100
62
100
100
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100
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100
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65
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65
100
50
65
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0.1
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 Mass41 2006/USA/FJ904713
 Delaware072/USA/GU393332
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 CK/CH/LGD/120723/China/KC013541
 SAIBK/China/DQ288927
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 CK/CH/LDL/091022/China/JX195175
 CK/CH/LZJ/111113/China/JX195176
 ITA/90254/2005/Italy/FN430414
 BJ/China/AY319651
 A2/China/EU526388
 TW2575/98/Taiwan/DQ646405
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 H52/China/EU817497
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 H120/China/FJ807652
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95
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0.1
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 ITA/90254/2005/Italy/FN430414
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 SAIBK/China/DQ288927
 SC021202/China/EU714029
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 Gray/USA/GU393334
 JMK/USA/GU393338
 Holte/USA/GU393336
 Iowa97/USA/GU393337
 ArkDPI11/USA/EU418976
 Conn461996/USA/FJ904716
 Mass41 2006/USA/FJ904713
 FL18288/USA/GU393333
 CK/CH/LJL/111054/China/KC506155
 CK/CH/LDL/110931/China/KJ425485
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55
55
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 CK/CH/LDL/091022/China/JX195175
 CK/CH/LZJ/111113/China/JX195176
 CK/CH/LGD/120723/China/KC013541
 A2/China/EU526388
 BJ/China/AY319651
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 CK/SWE/0658946/10/Sweden/JQ088078
 SNU8067/Korea/JQ977697
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 Holte/USA/GU393336
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 B1648/Belgium
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 ITA/90254/2005/Italy/FN430414
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 Mass41 2006/USA/FJ904713
 Conn461996/USA/FJ904716
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49
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0.1
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The E or 3c (94 aa) protein had the highest amino acid identities to Mass 41(2006), 
Conn461996, CK/CH/LDL/110931 and CK/CH/LJL/111054 (93.1%). The M protein 
(225 aa) was closest to ITA/90254/2005, CK/SWE/0658946/10 and Ukr27-11 (94.6 to 
96.6%). The N protein (409 aa) showed the highest amino acid identities to Mass 
41(2006), and many other Mass and non-Mass type strains (96.7%). 
 
Figure 4. Amino acid sequence differences in C-terminal of E protein of B1648 strain 
with other Mass (red) and non-Mass type strains. In the B1648 strain 3′ terminal E 
(3c) protein, a region of total 12 amino acids was discontinuously deleted (blue). The 
dashes (-) indicate the deleted sequences. 
4.1.4.6. Accessory proteins alignments 
There were 7 probable accessory proteins in the B1648 strain, such as 3a (57 aa), 3b 
(64 aa), 4b (94 aa), 4c (56 aa) 5a (65 aa), 5b (82 aa) and 6b (74 aa). The accessory 
proteins 3a (69.5% to 97.3%), 3b (51.2% to 96.4%), 4b (76.9% to 97%), 4c (46.4% to 
100%) and 6b (15.9% to 96%) were variable whereas 5a (81.1% to 93.5%) and 5b 
(82.3% to 92.2%) were more conserved (Table 2). The highest amino acid identities 
of 3a, 3b, 4b, 4c, 5a, 5b and 6b were 97.3% (Ukr27-11 and TW2575/98), 96.4% 
(CK/CH/LDL/110931, California99 and many other non-Mass type strains), 97% 
(Ukr27-11), 100% (Ukr27-11), 98.4% (CK/SWE/0658946/10), 92.2% (Holte and 
Iowa97) and 96% (Ukr27-11, CK/SWE/0658946/10, Gray, ArkDPI11 and many other 
non-Mass type strains), respectively. 
 
ITA/90254/2005/Italy/FN430414     VNEFPKNGWNNKNPAIFQDVERHGKLHS* 
CK/SWE/0658946/10/Sweden/JQ088078 VNDFPKNGWNNKNPAIFQDVEPHHQLHS* 
Beaudette/Europe/M95169           VNEFPKNGWNNKNPANFQDAQRD-KLYS* 
H52/China/EU817497                VNEFPKNGWNNKNPANFQDVQRD-KLYS* 
H120/China/FJ807652               VNEFPKNGWNNKNPANFQDVQRN-KLYS* 
Mass41 1985/USA/FJ904723          VNEFPKNGWNNKNPANFQDVQRD-KLYS* 
Mass41 2006/USA/FJ904713          VNEFPKNGWNNKSPANFQY---DGKLHT* 
ArkDPI11/USA/EU418976             VNEFPKNGWNNKSPANFQY---DGKLHT* 
Conn461996/USA/FJ904716           VNEFPKNGWNNKSPANFQY---DGKLHT* 
Gray/USA/GU393334                 VNEFPKNGWNNKIPENFQH---GGKLHT* 
Holte/USA/GU393336                VNEFPKNGWNNKNPANFQY---GGKLHT* 
B1648/Belgium                     VNEFPKNGWK--------Y----G*---- 
NGA/A116E7/2006/Nigeria/FN430415  VNEFPKNGWK*------------------ 
Ukr27-11/Ukraine/KJ135013         VNEFPKNGWKN------------G*---- 
Cal557 2003/USA/FJ904715          VNEFPKNGWKQ*----------------- 
Cal56b/USA/GU393331               VNEFPKNGWKQ*----------------- 
KM91/Korea/JQ977698               VNEFPKNGWNNKNPAIFQDVERHGKLHS* 
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4.1.4.7. Recombination analysis 
B1648 was used as a putative parental strain and 10 relevant pathogenic and vaccine 
strains were queried in the Simplot analysis (Figure 5). The B1648 strain was 
considered as parental strain, because the strains that clustered with B1648 (Figures 
1–3), were reported after the B1648 outbreak. In gene 1a, a part of NSP2 and NSP4 
showed a higher similarity to ITA/90254/2005; a part of NSP3 showed a higher 
similarity to ITA/90254/2005 and NGA/A116E7/2006, and part of NSP6 showed a 
higher similarity to CK/SWE/0658946/10. In the gene 1b, a part of NSP13 and NSP14 
shared a higher similarity with NGA/A116E7/2006, and a part of NSP15 did that with 
UKr 27-11. In the S gene, a part of the S1 region showed similarities with Gray and 
UKr 27-11 and a part of S2 did that with NGA/A116E7/2006. The 4b, 4c and 5a 
genes were very similar to those of UKr 27-11. 
 
Figure 5. Simplot analysis (Simplot 3.5.1) of B1648 strain. The full genome sequence 
of B1648 strain was tested against 10 relevant IBV strains. The 70% bootstrap level is 
considered. 
4.1.5. Discussion 
The B1648 strain is a Belgian reference nephropathogenic IBV serotype. Earlier, in 
our laboratory it was demonstrated that B1648 was antigenically different from the 
Mass type and other variant strains. Furthermore, it was shown that Mass type vaccines 
(H120 and D274) did not provide protection (Lambrechts et al., 1993; Pensaert and 
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Lambrechts, 1994). More recently, Cook et al. (2001) found that the 4/91 type (variant 
type) vaccine alone or the 4/91 and Ma5 (Mass type) combination vaccine protected 
against B1648 nephropathogenicity. In spite of the intensive vaccination program, the 
B1648 strain or its variants are still circulating or reemerging throughout Europe and 
North Africa (Bochkov et al., 2006; Ducatez et al., 2009; Krapež et al., 2010; Toffan 
et al., 2013b). Hence, in the present study the complete genome of the B1648 strain 
was characterized to speculate putative genetic factors that might be involved in the 
tissue tropism, and to understand their role in evolution (Lambrechts et al., 1993; 
Meulemans et al., 1987; Pensaert and Lambrechts, 1994). 
The B1648 genome organization (5′-1a-1b-S-3a-3b-E-M-4b-4c-5a-5b-N-6b-3′) was 
slightly different from most previously reported IBV genomes (5′-1a-1b-S-3a-3b-E-
M-5a-5b-N-3′). 4b, 4c and 6b were additional ORFs present in the B1648 genome. 
Although 4b, 4c and 6b were present in the most of the IBV genomes, they have 
rarely been reported in literature (Abolnik, 2015; Hewson et al., 2011; Xue et al., 
2012). ORFs 4b, 4c and 6b have also been reported in a turkey coronavirus (Cao et 
al., 2008). The exact reason for the rare reports of these ORFs (4b, 4c and 6b) in most 
of the IBV genomes is not known. It could be that 4b, 4c and 6b ORFs are present in 
most of the IBV genomes, but that the success of their identification depends on the 
algorithms of ORF prediction software that was used. Recently, Bentley et al. (2013) 
has demonstrated and confirmed 4b as a 5th accessory protein in IBV, besides 3a, 3b, 
5a and 5b. The 4b homologue of Middle East respiratory syndrome coronavirus 
(MERS-CoV) was found to be an interferon antagonist (Yang et al., 2013). The 6b 
homologue of SARS coronavirus was found to induce apoptosis (Ye et al., 2008). For 
IBV, further investigations are necessary to demonstrate the production of 4b, 4c and 
6b proteins and to identify their functions in pathogenesis. 
The phylogenetic analysis of the full-length genome, replicase transcriptase complex, 
spike protein, partial S1 gene and M protein has suggested that B1648 may have 
played an important role in evolution, because the strains which were clustered 
(NGA/A116E7/2006, UKr 27-11, QX-like ITA/90254/2005, QX-like 
CK/SWE/0658946/10, TN20/00, RF-27/99, RF/06/2007 and SLO/266/05) with 
B1648 were reported in Europe and North Africa, after the initial B1648 outbreak. 
The geographical proximity of all these countries and frequent movements of poultry 
and their products in between these countries might be an important reason for this 
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observed cluster. All the above clustered strains belong to a group referred to as non-
Mass type strains. In the above-mentioned cluster, QX like ITA/90254/2005 and QX 
like CK/SWE/0658946/10 are presently predominant IBV strains in Europe 
(Germany, The Netherlands, Belgium, France, Sweden, Poland, Russia, Slovenia, 
Spain and the UK) (Abro et al., 2012; Benyeda et al., 2009; Cumming, 1969; 
Domanska-Blicharz et al., 2006; Gough et al., 2008; Krapez et al., 2011; Valastro et 
al., 2010; Worthington et al., 2008). The QX IBV strains were first reported in China 
(Liu and Kong, 2004; YuDong et al., 1998). The QX like IBV strains were later 
reported in Europe, which was mainly associated with the nephropathogenicity and 
cystic oviducts (Abro et al., 2012; Benyeda et al., 2009; Cook et al., 2012; de Wit et 
al., 2011). In Europe, the nephropathogenicity of QX like IBV strains may have 
derived from the initial European nephropathogenic strains like B1648. By natural 
recombination events segments of the B1648 genome may have been transferred into 
genomes of NGA/A116E7/2006, UKr 27-11, ITA/90254/2005 and 
CK/SWE/0658946/10. The emergence or evolution of different coronaviral genotypes 
or strains by recombination events has been well documented in IBV and other 
coronaviruses (Hughes, 2011; Thor et al., 2011). Recombination analysis has 
suggested that the genetic recombination sites can be located in multiple genes (Lim 
et al., 2011). Regions that have the highest occurrence of recombination were located 
on the parts of replicase transcriptase complex (NSP2, 3, 4, 6, 13 and 14) and spike 
protein. The rate of recombination may be one of the important mechanisms for 
generating genetic and antigenic diversity within IBV (Hughes, 2011; Thor et al., 
2011). Accumulation of mutations and recombination events between the live 
vaccines and field strains likely produce novel variant strains or recombinant strains 
like, NGA/A116E7/2006 or Ukr27-11 (Ducatez et al., 2009). These novel strains are 
known to cause disease epidemics in chickens and vaccination failure (Lim et al., 
2011), and further studies are necessary to better understand the frequency of natural 
recombination events and which genes are preferentially involved in recombination. 
Pairwise comparisons have shown that B1648 was closely related to pathogenic non-
Mass type strains but not to Massachusetts type strains and vaccines. Based on the 
full-length genome, Nigerian reference IBADAN strain (NGA/A116E7/2006) was the 
closest relative with 91.6% nucleotide identity. Next closest were Ukrainian (UKr 27-
11) and American (Gray and JMK) strains with 91.2% nucleotide identity. It is known 
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that Gray is a nephropathogen and JMK is a respiratory pathogen, but the information 
on NGA/A116E7/2006 and UKr 27-11 strains about their tissue tropism is not 
available. Pairwise comparisons of 1a, Spike, M and accessory proteins (3a, 3b, 4b, 
4c, 5a, 5b and 6b) have suggested that B1648 was most closely related to non-Mass 
type strains. However, based on 1b, E and N proteins B1648 was closely related to 
both Mass and non-Mass types strains. All these comparisons have implicated that the 
determinants of nephropathogenicity (B1648 strain) might be located on the 1a, spike, 
M and accessory proteins. Many authors have shown that the pathogenicity 
determinants of IBV are multi-genic, and associated outside the spike protein 
(Ammayappan et al., 2009; Armesto et al., 2009; Britton et al., 2005; Casais et al., 
2003; Hodgson et al., 2006; Phillips et al., 2012). With the well-studied coronavirus, 
murine hepatitis virus (MHV), NSP1, Nsp3 and Nsp14 have been linked with 
virulence (Eriksson et al., 2008; Sperry et al., 2005; Züst et al., 2007). It is very well 
possible that the non-structural proteins (Nsp1 to Nsp11) encoded by ORF 1a may be 
strong candidates for being involved in the nephropathogenicity. However, this 
hypothesis has to be investigated and confirmed by RGS. 
Classification of the IBV serotypes is mainly based on the variability of the spike 
protein or partial S1 fragment (Abro et al., 2012; Cavanagh, 2007; Ducatez et al., 
2009; Rimondi et al., 2009). According to partial S1 gene analysis, Tunisian 
(TN20/00), Russian (IBV-27/99 and RF/06/2007) and Slovenian (SLO/266/05) strains 
were clustered together with B1648. This cluster is referred to as B1648 genotype. 
Moreover, TN20/00 was the closest among all the reported IBV strains with 97.4% 
nucleotide homology. Next closest were RF-27/99 (96.4%), RF/06/2007 (96.1%) and 
SLO/266/05 (89.4%) (Bochkov et al., 2006; Krapež et al., 2010). The partial S1 
fragment analysis has revealed that the B1648 genotype or its variants has been 
intermittently circulating in Europe and North Africa for over three decades 
(Bourogaa et al., 2012; Capua et al., 1999; Dolz et al., 2006; Ducatez et al., 2009; 
Meulemans et al., 1987; Ovchinnikova et al., 2011; Terregino et al., 2006; Toffan et 
al., 2013a; Tosi et al., 2010). Although the B1648 strain outbreak has occurred in 
1984, its origin remains still unidentified. This raises the question, whether B1648 
type has emerged from another animal species, like MERS-CoV of humans emerged 
from bats/camels (Abdel-Moneim, 2014; Chastel, 2014). The comparison with 
MERS-CoV is interesting because it is also associated with kidney problems in 
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humans. However, the phylogenetic analysis, full-length nucleotide identities and 
recombination analysis has shown that B1648 is distinct from other known avian and 
mammalian coronaviruses, and provides no information on its origin (data not 
shown). Based on the danger of cross species jumps of coronaviruses, more 
epidemiologic and surveillance studies should be done on coronaviruses in species 
living in the wild. Gammacoronaviruses could be circulating asymptomatically in 
wild birds as reservoirs, before emerging as a novel pathogenic IBV strains in 
chickens (Kim and Oem, 2014; Muradrasoli et al., 2010). In this context, efforts 
should be done to generate a database of full-length sequences of coronaviruses in 
wild animals e.g., wild migratory birds. 
In summary, the present study has demonstrated that B1648 is a distinct strain setting 
it apart from all strains reported so far in Europe and other parts of the world. Partial 
S1 gene analysis has suggested that B1648 genotype or its variants has been 
circulating in Europe and North Africa for over three decades. The pathogenicity 
determinants of B1648 strain might be located on the 1a, spike, M and accessory 
proteins (3a, 3b, 4b, 4c, 5a, 5b and 6b). However, the conclusions of this chapter 
should be confirmed by RGS and in vivo chicken experiments. Thus, one should be 
careful with over interpreting the results of this study. 
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Productive replication of nephropathogenic infectious bronchitis 
virus in peripheral blood monocytic cells, a strategy for viral 
dissemination and kidney infection in chickens 
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4.2.1. Abstract 
In the present study, the replication kinetics of nephropathogenic (B1648) and 
respiratory (Massachusetts-M41) IBV strains were compared in vitro in respiratory 
mucosa explants and blood monocytes (KUL01+ cells), and in vivo in chickens to 
understand why some IBV strains have a kidney tropism. B1648 was replicating 
somewhat better than M41 in the epithelium of the respiratory mucosa explants and 
used more KUL01+ cells to penetrate the deeper layers of the respiratory tract. B1648 
was productively replicating in KUL01+ monocytic cells in contrast with M41. In 
B1648 inoculated animals, 102.7-6.8 viral RNA copies/100 mg were detected in tracheal 
secretions at 2, 4, 6, 8, 10 and 12 days post inoculation (dpi), 102.4-4.5 viral RNA 
copies/ml in plasma at 2, 4, 6, 8, 10 and 12 dpi and 101.8-4.4 viral RNA copies/106 
mononuclear cells in blood at 2, 4, 6 and 8 dpi. In M41 inoculated animals, 102.6-7.0 
viral RNA copies/100 mg were detected in tracheal secretions at 2, 4, 6, 8 and 10 dpi, 
but viral RNA was not demonstrated in plasma and mononuclear cells (except in one 
chicken at 6 dpi). Infectious virus was detected only in plasma and mononuclear cells 
of the B1648 group. At euthanasia (12 dpi), viral RNA and antigen positive cells were 
detected in lungs, liver, spleen and kidneys of only the B1648 group and in tracheas 
of both the B1648 and M41 group. In conclusion, only B1648 can easily disseminate 
to internal organs via a cell-free and -associated viremia with KUL01+ cells as 
important carrier cells. 
4.2.2. Introduction  
Avian infectious bronchitis virus (IBV) causes mild to acute respiratory disease in 
chickens, characterized by coughing, sneezing, tracheal rales and dyspnea (Cavanagh 
and Naqi, 2003a). IBV belongs to the order of the Nidovirales, family Coronaviridae, 
subfamily Coronavirinae and genus Gammacoronavirus (Woo et al., 2014). 
Worldwide, IBV causes huge economic losses in both broilers and layers. IBV has a 
tropism not only for the epithelium of the respiratory tract but also for the epithelium 
of kidneys, oviduct, gastrointestinal tract (oesophagus, proventriculus, duodenum, 
jejunum, bursa of Fabricius, caecal tonsils, rectum and cloaca) and testes (Cavanagh, 
2007; Jackwood, 2012). IBV is clinically associated with poor performance of birds, 
reduced egg production and quality, as well as increased predisposition to other 
secondary bacterial infection (Cavanagh, 2005). IBV is highly contagious. Currently, 
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multiple serotypes of IBV exist, and new variants emerge due to frequent point 
mutations and recombination events in the viral genome (Jackwood, 2012). 
Vaccination failure is very common against IBV due to poor or no cross- protection 
between different IBV serotypes (Cook et al., 2001; Lambrechts et al., 1993; Pensaert 
and Lambrechts, 1994). 
The first IBV was isolated from birds showing respiratory problems in the United 
States in 1931 (Fabricant, 1998). In the early 1950s, the well-known respiratory 
Massachusetts type of IBV (Mass) was isolated in the United States. In subsequent 
years, Mass-type (prototype: M41) strains have been identified worldwide, and many 
variants emerged. Some IBV strains were called nephropathogenic because the initial 
respiratory infection was followed by severe kidney infection. Important clinical signs 
of nephropathogenic IBV strains include increased water consumption, low body 
weight gain, watery droppings and significant mortality. Necropsy of birds that died 
during a nephropathogenic infection reveals enlarged and pale kidneys with urates in 
the collecting tubules (Cook et al., 2012). In the 1960s, the first nephropathogenic 
IBV strains were reported in the US and Australia, and later worldwide. In the last 15 
years, nephropathogenic IBV strains have been emerging as most prevalent IBV 
strains in commercial poultry (Abdel-Moneim et al., 2006; Bayry et al., 2005; Lim et 
al., 2011; Mahmood et al., 2011; Meir et al., 2004). The B1648 strain is a Belgian 
reference nephropathogenic IBV serotype, that was responsible for large outbreaks of 
kidney disease in broiler farms in Belgium, The Netherlands and Northern France, 
and was first isolated in 1984 (Cook et al., 2012; Meulemans et al., 1987; Pensaert 
and Lambrechts, 1994; Reddy et al., 2015). 
In September 2012, a novel coronavirus emerged in humans, designated Middle East 
respiratory syndrome coronavirus (MERS-CoV). MERS-CoV has a higher mortality 
rate (>35%) than another well-known coronavirus, the severe acute respiratory 
syndrome coronavirus (SARS-CoV) (9.6%). The MERS-CoV infected patients 
usually end up with a severe pneumonia complicated with kidney failure. The severity 
of MERS CoV infections in humans, caused by its extra-pulmonary infection of 
kidneys have prompted us to question why this virus has a strong tropism for the 
kidneys. The same question has been raised for the kidney tropism of certain IBV 
strains, for the past 25 years. (Cook et al., 2012; Meulemans et al., 1987; Pensaert and 
Lambrechts, 1994; Reddy et al., 2015).  
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In mammals, many highly pathogenic viruses or virus strains exploit and replicate 
productively in macrophages to cause severe systemic disease (Cline et al., 2013; 
Dewerchin et al., 2005; Hoeve et al., 2012; Zhou et al., 2014). Because 
monocytes/macrophages are usually the first line of defense against virus entry, the 
successful replication of virus in these cells may hamper their immunological 
functions and by the migratory characteristics of these cells, virus is disseminated 
throughout the body. In this context, peripheral blood mononuclear cells (PBMC) 
were used to elucidate replication kinetics of IBV nephrpathogenic (B1648) and 
respiratory (M41) strains. 
Hence, in the present study, we aimed to explore the tissue tropism characteristics of 
IBV nephropathogenic (B1648) and respiratory (M41) strains in chickens. To this end, 
replication kinetics of IBV B1648 and M41 were evaluated in vitro in tracheal 
mucosa explants and blood monocytes by a reproducible quantitative analysis system 
using confocal microscopy (Frydas et al., 2013; Vairo et al., 2013; Vandekerckhove 
et al., 2010). A new 5’ RT-qPCR was validated and used for comparing in vivo the 
viral replication kinetics in the respiratory tract and dissemination in blood of IBV 
B1648 and M41 (Desmarets et al., 2016). Elucidating the tissue tropism mechanisms 
of B1648 and M41 is important to plan better prevention strategies for emerging 
highly nephropathogenic IBV infections. 
4.2.3. Materials and Methods 
4.2.3.1. IBV B1648 and M41 replication characteristics in tracheal mucosa 
explants and peripheral blood monocytes 
4.2.3.1.1. Viruses 
The virulent nephropathogenic IBV B1648 and the respiratory prototype M41 were 
used in this study. B1648 is a Belgian field isolate obtained in 1984 and described 
previously (Lambrechts et al., 1993; Meulemans et al., 1987; Reddy et al., 2015). 
M41 with unknown passage history was obtained from the avian pathology laboratory, 
Ghent University (Pensaert et al., 1981). Virus was propagated in specific pathogen 
free (SPF) 10 days old embryonated chicken eggs. From both B1648 and M41, a 
second passage was produced and utilized in the present experiment. The allantoic 
fluids were harvested 48 hours after infection, cleared by low-speed centrifugation 
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and stored at -70°C. Virus titration was performed in 10 days old chicken embryos by 
inoculation of 10-fold dilutions via allantoic route and expressed as 50% egg 
infectious dose per ml (EID50/ml). 
4.2.3.1.2. Virus titration 
Intracellular and extracellular virus titers were determined by an EID50 assay using 
embryonated chicken eggs. Embryonated chicken eggs were obtained from an SPF 
flock and used when the embryos were 10 days old. Ten-fold dilutions of virus were 
prepared in PBS (1x Dulbecco’s phosphate buffered saline (DPBS) with 0.9 mM 
CaCl2, 0.5 mM MgCl2 × 6H2O and 20 mg/L phenol red) (Jackwood, 2012) and 100 µl 
of the dilutions were inoculated into the allantoic cavity of eggs. Eggs were incubated 
at 37°C for 7 days. The embryos were collected and examined for the presence of 
embryo dwarfing and curling, which is characteristic for an IBV infection. Based on 
the observations, end points were calculated (Cook et al., 1976; Cook et al., 2012). 
Virus titers were assessed by a fifty percent end-point, according to the method of 
Reed and Muench, and expressed as EID50/ml. 
4.2.3.1.3. Isolation and cultivation of chicken tracheal mucosa explants 
This study was performed in agreement with the guidelines of the local Ethical and 
Animal Welfare Committee of the Faculty of Veterinary Medicine and Bio-Science 
Engineering of Ghent University. The chicken tracheal mucosa explants were 
prepared as described previously (Reddy et al., 2014). Briefly, three eight-week-old 
specific-pathogen free (SPF) chickens were euthanized by intravenous injection of 
sodium pentobarbital (100 mg/kg) in the brachial wing vein. Tracheas were collected 
and carefully split into two equal halves with surgical blades (Swann-Morton). 
Tracheal mucosal explants covering a total area of 10 mm2 were made and placed on 
top of fine-meshed gauzes in six-well culture plates (Nunc), epithelium upwards. The 
explants were maintained in serum-free medium (50% Ham’s F12 (Gibco)/50% 
DMEM (Gibco)) supplemented with 100 U/mL penicillin (Continental Pharma), 
0.1 mg/mL streptomycin (Certa), 1 µg/mL gentamycin (Gibco) and 25 mM HEPES 
(Gibco). The epithelium of the explants was slightly immersed in the fluid to achieve 
an air liquid interface. Explants were maintained up to 96 hours at 37°C and 5% CO2. 
4.2.3.1.4. Isolation of blood monocytes 
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Five ml blood was collected on heparin (15 U/ml) (Leo) from the brachial wing vein 
of three chickens. Monocytes were isolated from chicken PBMC by Ficoll-paque 
gradient centrifugation as described by the manufacturer (Pharmacia Biotech AB). 
Mononuclear cells were resuspended in RPMI-1640 (Gibco) medium containing 10% 
fetal calf serum (FCS, Gibco), 100 U/ml penicillin (Continental Pharma), 0.1 mg/ml 
streptomycin (Certa), 1 µg/ml gentamycin (Gibco), and 1% non-essential amino acids 
(Gibco). Afterwards, 2×106 cells/ml were seeded in a 24-well plate (Nunc) and 
cultivated at 37°C with 5% CO2. Non-adherent cells were removed by washing two 
times with RPMI-1640 medium at 2 and 24 h after seeding. The adherent cell 
population consisted of 80.2 ± 7.3% of monocytes, based on the fluorescent staining 
with the monocyte/macrophage marker KUL01 (Mast et al., 1998). KUL01+ cells 
were cultured up to 96 hours at 37°C and 5% CO2. All experiments were performed in 
triplicate. 
4.2.3.1.5. IBV inoculation and sample collection of tracheal mucosa explants and 
monocytes 
Tracheas of three chickens were used. Explants were inoculated with IBV B1648 and 
M41 at 24 h of cultivation. For the inoculation, explants were taken from their gauze 
and placed at the bottom of a 24-well plate with the epithelial surface upwards. 
Explants were washed twice with warm serum-free medium and inoculated with 1 ml 
of a virus stock containing 107.0 EID50 (1 h, 37°C, 5% CO2). In in vitro tracheal 
mucosa experiments, the local mucus layer and other innate defense barriers reduce 
infectivity of the mucosa. Therefore, the mucosal explants were washed before 
inoculation to remove mucus and other innate defense barriers and high virus titers 
were used (107 EID50/ml) in order to have sufficient virus to reach the epithelial cells. 
In addition, the main aim of this study was to evaluate replication kinetics at early 
time points, before the viability of the mucosal explants goes down, i.e. 96 h of 
cultivation and 72 h after virus inoculation. To meet the above expectations, the use of 
a high virus titer for the inoculation of in vitro mucosal explants is a general 
standardized protocol in our laboratory (Glorieux et al., 2011; Steukers et al., 2011, 
2012; Vairo et al., 2013). After one hour of virus incubation, the inoculated explants 
were washed three times with warm medium and placed back on the gauze. Explants 
were collected at 0, 6, 12, 24, 48 and 72 hours post-inoculation (hpi), embedded in 
Methocel® (Fluka) and frozen at -70°C. 
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Monocytes were inoculated with IBV B1648 and M41 at a multiplicity of infection 
(m.o.i.) of 5. To maintain uniformity and consistency, the virus titer of inoculum, 
incubation time, washing steps and sample collection time points should be similar in 
TOC and monocyte cultures under in vitro conditions. Therefore, the same virus titer 
was used to inoculate in vitro cultured monocytes. After 1 h of virus incubation (37°C, 
5% CO2), cells were washed three times with warm RPMI-1640 medium and further 
incubated in medium. Cells and supernatant were collected at 0, 6, 12, 24, 48 and 72 
hpi for viral antigen quantification and virus titration. The cells were removed from 
the well by scraping and added to the pellet for determination of intracellular virus 
titers. Virus was released from the cells by 2 freeze-thaw cycles. The supernatants 
were used for determination of extracellular virus titers. The samples were stored at -
70°C until virus titration on embryonated eggs. 
4.2.3.1.6. Identification and quantification of IBV infected cells in the tracheal 
mucosa explants and monocytes 
A double immunofluorescence staining was performed to identify and quantify 
individual IBV-positive cells. At 0, 6, 12, 24, 48 and 72 hpi, 15 consecutive 
cryosections of 10 µm were made from the frozen tracheal explants and fixed (4% 
paraformaldehyde for 10 minutes and 0.1% Triton® X-100 for 2 minutes). The 
cryosections were first stained for monocytes/macrophages (KUL01 marker), and 
next for IBV antigens. The cryosections were incubated (1 h, 37°C) with mouse 
monoclonal anti-chicken monocyte/macrophage (KUL01) antibodies (Southern 
Biotech) (1:250 in PBS containing 10% negative goat serum) and washed three times 
after incubation. Cryosections were then incubated (1 h, 37°C) with Texas Red-
labelled goat anti-mouse IgG1 antibodies (Molecular Probes) (1:250 in PBS 
containing 10% negative goat serum and 10% negative chicken serum). Subsequently, 
after washing, the sections were incubated (1 h, 37°C) with a polyvalent IBV 
hyperimmune serum conjugated with FITC (Lambrechts et al., 1993; Pensaert and 
Lambrechts, 1994) (1:20 in PBS for B1648; 1:7 in PBS for M41). Finally, after 
washing, the sections were incubated (10 min, room temperature [RT]) with Hoechst 
33342 (1:100 in PBS), washed and mounted with glycerin-DABCO (Janssen 
Chimica).  
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Based on cross serum neutralization tests, B1648 is distantly related to respiratory 
IBV strains. FITC-conjugated antibodies were prepared from a polyclonal 
hyperimmune serum against B1648 strain, and their reactivity against B1648 infected 
cells was quite different from the reactivity against M41 infected cells (Lambrechts et 
al., 1993; Pensaert and Lambrechts, 1994). As a result, the concentration of FITC-
conjugated polyclonal anti-B1648 antibodies that is needed to detect IBV-positive 
cells was higher for M41 than for B1648 (Pensaert et al., 1981). The IBV-positive cell 
quantification done with FITC-conjugated polyclonal anti-B1648 antibodies was 
confirmed by monoclonal antibodies directed against the nucleocapsid protein 
(Ignjatovic and McWaters, 1991). The number of virus-infected cells was determined 
in 15 consecutive cryosections in both the epithelium and lamina propria of the 
tracheal mucosa explants. Further, at each time point, the number of infected KUL01+ 
cells was calculated both in the epithelium and lamina propria. 
Monocytes were fixed in 4% paraformaldehyde for 10 minutes and 0.1% Triton® X-
100 for 2 minutes at 0, 6, 12, 24, 48 and 72 hpi. IBV-positive cells in monocytes were 
visualized using the same technique as for the cryosections. The percentage of B1648 
and M41-positive cells was determined for the KUL01+ cells (colocalization). A 
reproducible quantitative analysis system was followed for the elucidation of IBV 
replication in the tracheal mucosal explants and blood monocytes/macrophages 
(KUL01+ cells) by using a confocal microscopy (Leica TCS SPE confocal microscope) 
(Frydas et al., 2013; Vairo et al., 2013; Vandekerckhove et al., 2010). 
4.2.3.2. Replication kinetics of IBV B1648 and M41 in chickens 
4.2.3.2.1. Experimental design 
Table 1. Experimental design of in vivo IBV (B1648/M41) infection study. 
Group  Time of inoculation (days post inoculation) 
Virus strain 
Number of 
animals  
Observation of clinical 
signs 
Tracheal swab 
collection 
Blood collection 
(plasma and 
PBMC*) 
Euthanasia 
B1648  3 -3 to 12 0, 2, 4, 6, 8, 10, 12 0, 2, 4, 6, 8, 10, 12 12 
M41  3 -3 to 12 0, 2, 4, 6, 8, 10, 12 0, 2, 4, 6, 8, 10, 12 12 
PBS 
control  
3 -3 to 12 0, 2, 4, 6, 8, 10, 12 0, 2, 4, 6, 8, 10, 12 12 
      
* Peripheral blood mononuclear cells. 
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The experimental setup is presented in Table 1. Nine 3-week-old SPF White Leghorn 
chickens were individually tagged and 3 chickens per group were housed in separate 
negative pressure (150 pa) isolation units (IM 1500, Montair). Before the start of the 
experiment, an acclimatization period of two-weeks was respected. Drinking water 
and food were provided ad libitum. The experimental design was evaluated and 
approved by the Ethical and Animal Welfare Committee of the Faculty of Veterinary 
Medicine of Ghent University (EC 2014/160). 
4.2.3.2.2. Virus inoculation 
Three 5-week-old chickens were inoculated with the virulent nephropathogenic 
B1648 strain or respiratory M41 via intratracheal (200 µl), nasal (50 µl each nostril) 
and ocular routes (50 µl each eye) with 103 EID50/400 µl. The main aim of our in vivo 
study was to study the replication kinetics of IBV in the respiratory mucosa and its 
spread via blood to internal organs (0 to 12 dpi). To conduct this in vivo study 
successfully, mortality should not be induced. Based on our experience of past 
experiments and available literature, we have selected 103 EID50/400 µl to keep the 
chance of mortality at a minimal level (Ariaans et al., 2008; Lambrechts et al., 1993; 
Tang et al., 2008). The control chickens were mock inoculated with PBS and served 
as a negative control group. 
4.2.3.2.3. Clinical signs and water consumption 
Clinical signs, such as depression, huddling together, ruffled feathers, sneezing, 
coughing, tracheal rales and dyspnoea were recorded daily from -3 until 12 days post 
inoculation (dpi). Drinkers were regularly weighed in each group to calculate water 
consumption per bird. 
4.2.3.2.4. Post mortem findings 
At 12 dpi, the chickens from the three groups were humanely euthanized. During 
necropsy, all tissues were examined macroscopically. After macroscopical 
examination, two samples were collected from the following tissues: trachea, lungs, 
liver, spleen and kidneys. The first tissue sample was stored at -70°C for viral RNA 
quantification by RT-qPCR. The second tissue sample was embedded in Methocel® 
(Fluka) and was snap frozen for immunofluorescence staining. 
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4.2.3.2.5. Standardization of SYBR green-based RT-qPCR assay for ORF 1a 
gene 
To avoid the detection of subgenomic mRNAs, the real-time 5’ RT-qPCR primers 
were designed by targeting the highly conserved region of open reading frame (ORF) 
1a of B1648 strain  (Table 2). Then, a single step SYBR green-based 5’ RT-qPCR 
assay was developed for ORF1a gene. 
Table 2. Primers used for real-time RT-PCR of ORF 1a. 
Primer name Gene Primer sequence 
Amplicon 
Size 
cDNA_fw ORF 1a 5’-GGT GTT AGG CTT ATA GTT CCT CAG-3’ 254 nt 
cDNA_rv ORF 1a 5’-TAA ACA TTA GGG TTG ACA CCA GT-3’  
T7_fw ORF 1a 5’-TAA TAC GAC TCA CTA TAG GGG GTG TTA GGC TTA TAG TTC CTC AG-3’  
qPCR_fw ORF 1a 5’-GCT ATT GTA GAG GTA GTG TAT GTG AG-3’ 176 nt 
qPCR_rv ORF 1a 5’-AGG GTT GAC ACC AGT AAA GAA T-3’  
 
4.2.3.2.6. Primer design and in silico validation 
Multiple sequence alignments were performed with the relevant IBV sequences of 
GenBank in the MEGA software version 5.2.2. The real-time RT-qPCR primers were 
designed using the online web tool Primer 3 plus http://www.bioinformatics.nl/cgi-
bin/primer3plus/primer3plus.cgi/. The sequences of the primers for real-time RT-
qPCR targeting ORF 1a and amplicon size are listed in Table 2. Primer-specificity 
was assessed in silico by use of the Basic Local Alignment Search Tool (BLAST) in 
public databases and by aligning these primers to ORF 1a genes of pan IBV strains of 
the worldwide. The risk of primer-dimer formation, and the presence of hairpins at the 
annealing site were analyzed using OligoAnalyzer 3.1 (Integrated DNA Technologies) 
with a correction for ion concentrations set at 50 mM for Na+ and 3 mM for Mg2+. All 
primers used in this study were synthesized by Integrated DNA Technologies and 
purified by standard desalting. 
4.2.3.2.7. Preparation of RNA standards for absolute quantification  
Standard RNA for absolute quantification was prepared from B1648. Viral RNA of 
the B1648 was extracted using the QIAamp Viral RNA Mini Kit (Qiagen). A 
synthetic fragment containing the amplicon size of 254 nt of ORF 1a gene was 
generated in vitro to prepare the standard RNA for absolute quantification. The RNA 
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was reverse-transcribed into cDNA with the QIAGEN OneStep RT-PCR Kit (Qiagen), 
using primer set ORF 1a cDNA_fw/cDNA_rv (Table 2). ORF 1a cDNA_fw primer 
was modified to T7_fw with a T7 promoter sequence at its 5’ end by Herculase II 
fusion DNA polymerase (Agilent Technologies Inc., Santa Clara, CA, USA). The T7 
promoter sequence incorporation was necessary for subsequent in vitro transcription 
(Table 2). A 50 µl OneStep RT-PCR (Qiagen) reaction mixture consisting 10 µl 
OneStep RT-PCR buffer (Qiagen), 2 µl dNTP (10 mM) mix, 3 µl forward primer (10 
µM), 3 µl reverse primer (10 µM), 2 µl OneStep RT-PCR enzyme mix, 20 µl nuclease 
free water and 10 µl RNA. To generate the cDNA fragment, a reverese transcription 
step of 30 min at 50°C and an enzyme activation step of 15 min at 95°C were 
followed by 35 cycles each denaturation 30 s at 94°C, annealing 30 s at 48°C and 
extension 1 min at 72°C. A final extension step was performed for 10 min at 72°C and 
stored at 4°C until further processing. Then, the cDNA fragment was analyzed by 2% 
agarose gel electrophoresis, and fragments with the correct length were excised and 
purified from gel using the Nucleospin Gel and PCR-Clean up kit (Macherey-Nagel). 
The cDNA was either used directly for in vitro transcription or stored at -70°C. In 
vitro transcription of RNA was performed by incubation for 1h at 37°C with 10x 
transcription buffer, 500 µM rNTPs and 20 U T7 RNA Polymerase-Plus Enzyme Mix 
(Applied Biosystems). Template DNA was removed by treatment with enzyme 2U 
DNase I (Sigma Aldrich) for 15 min at 37°C. Then, enzyme DNase I inactivation was 
done for 10 min at 75°C. Finally, the in vitro generated RNA was purified using the 
RNeasy Mini Kit (Qiagen) and the amount of RNA was determined using the 
Nanodrop 2000 Spectrophotometer (Thermo Scientific). RNA standards were stored 
in single-use aliquots of 20 µl (8 ng/µl, 5.27×1010 copies/µl) volume at -70°C. Ten 
microliters of RNA was used for preparation of a standard curve, and the remainder (6 
µl) was used to determine the RNA concentration with the Nanodrop 2000 
Spectrophotometer. The ENDMEMO online web tool was used to calculate the 
number of RNA copies per microliter (http://endmemo.com/bio/dnacopynum.php). 
4.2.3.2.8. SYBR Green based one step RT-qPCR protocol  
In order to generate a standard curve, the concentration of RNA was measured as 
described above, and further serially ten-fold diluted in nuclease free water (Gibco). 
RT-qPCR reaction mixtures (20 µl) consisted of 10 µl Precision OneStep qRT-PCR 
Mastermix with SYBR Green and ROX (Primer Design), 200 nM (0.4 µl/reaction) of 
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each primer (qPCR_fw and qPCR_rv), 6.2 µl nuclease free water and 3 µl of standard 
RNA template or H2O. Reaction mixtures were loaded in MicroAmp Optical 96-Well 
Reaction plates (Applied Biosystems), sealed with MicroAmp Optical Adhesive Films 
(Applied Biosystems), and experiments were performed in a StepOnePlus apparatus 
(Applied Biosystems). A reverse transcription step of 10 min at 55°C and an enzyme 
activation step at 95°C for 8 min were followed by 40 cycles, each 10 s at 95°C and 
60 s at 58°C. Afterwards, a first-derivative melting curve analysis was performed by 
heating the mixture to 95°C for 15 s, then cooling to 60°C for 1 min, and heating back 
to 95°C at 0.3°C increments. Results were analyzed using the StepOnePlus Software 
version 2.2. The baseline was set automatically, and the threshold was placed 
manually in the exponential phase of the amplification reaction. Melt curve analysis 
and agarose gel electrophoresis were performed to assess specificity of the reactions. 
Amplification efficiency was determined by running a standard curve over a linear 
dynamic range (LDR) from 7 log10 copies/reaction to 1 log10 copies/reaction in 1:10 
dilution steps. Each dilution point of the standard curve was analyzed in triplicate and 
also three non-template control reactions (nuclease free water) were included in each 
experiment. 
4.2.3.2.9. Collection of tracheal secretions, plasma and PBMCs 
Tracheal secretions and 2 ml of blood [with EDTA (VWR)] were collected from each 
chicken at 0, 2, 4, 6, 8, 10 and 12 dpi. Immediately after collection, tracheal secretions 
were immersed in transport medium containing PBS [1x Dulbecco’s PBS (DPBS) 
with 0.9 mM CaCl2, 0.5 mM MgCl2 × 6H2O and 20 mg/L phenol red] supplemented 
with 10% FCS, 1000 U/ml penicillin, 1 mg/ml streptomycin and 0.5 mg/ml 
kanamycin. Plain swabs were weighed before and after swabbing, and viral RNA 
copies were calculated per 100 mg of secretions. Plasma was harvested from blood 
after centrifugation (300g, 10 min) and the remaining pellet was used for isolation of 
PBMCs (mononuclear cells). Mononuclear cells were isolated by Ficoll-paque 
gradient centrifugation as described above (section A). Infection in mononuclear cells 
was evaluated by three methods. With the first method, 200,000 mononuclear cells 
were used to make cytospins and to perform immunostainings (protocol was 
described in section A), to quantitate the number of viral antigen positive cells. With 
the second method and third method, 106 mononuclear cells were lysed by one freeze-
thaw cycle to determine the number of viral RNA copies by RT-qPCR, and to confirm 
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the presence of infectious virus by virus isolation, respectively. Plasma and 106 
mononuclear cells were stored at -70°C until use. 
4.2.3.2.10. RT-qPCR in tracheal secretions, plasma and mononuclear cells 
Viral RNA was extracted from tracheal secretions, plasma and mononuclear cells 
using the QIAamp Viral RNA Mini Kit (Qiagen). Three µl of RNA was used per RT-
qPCR reaction. Viral RNA extracts from tracheal secretions, plasma and mononuclear 
cells were analyzed in duplicate RT-qPCR reactions as described above. 
4.2.3.2.11. Virus isolation in plasma and mononuclear cells 
Virus isolation from the plasma and 106 mononuclear cells samples were performed 
on 10 days old embryonated SPF eggs, to confirm the presence of infectious virus 
(protocol described in section A). If embryo dwarfing and curling lesions were not 
observed after the first inoculation, up to five blind passages of the samples were 
performed. 
4.2.3.2.12. RT-qPCR and immunofluorescence staining of tissues 
RNA was extracted from tissues using the QIAamp cador Pathogen Mini Kit (Qiagen). 
Quantification of the number of viral RNA copies in tissues (RNA copies/g) was 
similar like in other samples. IBV-positive cells in tissues were visualized and 
quantified using the same technique as for the cryosections of tracheal mucosa 
explants. Twenty consecutive cryosections of 10 µm were analyzed per tissue. The 
average number of infected cells was expressed per 10 mm2 of tissue. 
4.2.3.2.13. Statistical analysis 
SigmaPlot (Systat Software, Inc.) software was used to analyse the data statistically 
with one-way analysis of variance (ANOVA). Viral loads in tracheal secretions, 
plasma and mononuclear cells were log-transformed prior to analysis. The 
quantification limit of RT-qPCR was 3.4 log10 copies/ml (quantification limit is the 
concentration/amount of viral RNA copies, which can be quantified reliably). The 
detection limit of RT-qPCR was 2.4 log10 copies/ml (detection limit is the minimal 
concentration of viral that can be detected). The results of three independent 
experiments were shown as mean ± standard deviation (SD). P values of < 0.05 were 
considered to be significant. 
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4.2.4. Results 
4.2.4.1. IBV B1648 and M41 replication characteristics in respiratory mucosa 
and KUL01+ cells 
4.2.4.1.1. B1648 and M41 replication in tracheal mucosa explants  
Inoculation of chicken tracheal mucosa explants with IBV B1648 and M41 led to the 
appearance of viral antigen positive (infected) cells in the epithelium and lamina 
propria of the tracheal mucosa starting from 6 hpi (Figure 1). In the epithelial layer of 
the tracheal mucosa, the number of B1648 and M41 infected cells gradually increased 
until 12 hpi, and later gradually decreased up to 72 hpi (Figure 1A). The number of 
B1648 infected cells in the epithelium was significantly higher than M41 infected 
cells at 6 (B1648: 2856.3 ± 217.2 [which equals 37.2 ± 2.8% of the epithelial cells], 
M41: 877.0 ± 142.7 [11.2 ± 2.9%], P = 0.0002), 12 (B1648: 6490.3 ± 298.9 [82.5 ± 
4.1%], M41: 4380.0 ± 203.1 [57.6 ± 3.4%], P = 0.0005) and 24 hpi (B1648: 4077.3 ± 
225.4 [51.8 ± 4.8%], M41: 3064.3 ± 144.9 [38.9 ± 3.0%], P = 0.0028). The number of 
M41 infected cells was significantly higher than B1648 infected cells at 48 hpi 
(B1648: 664.7 ± 164.7, M41: 1446.7 ± 354.3, P = 0.0257) and were slightly higher at 
72 hpi (B1648: 130.0 ± 62.4, M41: 179.3 ± 67.6, P = 0.4057). From 48 hpi, the 
epithelial layer was almost totally gone, which explained the drop of positive cells. 
In the lamina propria of the tracheal mucosa, B1648 and M41 infected cells were 
visible from 6 hpi and increased in number over time (Figure 1A). In the lamina 
propria, the average number of B1648 infected cells was only slightly higher than 
M41 infected cells at 6, 12, 24 and 48 hpi (P = 0.6433 to 0.1578) but significantly 
higher at 72 hpi (P = 0.0249).  
Double immunofluorescence staining was performed for the identification of IBV 
susceptible cells. IBV infected KUL01+ cells were detected in the epithelium and 
lamina propria of the respiratory mucosa inoculated with both B1648 and M41 
(Figure 1A). In the epithelium, the average number of B1648 infected KUL01+ cells 
was slightly higher than M41 infected KUL01+ cells at 24 and 48 hpi (P = 0.2302 to 
0.0705) but significantly higher at 72 hpi (P = 0.0270). In the lamina propria, the 
average number of B1648 infected KUL01+ cells was higher than M41 infected 
KUL01+ cells at 12, 24, 48 and 72 hpi (P = 0.0686 to 0.0550). Interestingly, the 
Productive replication of NIBV in PBMCs, a strategy for kidney infection	  
	   125 
number of infected KUL01+ cells (monocytic cells) started to increase from 12 hpi, 
when the total number of IBV infected cells started to decrease. Representative 
images of IBV infected cells and IBV infected KUL01+ cells are given in Figure 1B. 
The above results indicate that in the epithelium B1648 replicated better than M41 
until 24 hpi. Then, the replication pattern changed. B1648 exploited more infected 
KUL01+ cells but without significant differences with M41 in most of the times post 
inoculation evaluated. 
 
Figure 1. IBV infected cell quantification (A) and antigen expression (B) in tracheal 
mucosa explants. (A) Number of IBV B1648 and M41 infected cells and infected 
KUL01+ cells were quantified in the epithelial layer and lamina propria of tracheal 
mucosa explants. Fifteen consecutive cryosections were analysed at 0, 6, 12, 24, 48 
and 72 hpi to quantify infected cells. The number of infected KUL01+cells starts to 
!
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increase from 12 hpi, when the total number of IBV infected cells starts to decrease. 
Lines represent the evolution of arithmetic means without any transformation of 
original data. Solid line represents mean values of B1648, dashed line represents mean 
values of M41 and dotted line represents mean values of mock. An asterisk (*) 
indicates a significant difference (P < 0.05) between B1648 and M41. (B) 
Representative confocal photomicrograph illustrating IBV infected cells (left panel) in 
the epithelium (arrows) and lamina propria (arrowheads), and IBV infected 
KUL01+cell (middle panel) in lamina propria (arrowhead) of the tracheal mucosa. 
Mock-inoculated tracheal mucosa (right panel). Green fluorescence visualises IBV 
antigens. KUL01+ cells are visualised by red fluorescence. Cell nuclei were stained 
with Hoechst (blue). White dotted line indicates the BM. Scale bar represents 50 µm. 
4.2.4.1.2. IBV B1648 and M41 replication in blood monocytic cells (KUL01+ cells) 
The replication kinetics of IBV B1648 and M41 were compared in the peripheral 
blood monocytic cells (KUL01+ cells) (Figure 2). In blood monocytes (KUL01+ cells), 
the percentage of B1648 infected cells was significantly higher than M41 infected 
cells at 12 (B1648: 9.7 ± 1.3%, M41: 2.2 ± 1.9%, P = 0.0051), 24 (B1648: 16.0 ± 
2.6%, M41: 2.3 ± 1.5%, P = 0.0013), 48 (B1648: 21.1 ± 6.0%, M41: 1.4 ± 1.7%, P = 
0.0053) and 72 hpi (B1648: 46.0 ± 8.6%, M41: 2.2 ± 1.7%, P = 0.0010). Virus titers 
were analyzed in the cell lysate (intracellular virus) and supernatant (extracellular 
virus) of the infected blood monocytes. The intracellular and extracellular B1648 
virus titers increased over time until 24 hpi, and later reached a plateau or slightly 
decreased up to 72 hpi. The intracellular virus titers with strain B1648 were 
significantly higher than M41 strain at 12 (P = 0.0115), 24 (P = 0.0152), 48 (P = 
0.0014) and 72 hpi (P = 0.0063). The extracellular titers with B1648 were higher than 
with M41 at 12 hpi (P = 0.0501), and were significantly higher at 24 (P = 0.0077), 48 
(P = 0.0118) and 72 hpi (P = 0.0270). On the contrary, no increase in viral titers was 
seen in cell lysate and supernatant of blood monocytic cells infected with M41, with a 
slope comparable to the inactivation curve. Over all, the above results demonstrated 
that only B1648 could establish a productive infection in the peripheral blood 
monocytic cells (KUL01+ cells). 
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Figure 2. IBV replication kinetics in blood monocytes (KUL01+ cells). The 
monocytes were inoculated with IBV B1648 or M41 at a m.o.i. = 5. Percentage of 
viral antigen positive KUL01+ cells was determined in B1648 and M41 infected blood 
mononuclear cells at 0, 6, 12, 24, 48 and 72 hpi by double immunofluorescence. For 
viral antigen positive cells, the solid line represents the mean values of the B1648 
group, the dashed line represents the mean values of the M41 group and the dotted 
line represents the mean values of the mock group. Intracellular and extracellular 
virus titers of cell lysate and supernatant were determined at designated time points. 
For viral titers, the solid line represents the mean values of the intracellular virus titers, 
the dashed line represents the mean values of the extracellular virus titers and the 
dotted line represents the mean values of the inactivation curve. An asterisk (*) 
indicates a significant difference of viral antigen positive KUL01+ cells between 
B1648 and M41 (P < 0.05). The inactivation curve shows the drop of virus titers at 
37°C in culture medium due to inactivation events.  
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4.2.4.2. Replication kinetics between B1648 and M41 strains in chickens  
4.2.4.2.1. Clinical signs and water consumption 
After inoculation with B1648 and M41, all chickens showed signs of illness 
characterized by depression, ruffled feathers, huddling together, tracheal rales, 
sneezing, coughing and dyspnoea from 2 dpi to 10 dpi. None of the control chickens 
showed any clinical signs during the whole experiment. Water consumption was 
increased in the B1648 group (1370.7 g/bird) compared to the control group (853.7 
g/bird) and the M41 group (792.2 g/bird). Reduced body weight gain was observed in 
the B1648 group compared to the control group and the M41 group (data not shown). 
4.2.4.2.2. Post mortem findings 
Chickens were euthanized at 12 dpi. Tissue samples of trachea, lungs, liver, spleen 
and kidneys were collected from all three groups. At necropsy, enlarged kidneys were 
observed in animals of the B1648 group. No lesions were observed in kidneys of the 
M41 group (Figure 3). Gross lesions were not observed in trachea, lungs, liver and 
spleen of animals of the B1648, M41 and control groups. 
 
Figure 3. Representative photographs of kidneys after euthanasia (12 dpi). Kidneys 
were collected from chickens inoculated with IBV B1648 and M41, and PBS (mock). 
The kidneys of the chicken infected with B1648 were clearly enlarged.  
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4.2.4.2.3. Standardization of SYBR green-based RT-qPCR assay for ORF 1a 
gene and interpretation of results 
SYBR green-based one step RT-qPCR was performed to generate a standard curve, 
using 1:10 serially diluted standard RNA templates. The results indicated that the 
standard curve had a wide dynamic range (101-107 copies/reaction) with the high 
linear correlation (R2 = 0.9999) between the cycle threshold (Ct) value and template 
concentration (Figure 4A). The slope of the standard curve was -3.297. The 
amplification efficiency of the RT-qPCR assay was 102.3%, according to the slope of 
the exponential phase in the amplification chart (Figure 4B). Melt curve analysis 
showed amplification of a specific product with a melting peak at 78.31°C (Figure 
4C), which was confirmed by the agarose gel electrophoresis analysis. Amplification 
was not observed in the non-template control. RNA extracts from samples were 
analyzed in duplicate reactions. Quantification of the viral RNA copies was possible 
if the Cq values of both reactions fell within the LDR of the RT-qPCR assay. Samples 
with a specific melt curve were considered positive but not quantifiable when the Cq 
value of the reactions fell at Cq values higher than the lowest peak of the LDR. 
 
Figure 4. Standardization of SYBR green-based RT-qPCR for ORF 1a gene. (A) 
Standard curve, (B) amplification plot and (C) melt curve analysis over a linear 
dynamic range from 1 log10 to 7 log10 copies/reaction. 
4.2.4.2.4. RT-qPCR for tracheal secretions, plasma and mononuclear cells 
Viral RNA in tracheal secretions, plasma and mononuclear cells was quantified by 
RT-qPCR (Figure 5). The virus-shedding pattern in tracheal mucosa was the same 
until 10 dpi for both B1648 and M41. Viral shedding in tracheal mucosa was 
10^7 10^6 10^5 10^4 10^3 10^2 10^1 
Threshold 
NTC 
Cycle 
R
n 
Th
re
sh
ol
d 
C
yc
le
 (C
T)
 
Quantity (copies) Temperature (oC) 
D
er
iv
at
iv
e 
R
ep
or
te
r (
-R
n’
) 
A. C. B. 
Chapter 4.2 
	   130 
identified from 2 to 12 dpi in the B1648 group with a maximum number of 106.8 viral 
RNA copies/100 mg, and from 2 to 10 dpi in the M41 group with a maximum number 
of 107.0 viral RNA copies/100 mg. In the B1648 group, two chickens were positive at 
10 and 12 dpi. Two chickens were positive at 10 dpi, in the M41 group. In tracheal 
secretions, viral RNA copies were not significantly different between the B1648 and 
M41 groups. 
 
Figure 5. IBV RNA in tracheal secretions, plasma and mononuclear cells. Samples 
were collected from IBV B1648 and M41, and PBS (mock) inoculated chickens at 0, 
2, 4, 6, 8, 10 and 12 dpi. Viral RNA was measured by RT-qPCR. Solid and dashed 
lines represent mean viral RNA copies per strain and per day. Mock is represented by 
the dash-dotted line. The quantification limit of RT-qPCR was 3.4 log10 copies/ml 
(dotted line). The detection limit of RT-qPCR was 2.4 log10 copies/ml (bold dotted 
line). 
In plasma, viral RNA was first detected in the B1648 group at 2 dpi and was observed 
until the end of the study (12 dpi, n = 2), with a peak number of 104.5 viral RNA 
copies/ml. In the M41 group, viral RNA was not detected in plasma, except of one 
animal at 6 dpi (n = 1, 102.6 viral RNA copies/ml).  
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In mononuclear cells, viral RNA was first detected in the B1648 group at 2 dpi and 
lasted until 8 dpi (n = 2) with a peak number of 104.4 viral RNA copies/106 cells. In 
contrast, viral RNA was not detected in mononuclear cells of the M41 inoculated 
animals, except of one chicken at 6 dpi (n = 1, 102.8 viral RNA copies/106 cells). 
The statistical analysis was not performed on viral RNA copies in plasma and 
mononuclear cells because the M41 group was negative except of one chicken at 6 dpi. 
4.2.4.2.5. Immunostainings of cytospinned mononuclear cells 
Immunofluorescence stainings of 200,000 cytospinned mononuclear cells revealed 
B1648 infected cells at 2 (2/3 animals), 4 (3/3) and 6 (2/3) dpi, and B1648 infected 
KUL01+ cells at 4 (1/3) and 6 (1/3) dpi. Infected cells were not observed in 
cytospinned mononuclear cells of M41 and control groups (Figure 6). 
 
 
 
 
 
 
 
 
 
 
Figure 6. Quantification and identification of IBV B1648 and M41 infected total and 
KUL01+ PBMC. IBV B1648 and M41, and PBS (mock) inoculated blood samples 
were collected at 0, 2, 4, 6, 8, 10 and 12 dpi; 200,000 mononuclear cells were 
cytospinned and immunostainings were performed. B1648+ infected PBMC were 
observed at 2, 4 and 6 dpi and KUL01+B1648+ infected cells were observed at 4 and 6 
dpi. 
 
4.2.4.2.6. Virus isolation in plasma and mononuclear cells  
To demonstrate the presence of infectious virus from plasma and mononuclear cells of 
infected animals, virus isolation was performed by several passages on 10 days old 
embryonated B1648 inoculated eggs (Cook et al., 1976). After two blind passages, 
plasma of all B1648 inoculated animals at 2, 4, 6, 8, 10 and 12 dpi and mononuclear 
cells of all B1648 inoculated animals at 2, 4, 6 and 8 dpi caused clear dwarfing and 
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curling of inoculated embryos (Table 3). With mononuclear cells of the B1648 group, 
lesions were observed in one out of three chickens at 10 and 12 dpi, after two blind 
passages. Even after five blind passages, plasma and mononuclear cells from the M41 
group showed no embryonic lesions, demonstrating the absence of infectious virus. 
 
Table 3. Infectious virus in tracheal swabs, plasma and mononuclear cells. Tracheal 
swabs, plasma and mononuclear samples were collected in chickens at different time 
points post inoculation of IBV B1648 and M41. Infectious virus was measured by 
inoculating embryonated eggs. 
 
Samples 
IBV 
strain 
Number of positive animals per three inoculated animals at 
… days post inoculation (n =3) 
0 2 4 6 8 10 12 
Plasma 
B1648 0/3 3/3 3/3 3/3 3/3 3/3 3/3 
M41 0/3 0/3 0/3 0/3 0/3 0/3 0/3 
Control 0/3 0/3 0/3 0/3 0/3 0/3 0/3 
Mononuclear 
cells 
B1648 0/3 3/3 3/3 3/3 3/3 1/3 1/3 
M41 0/3 0/3 0/3 0/3 0/3 0/3 0/3 
Control 0/3 0/3 0/3 0/3 0/3 0/3 0/3 
 
4.2.4.2.7. RT-qPCR and immunofluorescence staining of tissues 
Viral RNA was measured in samples of trachea, lungs, liver, spleen, and kidneys by 
RT-qPCR (Figure 7). Viral RNA was present in all collected tissues of the B1648 
group and, only in tracheal samples of the M41 group (B1648: 104.9±0.5 copies/g, M41: 
103.4±0.5 copies/g). The average B1648 viral RNA content in the lungs, liver, spleen 
and kidneys were 105.8±1.0 copies/g, 103.0±2.6 copies/g, 105.5±0.5 copies/g and 108.1±0.3 
copies/g, respectively. Immunofluorescence staining was performed on tissues to 
quantify viral antigen positive cells (Figure 8). IBV infected cells were detected in the 
tracheal mucosa of animals inoculated with both strains (B1648: 0.33 ± 0.06/10 mm2, 
M41: 0.40 ± 0.33/10 mm2) and in the lungs (0.96 ± 0.13/10 mm2), liver (1.86 ± 
0.80/10 mm2), spleen (1.81 ± 1.16/10 mm2) and kidneys (85.71 ± 12.06/10 mm2) of 
only animals inoculated with B1648. 
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Figure 7. Viral RNA copies in the trachea, lungs, liver, spleen and kidneys at 12 dpi. 
Tissues were collected at euthanasia (12 dpi) from chickens inoculated with IBV 
B1648 and M41, and PBS (mock). Viral RNA copies (log10 viral RNA copies/g of 
tissue) were measured by RT-qPCR. The quantification limit of RT-qPCR was 3.4 
log10 copies/ml (dotted line). The detection limit of RT-qPCR was 2.4 log10 copies/ml 
(bold dotted line). 
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Figure 8. IBV infected cell localization (A) and quantification (B) in various tissues 
at 12 dpi. Trachea, lungs, liver, spleen and kidneys were collected from IBV B1648 
and M41, and PBS (mock) inoculated chickens at 12 dpi. (A) Representative confocal 
photomicrographs illustrating viral antigen positive cells (arrowheads). Green 
fluorescence visualises IBV antigens. Cell nuclei were stained with Hoechst (blue). 
Scale bar represents 50 µm. (B) Quantification of viral antigen positive cells was 
performed per 20 consecutive cryosections of 10 µm tissue. Viral antigen positive 
cells were quantified in the tracheal mucosa of B1648 and M41 infected animals and 
in the lungs, liver, spleen and kidneys of only B1648 infected animals. The average 
number of viral antigen positive cells present in different tissues is presented per 10 
µm2. For each tissue, mean and standard deviation (SD) are shown. 
!
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4.2.5. Discussion 
Despite the circulation of nephropathogenic and respiratory IBV strains for over five 
to six decades, it is not well understood why some IBV strains have a kidney tropism 
(Cavanagh, 2007; Cook et al., 2012; Reddy et al., 2015). Hence, we have investigated 
the replication patterns of IBV nephropathogenic (B1648) and respiratory (M41) 
strains in vitro, in respiratory mucosa explants and peripheral blood monocytes, and in 
chickens.  
The replication kinetics and invasion strategies of IBV B1648 and M41 were better 
understood by the work done with respiratory mucosa explants. Similar to many other 
IBV viruses, B1648 and M41 are epitheliotropic in the respiratory mucosa (Cavanagh, 
2005, 2007; Cook et al., 2012). Replication kinetics of B1648 and M41 in the 
respiratory mucosa explants have revealed some important differences between these 
strains. B1648 replicated somewhat better than M41 in the epithelium of the 
respiratory mucosa at 6, 12 and 24 hpi (P<0.05). Consequently, B1648 destroyed the 
epithelial layer more severely than M41. The desquamation of the cells present in the 
epithelial layer is the main reason for the decreased number of IBV infected cells after 
24 hpi (Raj and Jones, 1997). Above results indicated that B1648 was highly virulent 
compared to M41 in the epithelial layer of respiratory mucosa.  
There have been several reports on the virulence of IBV strains in in vitro tracheal 
organ cultures. Chhabra et al. (Chhabra et al., 2016) and Raj and Jones (1996b) have 
reported that in tracheal organ cultures, the M41 strain was highly pathogenic 
compared to the variant nephropathogenic IS/885/00-like and QX-like IBV strains and 
other variant strains (Strain G and strain 6/1432/81) . In addition, Abd El Rahman et al. 
(Abd El Rahman et al., 2009) have shown that Beaudette (highly passaged 
Massachusetts-derived strain) and QX were highly pathogenic compared to Italy 02 
and 4/91 variant strains (Boursnell et al., 1985). M41 strain used in the present study 
seems to be somewhat less virulent than other M41 strains reported in literature 
(Chhabra et al., 2016; Raj and Jones, 1996b). 
Although speculative, a hypothesis can be formed to explain the lower virulence of 
M41 strain in vitro, which was used in the present study. The passage history of the 
strain and genome sequence should be considered. The passage history of the present 
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study M41 strain is unknown (Cook et al., 1976; Pensaert et al., 1981). For IBV 
isolation from infected chickens, sometimes several passages of the strain in 
embryonated eggs are necessary to observe characteristic clinical signs of infection on 
embryos (Cook et al., 1976). The repeated passages may alter the virulence and 
antigenicity of the virus (Cook et al., 1976). If the present study M41 strain has been 
serially passaged in the past, then it may have lost part of its replication ability, and it 
may not be able to replicate or show virulence to the extent that is associated with 
other reported M41 strains (Chhabra et al., 2016; Raj and Jones, 1996b). Therefore, it 
is important to give more emphasis on the passage history of the strains to have a 
better understanding about their virulence and its associated biological properties 
(Zhang et al., 2015). The genome sequence of the present study M41 strain may be 
different from those of the M41 strains reported by Chhabra et al. (Chhabra et al., 
2016), Raj and Jones (Raj and Jones, 1996b) and Abd El Rahman et al. (Abd El 
Rahman et al., 2009). At present, there is no information available on the full genome 
sequence of M41 strain used in the present study. In the future, our M41 strain will be 
sequenced and analyzed. However, in contrast with the in vitro findings, our M41 was 
replicating better than the B1648 IBV strain in vivo demonstrating the fitness of our 
M41 in birds. Therefore, one should be careful with over interpreting the in vitro 
results. 
Similar replication differences were observed in tracheal organ cultures with many 
other IBV strains and serotypes (Cubillos et al., 1991; Raj and Jones, 1996a, b). 
Recently, Wickramasinghe et al. (2011) have reported that the attachment patterns of 
spike proteins were correlated with the tissue tropism and pathogenicity differences 
between IBV Beaudette, vaccine H120, M41 and B1648 strains. In general, the 
differences in virulence of strains at the respiratory mucosa might be related to the 
presence/absence, and/or differential expression of receptors on susceptible epithelial 
cells, antiviral responses of the host cells and immune-evasion mechanisms developed 
by the IBV strain (Widagdo et al., 2016). It would be interesting to compare the 
replication kinetics in in vitro tracheal mucosa explants, between B1648 and other 
worldwide important IBV strains such as variant nephropathogenic IS/885/00-like and 
QX-like strains, recent variant M41 strains and variant Italy 02 and 4/91 strains (Cook 
et al., 2012). 
Productive replication of NIBV in PBMCs, a strategy for kidney infection	  
	   137 
During the epithelial cell layer infection, both B1648 and M41 infected cells 
penetrated through the basement membrane (BM) into the lamina propria. The 
number of B1648 viral antigen positive cells in the lamina propria was quite higher 
than the number of M41 viral antigen positive cells at 6, 12, 24 and 48 hpi, and was 
significantly higher at 72 hpi (P<0.05). Certain infected cells were identified as 
KUL01+ cells (monocytic cells) and, whose number started to increase from 12 hpi, 
where the total number of IBV infected cells started to decrease. It could be that the 
infected monocytic cells (KUL01+ cells) that increased after 12 hpi, started to cross 
the BM to enter the lamina propria and underlying layers. These infected monocytic 
cells (KUL01+ cells) may play a crucial role in dissemination of virus to the blood 
circulation and internal organs. Therefore, monocytic cells may be identified as carrier 
cells that breach through the BM to reach underlying layers of the respiratory mucosa. 
The use of monocytic cells by nephropathogenic IBV as a Trojan horse to penetrate 
through connective tissues is in line with what has been observed with equine herpes 
virus 1 (EHV1) and European equine arteritis virus in the respiratory mucosa of 
horses (Gryspeerdt et al., 2010; Vairo et al., 2013; Vairo et al., 2012; 
Vandekerckhove et al., 2010). In our study, many infected cells in the epithelium and 
lamina propria were observed. Because only a certain percentage was identified as 
KUL01+, efforts will be made to identify the KUL01 negative IBV infected cells in 
the propria of tracheal mucosa explants.  
The percentage of infected peripheral blood monocytes (KUL01+ cells) and virus 
production was higher (P<0.05) with B1648 than with M41 at 12, 24, 48 and 72 hpi. 
The intracellular and extracellular titers showed that B1648 has a strong productive 
replication in the peripheral blood monocytes. The decrease or no change in the 
intracellular and extracellular virus titers of B1648 strain at 48 and 72 hpi may be due 
to the absence of available susceptible cells or due to an antiviral response (e.g. 
interferon). This is in line with the Middle East respiratory syndrome coronavirus 
(MERS-CoV) and dengue virus interactions with human macrophages, and classical 
swine fever virus interactions with monocyte derived dendritic cells (Carrasco et al., 
2004; Chen and Wang, 2002; Zhou et al., 2014). Absence of increase of percentage of 
infected cells and virus titers in the cell lysate and supernatant with M41 demonstrated 
that the M41 infection of monocytes was abortive. The productive replication of 
B1648 and abortive replication of M41 is most probably the result of differences at 
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certain steps of the replication cycle (entry, disassembly, genome release, transcription, 
translation and assembly). This issue will be further explored in the future. 
In general, coughing, dyspnea, tracheal rales, depression, ruffled feathers and 
huddling together are characteristic clinical signs of IB in chickens (Cavanagh and 
Naqi, 2003a). Increased water consumption is a typical clinical sign of 
nephropathogenic IB and was recorded in the B1648 group (Cavanagh and Naqi, 
2003b; Meir et al., 2004; Raj and Jones, 1997). Reduced body weight gain was 
another important clinical sign noticed in the B1648 group (data not shown). At 
postmortem, swollen kidneys were principal macroscopic lesions recorded in the 
B1648 group, which is consistent with other nephropathogenic strains (Cavanagh and 
Naqi, 2003a).  
RT-qPCR is a reproducible and reliable method for rapid quantification of IBV RNA 
in clinical samples (Callison et al., 2006; Meir et al., 2010; Roh et al., 2014). At 
present, most of the available RT-qPCR assays, which target the nucleocapsid gene, 5’ 
untranslated region, or the S1 gene of the IBV genome are not efficient to quantify 
B1648 and M41 strains in a consistent way, by the highly flexible and cost effective 
SYBR green method (Callison et al., 2006; Meir et al., 2010; Roh et al., 2014). Other 
RT-qPCR assays that target the 3’ end of the viral genome (Acevedo et al., 2013; 
Chousalkar et al., 2009; Hewson et al., 2009), usually give a 3-4 log10 overestimation 
of viral genomic RNA, as this 3’ RT-qPCR detects not only genomic RNA, but also 
all subgenomic mRNAs (Desmarets et al., 2016). Indeed, during coronavirus 
replication, RNA dependent RNA polymerase synthesizes genomic RNA, as well as 
minus strand and subgenomic mRNAs. Based on our past experience with feline 
coronavirus quantification, 5’ RT-qPCR is the most consistent and reliable 
quantification method, because it evades overestimation of genomic RNAs than 3’RT-
qPCR (Desmarets et al., 2013; Desmarets et al., 2016). Thus, 5’ RT-qPCR was 
developed to avoid quantification of the subgenomic mRNAs.  
After inoculation of virus, both B1648 and M41 initiate extensive virus replication in 
the epithelium of the upper respiratory tract (URT) and shed virus in the respiratory 
secretions between 2 to 12 dpi. In contrast to the in vitro results in tracheal mucosa 
explants, the replication of B1648 and M41 were very similar except that B1648 
replication was persisting longer (12 dpi). It would have been interesting, if tracheal 
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swabs and mucosal tissues were collected at 6, 12, 24, 48 and 72 hpi (similar to in 
vitro experiments) to better understand the infection kinetics at the epithelial layer and 
lamina propria layer of in vivo tracheal mucosa and to compare it with in vitro results. 
The primary local replication of both B1648 and M41 at the URT allows horizontal 
transmission virus to susceptible birds and ensures virus circulation in birds 
(Ignjatovic and Sapats, 2000). 
Viral RNA was detected in plasma of B1648 inoculated animals at 2 (n = 3), 4 (n = 3), 
6 (n = 3), 8 (n = 3), 10 (n = 3) and 12 dpi (n = 2) at a concentration of 102.4-4.5 and in 
mononuclear cells of B1648 inoculated animals at 2 (n = 3), 4 (n = 3), 6 (n = 3) and 8 
(n = 2) dpi at a concentration of 101.8-4.4 viral RNA copies/106 mononuclear cells. 
These B1648 viral RNA copies of plasma and mononuclear cells were originated from 
infectious virus as confirmed by virus isolation. In M41 inoculated animals, viral 
RNA was present in only one animal at 6 dpi in plasma and mononuclear cells but no 
infectious virus could be demonstrated by virus isolation. Infected cells were 
demonstrated by immunofluorescence in cytospinned mononuclear cells at 2 (n = 2), 4 
(n = 3) and 6 dpi (n = 2) with B1648. M41 infected cells were never demonstrated. 
These results demonstrated the onset of a cell free and cell-associated viremia at 2 dpi 
with B1648. This indicates that cell free B1648 virus and/or B1648 infected cells are 
able to enter in to the blood circulation very quickly. The potential spread of B1648 
from blood into the internal organs was demonstrated. In contrast with B1648, 
infectious virus was not demonstrated for M41 to reach the blood circulation and 
internal organs. Pseudorabies virus and classical swine fever virus are other examples 
of viruses that result in a combination of cell free and cell-associated viremia leading 
to the viral spread in mammals (Nawynck and Pensaert, 1995; Pensaert et al., 2004). 
For many avian viral infections, there is no information on the viremic phase and its 
pathogenic consequences. 
The infected mononuclear cells were mainly KUL01+ cells but also some KUL01 
negative cells were present. The latter were not identified. They could be unidentified 
blood monocytic cells (KUL01 negative), B and T lymphocytes. The KUL01 marker 
is not reported to identify all the monocytic cells of the blood circulation (Mast et al., 
1998). Hence, the role of blood dendritic cells, KUL01 negative monocytic cells, B 
and T lymphocytes in B1648 infection kinetics and dissemination needs to be 
elucidated in future work. 
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In the B1648 group, cell-free virus in plasma persisted until the end of the study (12 
dpi). Different sources may have continuously contributed to the cell-free virus in 
plasma during the course of B1648 infection. At early time points (2 and 4 dpi), cell 
free virions produced by tracheal epithelial cells may have infiltrated into the 
underlying submucosal layers. Then, through capillaries cell-free virions may have 
reached blood circulation. At 6 and 8 dpi, infected blood mononuclear cells may have 
released virus in plasma. The presence of infectious virus in plasma at later time 
points (10 and 12 dpi) but not in mononuclear cells indicated that cell free virions 
from infected internal organs may have leaked into the blood circulation. In the M41 
group, the absence of viral RNA and infectious virus, especially at later time points (8, 
10 and 12 dpi), is also an indication that infectious virus could not have reached 
internal organs. 
Viral RNA and antigen positive cells were only detected in lungs, liver, spleen and 
kidneys of B1648 infected animals at 12 dpi, demonstrating that only B1648 was 
disseminated through the mononuclear cells and plasma but not M41 at that stage of 
infection. In the M41 group, the possibility of presence of viral RNA and antigen 
positive cells in tissues at earlier time points (6, 8 and 10 dpi) cannot be completely 
excluded. B1648 replicated more productively in the kidneys compared to lungs, liver 
and spleen, illustrating the high nephropathogenicity of B1648 (Cook et al., 2012; 
Meulemans et al., 1987; Pensaert and Lambrechts, 1994). Infected KUL01+ cells 
(colocalization) were not observed in the tissues. This demonstrates that once the virus 
reached internal organs, it is replicating in non-KUL01+ cells (Cook et al., 2012). In 
kidneys it is known that it replicates in tubular cells. 
In this study, we observed several differences between B1648 and M41 strains at the 
level of mononuclear cells (KUL01+ cells). Firstly, the number of B1648 infected 
KUL01+ cells in the lamina propria of in vitro tracheal mucosa explants was quite 
higher than M41. Secondly, the percentage of infected cells and virus production in 
the in vitro inoculated blood mononuclear cells (KUL01+ cells) was higher for B1648 
than for M41. Thirdly, viral RNA copies were detected in mononuclear cells of all 
B1648 infected chickens and exceptionally with M41. The results above implicate that 
monocytic cells may be important carrier cells, which are required for the progress of 
B1648 disease. The productive and sustainable replication of B1648 virus in blood 
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monocytic cells (KUL01+ cells) may represent an important strategy used by B1648 to 
disseminate virus to the kidneys and other internal organs. 
Even though M41 infected KUL01+ cells were observed in the lamina propria of the 
tracheal mucosa explants, the abortive replication of M41 in monocytic cells (KUL01+ 
cells) most probably hampered the dissemination of M41 via blood to reach the 
kidneys and other internal organs. Furthermore, the replication ability of M41 may be 
lowest in the lamina propria and underlying layers to release cell free virus. Therefore, 
it can be stated that the M41 strain that was used in the present study can replicate 
only in the respiratory mucosa, and cannot spread to the internal organs for further 
disease progression. The results presented here are somewhat different with those 
from other reports, where Massachusetts type strains (M41) were detected in kidneys 
(Butcher et al., 1990; Ganapathy et al., 2005; Li and Yang, 2001; Owen et al., 1991). 
Some other studies with the M41 reference strain have shown only mild 
histopathological lesions with the absence of viral antigen positive cells (Benyeda et 
al., 2010). The basis for the differences between the different studies is not clear but 
might be due to different M41 strains, passage levels, experimental design and 
conditions, nutrition, environment, intercurrent infections, age/breed of the birds, and 
detection techniques (Benyeda et al., 2009; Raj and Jones, 1997).  
Otherwise, M41 strains used in recent reports might be mutants/variants of the 
prototype M41. Mutation and recombination events are common in coronaviruses, 
which are likely to contribute to the emergence of new variants/mutants and outbreaks 
of new diseases (Jia et al., 1995; Woo et al., 2009). Currently, at least 8 full genome 
sequences of M41 are available in Genbank. The full genome sequence of the latest 
M41_2006 was closest (90.8%) to the B1648 full genome sequence compared to 
earlier Mass 41_1965-85 (89.7%) full genome sequences (Reddy et al., 2015). It 
could be that the recent M41 strains may be recombinant viruses like M41_2006 with 
only the spike gene from the prototype M41 and the remaining genome regions from 
Connecticut and California serotypes (McKinley et al., 2011). The Mass type (M41) is 
identified/classified based on the sequence of its spike gene (3500 bp) only, but one 
should consider that remaining genomic regions (24000 bp) may also play an 
important role in the pathogenicity of the virus (Armesto et al., 2009; Reddy et al., 
2015). Thus, in the near future, full sequences should be considered and not only parts 
of it. Therefore, the full genome sequence of the M41 strain used in the present study 
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will be elucidated to understand its evolutionary relationship with other Massachusetts 
type strains. 
The cell-associated viremia in mononuclear leukocytes and cell free virus in plasma 
and the replication in kidneys of B1648 virus infected chickens is very similar to 
another coronavirus, MERS-CoV in humans. MERS-CoV was also reported in whole 
blood and plasma of humans (Chan et al., 2013; Drosten et al., 2013; Guery et al., 
2013). In addition, MERS-CoV is replicating in monocytic cells and kidneys, 
resulting in high mortality in humans (Chan et al., 2013; Drosten et al., 2013; Eckerle 
et al., 2013; Guery et al., 2013; Zhou et al., 2014). 
In summary, B1648 and M41 strains followed different tissue tropism mechanisms. 
Both B1648 and M41 strains successfully invade and replicate in the epithelium of the 
respiratory mucosa. B1648 uses more mononuclear cells as carrier cells to breach 
through the underlying layers of the respiratory mucosa. The penetration through the 
deeper layers of the respiratory mucosa was more intensive with B1648 compared to 
M41. B1648 spreads via a cell free and cell-associated viremia to target organs such 
as kidneys, liver, spleen and lungs whereas M41 does not do this. B1648 showed a 
fully productive replication in the KUL01+ blood monocytic cells. B1648 replication 
was more productive in kidneys and less in liver, spleen and lungs. During M41 
infection, the infected KUL01+ cells could not be able to infiltrate into the circulation 
or were abortive in the submucosal layers of the upper respiratory tract (trachea and 
bronchi). Our study unveils hitherto unknown, but crucial aspects of the tissue tropism 
of B1648 and M41 strains. B1648 has achieved highly nephropathogenic hallmarks by 
exploiting the carrier mononuclear cells in an active manner, whereas M41 is not 
nephropathogenic due to the abortive nature of M41 infection of mononuclear cells. 
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Respiratory tract infections are very common in worldwide poultry industry. A wide 
variety of respiratory viruses have been associated with the respiratory tract of 
poultry, and may cause high morbidity and mortality in chickens (Jones, 2010). 
Infectious laryngotracheitis virus (ILTV) and infectious bronchitis virus (IBV) are 
two of the most devastating respiratory viruses in commercial poultry worldwide 
(Cavanagh, 2007; Cook et al., 2012; Fuchs et al., 2007; Jones, 2010; Menendez et al., 
2014). The alphaherpesvirus ILTV and the coronavirus IBV are highly contagious 
avian viruses. Nostrils and eyes are the main portals of entry of ILTV and IBV. 
Although, ILTV and IBV are circulating already for several decades, their replication 
kinetics at the primary replication site and invasion mechanism are largely unknown 
(Cavanagh, 2007; May and Tittsler, 1925; Menendez et al., 2014; Schalk and Hawn, 
1931). In this study, several aspects of the pathogenesis of ILTV and IBV infections 
were examined under in vitro and in vivo conditions. 
Establishment of in vitro tracheal and conjunctival mucosal explant models of 
chickens  
ILTV replicates initially in the epithelial cells of the upper respiratory and 
conjunctival mucosae (Garcia et al., 2013; Guy and Bagust, 2003). After initial 
replication, ILTV may penetrate through the basement membrane (BM) to spread 
through underlying layers (Glorieux et al., 2009; Steukers et al., 2011). During severe 
infection, chickens end up with marked gasping, open mouth breathing, expectoration 
of bloody mucus and asphyxiation (Fuchs et al., 2007). The replication kinetics and 
invasion mechanisms at the initial replication site are largely not understood. These 
mechanisms are important to understand the pathogenesis and dissemination of virus 
to internal organs. The in vivo experiments are involved with high costs, and 
challenged with ethical questions (Bang and Bang, 1967; Kirkpatrick et al., 2006). 
Thus, the establishment of in vitro organ cultures is necessary to investigate specific 
questions about replication kinetics and invasion mechanisms. Chicken tracheal and 
conjunctival mucosal explants were collected from 4 to 8 weeks old chickens and 
cultured at an air liquid interface (chapter 3.1.). One side of the mucosal tissue was 
exposed to air, the other side was exposed to serum free medium. This positioning 
mimics physiological conditions of respiratory mucosa (Glorieux et al., 2009). In 
contrast to cell cultures, the in vitro explant models maintain morphology, cell-cell 
and cell-extracellular matrix interactions, and ultimately the 3D architecture of tissues 
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(Glorieux et al., 2009; Lin et al., 2001; Schmidt et al., 1996; Steukers et al., 2012; 
Yoon et al., 2002). The in vitro explant models are in line with the “three Rs” ethical 
dogma: Reduction, Refinement and Replacement. Refinement is minimizing the pain, 
Reduction is lowering the number of animals and Replacement is using in vitro 
alternatives instead of living animals (Russell and Burch, 1959). The use of in vitro 
models reduces inter-animal variation and experiment-to-experiment variations. 
Furthermore, the natural route of infection is well mimicked with these models.  
By light microscopy and fluorescent terminal deoxynucleotidyl transferase dUTP nick 
end-labelling (TUNEL) staining it was demonstrated that the organ culture could 
successfully be maintained up to 96 h of cultivation. The tracheal ring culture with 
alternating air and medium exposure is another commonly used method to study host 
pathogen interactions in chickens (Reemers et al., 2009). However, the explant 
culture on metal gauze with air liquid interface resembles better than the in vivo 
conditions. All together, this study established an in vitro model that very closely 
mimics the in vivo physiological situation. 
The established in vitro tracheal and conjunctival explant models are useful to 
study infection kinetics of avian viruses and/or pathogens 
The in vitro tracheal and conjunctival mucosal explant models were used to test 
whether ILTV (U76/1035) successfully infects and replicates in the mucosae (chapter 
3.1.). The in vitro mucosal explant models were susceptible to ILTV infection. By 
confocal microscopy, a complete 3D picture of horizontal and vertical spread of ILTV 
was elucidated. From 24 hpi, ILTV spreads in a plaquewise manner through both 
tracheal and conjunctival mucosal explants. ILTV spreads laterally in both mucosae 
(latitude) and vertically through the BM of the mucosae (invasion depth). The plaque 
latitude increased with time and breached through the BM from 48 hpi. At later time 
points (72 hpi), ILTV was replicating more extensively in the conjunctival mucosa 
compared with the tracheal mucosa. This is due to variation in its tropism for the 
tracheal and conjunctival mucosa (Kirkpatrick et al., 2006). ILTV invasion through 
the BM is very limited, when compared to mammal alphaherpesviruses SHV1, BHV1 
and HSV1, which are all highly invasive (Glorieux et al., 2011a; Glorieux et al., 
2009; Steukers et al., 2011). The limited invasion of ILTV through the BM agrees 
with the in vivo pathogenesis of ILTV, where no clear evidence exists for viraemia 
Chapter 5 
	   154 
(Garcia et al., 2013; Guy and Bagust, 2003). In addition, this study clearly confirmed 
that ILTV penetrates through the BM of the tracheal and conjunctival mucosae. 
Indeed, Zhao et al. (2013) and Roy et al. (2015) have reported ILTV in the internal 
organs of infected chickens. 
The above results have proved that ILTV (U76/1035) is well adapted to replicate and 
spread in the in vitro tracheal and conjunctival mucosae. Thus, these established in 
vitro explant models are valuable tools to elucidate replication kinetics of other avian 
respiratory viruses, bacteria, fungi and other pathogens. 
ILTV effects on apoptosis were evaluated for both tracheal and conjunctival mucosae 
by TUNEL assay. Among large number of ILTV-positive cells, only few ILTV 
infected cells were observed to be TUNEL-positive in both mucosae, and this 
observation corroborated that ILTV blocks apoptosis. Many other alphaherpesviruses 
such as HSV1, HSV2 and SHV1 were reported to show low levels of apoptosis in 
infected cells (Aleman et al., 2001; Asano et al., 1999; Glorieux et al., 2011). Further, 
apoptotic cells were observed in the vicinity of ILTV infected cells and these could be 
local immune cells (leukocytes) or uninfected bystander cells (Aleman et al., 2001; 
Asano et al., 1999). Usually, alphaherpesviruses evade the immune response by 
inhibiting apoptosis of infected cells (Aleman et al., 2001; Asano et al., 1999; Galvan 
and Roizman, 1998; Glorieux et al., 2011a; Winkler et al., 1999). This could be a 
strategy of ILTV to survive in infected cells long enough to support virus replication. 
After spreading through the BM, ILTV reaches the lamina propria and underlying 
mucosal layers. Then, ILTV may reach sensory nerves and the trigeminal ganglion. 
Finally, in the trigeminal ganglion ILTV establishes latency and makes from an 
animal a lifelong virus carrier. 
ILTV infected mucoid plugs/casts are associated with extracellular DNA fibrous 
structures but not with mucins (MUC5AC and MUC5B) 
An acute ILTV infection is associated with marked dyspnea, gasping, suffocation and 
increased mortality in chickens due to presence of the mucoid plugs/casts in the 
trachea (Linares et al., 1994). It has been speculated that the mucoid plugs/casts are 
formed due to mucus hypersecretion, however there are no published reports 
supporting this hypothesis (Garcia et al., 2013; Linares et al., 1994). In chapter 3.2, 
we first evaluated if main respiratory mucins MUC5AC and MUC5B were produced 
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in the mucosa of normal and ILTV infected chickens. Second, the tracheal mucosal 
thickness and the tracheal lumen diameter were compared between normal and ILTV 
infected chickens to understand their role in obstruction of the trachea. Third, the 
mucoid plugs/casts present inside the trachea were stained for mucins and nuclear 
DNA fibrous structures (extracellular traps). Fourth and last, the effect of ILTV on the 
formation of DNA fibrous structures from nuclei of blood heterophils was evaluated. 
MUC5AC and MUC5B were found to be the common mucins produced by the 
epithelium of the larynx, trachea and bronchi of normal chickens. This finding is in 
line with the respiratory mucosa of humans and pigs (Kirkham et al., 2002). The 
mucin (MUC5AC and MUC5B) production was higher in larynx and trachea 
compared to bronchi, which is from an anatomical point of view more relevant in the 
defense against pathogens/foreign substances. An important observation of this study 
was that mucins (MUC5AC and MUC5B) were exclusively present in the dorsal 
tracheal region (thinner) of the cranial and middle part of tracheal mucosa of normal 
chickens. In evolution, this property may have been developed to block the initial 
entry of pathogens at the dorsal surface. ILTV infects mainly the lateral and ventral 
areas. In ILTV infected chickens, the tracheal lumen diameter was reduced with 
almost 40% than tracheal lumen diameter of control chickens, and was caused by a 
strongly increased tracheal mucosal thickness. The reduced tracheal lumen and its 
associated increased mucosal thickness are most probably due to severe congestion, 
edema and heavy infiltration of heterophils, macrophages, lymphocytes and plasma 
cells in the mucosa and underlying layers (Devlin et al., 2006; Garcia et al., 2013; 
Hayashi et al., 1985). This observation strongly demonstrated that the reduced 
tracheal lumen due to the increased mucosal thickness is one of the important reasons 
for the obstruction of the trachea during an acute ILTV infection. 
Mucins (MUC5AC and MUC5B) were scarcely observed in the mucosa of the 
respiratory tract and almost absent in the mucoid plugs/casts in the trachea of ILTV 
infected chickens. This observation does not fit with the speculation that the mucoid 
plugs/casts are associated with mucus hypersecretion (Garcia et al., 2013; Linares et 
al., 1994). Surprisingly, DNA fibrous structures (ETs) were observed in 10.0 ± 7.3% 
nuclei of the cells from ILTV infected mucoid plugs/casts. The absence of mucins in 
the mucoid plugs/casts and presence of DNA fibrous structures (ETs) in the nuclei of 
the mucoid plugs/casts of ILT is in line with what has been reported in the sputum and 
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mucus of cystic fibrosis patients (Henke et al., 2004; Lethem et al., 1990; Rubin, 
2007). Further, these DNA fibrous structures (ETs) were demonstrated in 2.0 ± 0.1% 
nuclei from ILTV inoculated blood heterophils at 24 hpi. 
In general, extracellular DNA network (ETs) formation is a defense mechanism of 
host cells towards pathogenic microorganisms (Goldmann and Medina, 2012). During 
acute ILTV infection, the formation of extracellular DNA networks may also be a 
strategy to restrict virus replication and remove the virus in the respiratory mucosa. 
Further, these DNA fibrous structures may trap lipids, proteins, cations, cellular 
debris and other non-mucin components to form a jelly plug in the trachea, and 
obstruct normal air passage and may cause suffocation and mortality in chickens 
(Garcia et al., 2013; Lethem et al., 1990). Acute ILTV associated gasping, marked 
dyspnea, open mouth breathing and asphyxiation could be reduced by aerosol 
administration of DNase I (Rogers, 2007; Shak, 1995). 
IBV B1648 is a distinct strain from	  all the available worldwide IBV strains 
IBV has a tropism for the epithelial cells of the respiratory tract, kidneys, oviduct and 
alimentary tract of chickens. Massachusetts type strains (prototype: M41) cause 
mainly respiratory problems. Some IBV strains were described as nephropathogenic 
since the respiratory infection is followed by a severe kidney infection and increased 
mortality. Strain B1648 is a well-studied Belgian reference nephropathogenic IBV 
that became an important strain across the European continent. Despite the intensive 
vaccination program, IBV B1648 or its variants are still circulating through Europe 
and North Africa (Bochkov et al., 2006; Ducatez et al., 2009; Krapež et al., 2010; 
Toffan et al., 2013b). In the present PhD thesis, the full genome sequence of IBV 
B1648 was characterized to speculate possible genetic factors, which might be 
associated with the nephropathogenicity, and to understand its position in evolution 
(chapter 4.1.).  
Thirteen open reading frames (ORFs) were predicted in B1648 genome. 4b, 4c and 6b 
were additional ORFs present in the B1648 genome when compared with most 
available IBV genomes, and were rarely reported in the literature (Abolnik, 2015; 
Hewson et al., 2011). The success of ORFs identification depends on the algorithm of 
ORF prediction software that was used. NGA/A116E7/2006, UKr 27-11, QX-like 
ITA/90254/2005, QX-like CK/SWE/0658946/10, TN20/00, RF-27/99, RF/06/2007 
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and SLO/266/05 were grouped with B1648, according to the phylogenetic analysis of 
the full-length genome, replicase transcriptase complex, Spike protein, S1 gene and M 
protein, and this group was referred as non-Mass type strains. All the above grouped 
strains were reported after the first B1648 outbreak in Belgium, hence in the 
evolution, segments of the B1648 genome may have transferred into these strains. In 
IBV and other coronaviruses, the emergence of new coronaviral genotypes/strains by 
recombination events has been well reported (Hughes, 2011; Thor et al., 2011). 
Further, based on the recombination analysis, the recombination sites were distributed 
in several genes of the B1648 genome.  
According to pairwise comparison of the full genome, B1648 was closely related to 
NGA/A116E7/2006 (91.6%), UKr 27-11 (91.2%), Gray (91.2%) and JMK strains 
(91.2%), and these strains were earlier described as non-Mass type strains. B1648 was 
also closely related to non-Mass type strains, based on pairwise comparison of 1a, 
Spike, M and accessory proteins (3a, 3b, 4b, 4c, 5a, 5b and 6b). According to the 1b, 
E and N proteins, B1648 was closely related to most of the IBV strains. Pairwise 
comparison has implicated that the pathogenicity determinants of B1648 strain might 
be located on 1a, Spike, M and accessory proteins. Recently, many researchers have 
reported that the pathogenicity determinants of IBV are polygenic, and located outside 
the Spike protein (Ammayappan et al., 2009; Armesto et al., 2009; Britton et al., 
2005; Casais et al., 2003; Hodgson et al., 2006; Phillips et al., 2012). In murine 
hepatitis virus (MHV), another well-studied coronavirus, some authors have shown 
that the Nsp1, Nsp3 and Nsp14 are pathogenicity factors. In nephropathogenic IBV, 
the non-structural proteins of ORF 1a might be associated with nephropathogenicity. 
However, this hypothesis should be further investigated by reverse genetics system 
(RGS).  
The development of IBV Beaudette strain infectious clones or RGS has opened up the 
possibility to modify IBV spike, 3a, 3b, 5, E, M, N and other accessory proteins, to 
understand their role in the pathogenicity (Britton et al., 2005; Casais et al., 2005; 
Casais et al., 2003; Hodgson et al., 2006). Based on these IBV RGS studies, Armesto 
et al. (2009) have shown that the replicase gene (polyprotein 1ab) might be a 
determinant of the pathogenicity. However, further studies are necessary to 
understand the role of individual Nsps of the replicase gene in the pathogenicity 
(Armesto et al., 2009). Currently, RGS (Beau-R) is available only for a Beaudette 
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strain (Britton et al., 2005; Casais et al., 2001). Beaudette strain is a laboratory 
adapted non-virulent attenuated strain (Beaudette and Hudson, 1937; Casais et al., 
2001). Hence, Beaudette strain infectious clone is not an ideal model to study the 
pathogenicity determinants of the virulent IBV strains. In the future, more studies 
should be performed with RGS of virulent IBV strains to understand the role of 
individual Nsps of the replicase gene or other structural proteins. 
Based on the sequence of the partial S1 fragment, TN20/00, RF-27/99, RF/06/2007 
and SLO/266/05 strains were closest related and grouped with B1648, and named as 
B1648 genotype. Phylogenetic analysis and pairwise comparisons have suggested that 
B1648 is a distinct genotype, which has been intermittently circulating in Europe and 
North Africa for over three decades (Bourogaa et al., 2012; Capua et al., 1999; Dolz 
et al., 2006; Ducatez et al., 2009; Meulemans et al., 1987; Ovchinnikova et al., 2011; 
Terregino et al., 2006; Toffan et al., 2013a; Tosi et al., 2010). Further, the knowledge 
on the pathogenicity and tissue tropism of the strains NGA/A116E7/2006, Ukr27-11, 
TN20/00, RF-27/99, RF/06/2007 and SLO/266/05 are necessary to understand 
whether these strains are really nephropathogenic. 
Cell-free and cell-associated viremia in NIBV strain B1648 infection: a strategy 
for viral dissemination to kidneys  
In spite of the circulation of nephropathogenic (B1648) and respiratory strains (M41) 
for many decades, it is not well understood why some IBV strains have a kidney 
tropism. Therefore, replication kinetics of IBV B1648 (nephropathogenic) and M41 
(respiratory) were studied in vitro in tracheal mucosa explants and blood monocytes 
and in vivo in chickens (chapter 4.2.). 
Two important questions were answered in the work done with respiratory mucosa 
explants, namely i) what is the strategy that B1648 uses to invade at the level of the 
respiratory tract and ii) how does B1648 reach the blood circulation to disseminate 
virus to the kidneys. B1648 and M41 replicate in the epithelium of the respiratory 
mucosa similar to other IBV viruses. B1648 was highly virulent than M41 in the 
epithelium of the respiratory mucosa. With many other IBV strains and serotypes, 
similar replication differences were reported in tracheal organ cultures (Chhabra et 
al., 2016; Cubillos et al., 1991; Raj and Jones, 1996a, b). The antiviral responses of 
the host cells, presence/absence, and/or differential expression of receptors on 
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susceptible epithelial cells and immune-evasion mechanisms developed by the IBV 
strain might be important factors determining the differences in virulence of strains at 
the tracheal mucosa (Widagdo et al., 2016).  
After epithelium infection, B1648 and M41 viral antigen positive cells breached 
through the basement membrane (BM) into the lamina propria. In the lamina propria, 
the number of B1648 infected cells was slightly higher at 6, 12, 24 and 48 hpi, and 
was significantly higher at 72 hpi. Infected KUL01+ cells (monocytic cells) were 
observed in the both epithelium and lamina propria, for both B1648 and M41. The 
number of B1648 infected KUL01+ cells in the epithelium were somewhat higher than 
M41 infected cells at 24 and 48 hpi, and significantly higher at 72 hpi. The number of 
B1648 infected KUL01+ cells in the lamina propria was higher than M41 infected 
cells. The infected KUL01+ cells may have acted as carrier cells to disseminate virus 
through BM to reach underlying layers of the respiratory mucosa. This invasion 
mechanism is in line with equine herpes virus 1 (EHV1) and equine arteritis virus in 
the respiratory mucosa of horses (Gryspeerdt et al., 2010; Vairo et al., 2013; Vairo et 
al., 2012; Vandekerckhove et al., 2010). In summary, B1648 was replicating quite 
better than M41 in the respiratory mucosa explants and B1648 exploited more 
infected KUL01+ cells to breach through the underlying layers of the respiratory 
mucosa compared to M41. 
The percentage of infected peripheral blood monocytes (KUL01+ cells) was higher 
with B1648 than M41. B1648 showed 20-700 times higher viral titers than M41 in 
both cell lysate and supernatant of the inoculated blood monocytes. With M41, no or 
little increase in viral titers was seen in cell lysate and supernatant of blood monocytic 
cells. All together, B1648 productively replicates in the peripheral blood monocytes 
whereas M41 aborts. Similar to this study, productive replication of viruses in 
monocytic cells have been reported with many of the mammalian viruses such as, 
dengue virus with human macrophages, classical swine fever virus with monocyte 
derived dendritic cells, Middle East respiratory syndrome coronavirus (MERS-CoV) 
with human macrophages and monocyte derived dendritic cells, and feline infectious 
peritonitis virus with peripheral blood monocytes. On the other hand, an abortive 
replication has been observed with EHV1 and feline enteric coronavirus in blood 
monocytes, with severe acute respiratory syndrome coronavirus (SARS-CoV) in 
blood macrophages and monocyte derived dendritic cells, and with influenza virus in 
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mouse dendritic cells (Carrasco et al., 2004; Chen and Wang, 2002; Chu et al., 2014; 
Dewerchin et al., 2005; Ioannidis et al., 2012; Zhou et al., 2014). 
In the in vivo study, all chickens inoculated with IBV B1648 and M41 were infected 
and developed clinical signs, such as ruffled feathers, huddling together, tracheal 
rales, coughing and dyspnea. Increased water consumption and reduced body weight 
gains were typical with B1648 inoculated chickens. Enlarged kidneys was the most 
important gross lesion observed in the B1648 group, which is similar to other 
nephropathogenic strains (Cavanagh and Naqi, 2003). 
The highest viral shedding in the upper respiratory tract (URT) secretions occurred 
between 2 and 8 dpi. Such a respiratory shedding allows horizontal transmission of 
IBV to susceptible birds and ensures virus circulation in birds (Ignjatovic and Sapats, 
2000). In contrast to the in vitro results in tracheal mucosa explants, the replication of 
B1648 and M41 were very similar except that B1648 replication was persisting longer 
(12 dpi). Further, it would have been interesting, if tracheal swabs and mucosal tissues 
were collected at 6, 12, 24, 48 and 72 hpi to better understand the replication 
characteristics at the epithelium and lamina propria of in vivo tracheal mucosa and to 
compare it with in vitro results. 
In B1648 inoculated animals, 102.4-4.5 viral RNA copies/ml were detected in plasma at 
2, 4, 6, 8, 10 and 12 dpi and 101.8-4.4 viral RNA copies/106 mononuclear cells at 2, 4, 6 
and 8 dpi. Virus isolation has confirmed that these B1648 viral RNA copies of plasma 
and mononuclear cells were infectious virus. In M41 inoculated animals, viral RNA 
was detected in only one animal at 6 dpi in plasma and mononuclear cells but the 
infectivity could not be demonstrated by virus isolation. The infected cells were 
observed in cytospinned mononuclear cells at 2, 4 and 6 dpi with B1648 but not with 
M41. These results demonstrated the onset of cell free and cell-associated viremia at 2 
dpi with B1648 strain. This indicates that cell free B1648 virus and B1648 infected 
cells are able to spread through the epithelium and underlying submucosal layers of 
the respiratory tract to enter in to the blood circulation very quickly (before 48 hpi). 
Thus the potential spread of B1648 strain from blood into the internal organs was 
demonstrated. The combination of a cell free and cell-associated viremia of B1648 
strain is in line with pseudorabies virus and classical swine fever virus dissemination 
in pigs (Nawynck and Pensaert, 1995; Pensaert et al., 2004). 
General discussion 
	   161 
Viral RNA and antigen positive cells were only detected in kidneys, liver, lungs and 
spleen of B1648 infected animals at 12 dpi, providing evidence that only B1648 
productively infects internal organs, whereas M41 does not. B1648 replicated more 
actively in the kidneys compared to lungs, liver and spleen, explaining the 
nephropathogenicity of B1648 (Cook et al., 2012; Meulemans et al., 1987; Pensaert 
and Lambrechts, 1994). 
The cell-associated viremia in mononuclear leukocytes and cell free virus in plasma 
of B1648 virus infected chickens might be extrapolated to MERS-CoV tissue tropism 
mechanisms in humans. The comparison with MERS-CoV is compelling because it is 
also associated with severe kidney problems and high mortality in humans (Chan et 
al., 2013; Drosten et al., 2013; Eckerle et al., 2013; Guery et al., 2013). Moreover, 
MERS-CoV replicates in a productive way in human macrophages and its presence 
was also reported in whole blood and plasma of humans (Chan et al., 2013; Drosten et 
al., 2013; Guery et al., 2013; Zhou et al., 2014). At present, there is no detailed 
information on MERS-CoV disease, and no good animal models to study the 
pathogenesis of MERS-CoV (Momattin et al., 2013; Vijay and Perlman, 2016). Thus, 
although speculative, a correlation can be made between coronaviruses of chickens 
and humans to understand their evolution and replication mechanism and to plan 
control and prevention strategies in a better way. 
In conclusion, B1648 and M41 infection kinetics and pathogenesis mechanisms were 
different (Figure 1). Both B1648 and M41 strains successfully replicate and invade in 
the epithelium of the respiratory mucosa. B1648 uses more KUL01+ cells 
(monocytes/macrophages) as carrier cells to transport via the underlying layers of the 
respiratory mucosa. B1648 penetrates more vigorously than M41 in the deeper 
underlying layers of the respiratory mucosa. B1648 disseminates via a cell free and 
cell-associated viremia to target organs such as kidneys, liver, spleen and lungs 
whereas M41 does not do this. Only B1648 showed a fully productive replication in 
the KUL01+ peripheral blood monocytic cells. B1648 replicates more productively in 
kidneys when compared to liver, spleen and lungs. The M41 infected KUL01+ cells 
could not be able to disseminate into the circulation or were abortive in the lamina 
propria and underlying layers of the upper respiratory tract. Our study unravels very 
important invasion and tissue tropism mechanisms of B1648 and M41 strains. B1648 
has become nephropathogenic mainly by productively replicating in carrier 
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mononuclear cells, and M41 is not nephropathogenic due to abortive replication in 
mononuclear cells. 
 
Figure 1. Hypothetical model of IBV B1648 and M41 replication kinetics in 
respiratory mucosa, blood and internal organs of chickens. Stars represent infectious 
virus. Star number and infectivity are directly proportional to each other. After natural 
entry of virus through nostrils, both nephropathogenic IBV B1648 and M41 replicate 
in the respiratory mucosa. B1648 uses a higher number of infected KUL01+ cells as 
carriers to penetrate deeper in the layers of the respiratory mucosa in contrast to M41. 
B1648 productively infects KUL01+ blood monocytic cells while M41 infection is 
abortive. Only B1648 disseminates via a cell-associated viremia in mononuclear 
leukocytes and cell free virus in plasma to reach lungs, liver, spleen and kidneys. 
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Only B1648 shows a productive infection in kidneys and to a less degree in lungs, 
liver and spleen. 
Future perspectives 
The current thesis was dealt with the many important aspects of the pathogenesis of 
ILTV and IBV under in vitro and in vivo conditions. The knowledge gained in this 
pathogenesis study can be used in the development of new antiviral compounds and 
vaccines, especially against acute ILT and nephropathogenic IB diseases. 
• We found ILTV spreads by a plaquewise manner in the tracheal and conjunctival 
mucosae and subsequently penetrates the BM. The trypsin-like serine protease in 
SHV1 and the heterodimeric complex of gE/gI in BHV1, were reported to be 
involved in penetration of the BM (Glorieux et al., 2011b; Steukers, 2013). 
Similarly, ILTV might follow one of these mechanisms to penetrate the BM. The 
use of antiviral compounds against trypsin-like serine protease and heterodimeric 
complex of gE/gI will be an interesting strategy to stop ILTV invasion. The 
established in vitro mucosal explant models will be ideal tools to check new 
antiviral compounds. 
• Aerosol administration of DNase I could be used to prevent acute ILT associated 
mucoid plugs/casts formation, and further helpful to reduce gasping, open mouth 
breathing and suffocation problems in chickens. 
• Blocking IBV entry pathways to epithelial cells and NIBV to monocytes can 
prevent the IBV infection. However, many questions on virus entry steps are 
necessary to be addressed in the future. First, binding and internalization into 
epithelial cells and monocytic cells should be studied. Second, the internalization 
pathways and regulators can be evaluated to find the targets. Third, the receptors 
associated with the binding and internalization should be elucidated. Finally, 
differences between respiratory IBV and NIBV strains at binding and 
internalization would be interesting to study. 
• Further pathogenesis studies should be performed on currently available variant 
respiratory and nephropathogenic IBV strains to understand their tissue tropism 
mechanisms and differences. 
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• Construction and manipulation of infectious clones of the virulent ILTV genome, 
respiratory IBV and NIBV genome is needed for the development of novel 
vaccines. 
• The egg inoculation and primary cells studies with ILTV and IBV are tedious, 
cumbersome and hamper long-term studies. To obtain reproducible and relevant 
results, there is an increased demand for the well-characterized continued cell 
lines, which retain the phenotypic and functional characteristics of their non-
transformed primary cells. 
 
These studies would be helpful to plan effective preventive and control strategies 
against ILT and IB diseases. 
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Summary 
Infectious laryngotracheitis virus (ILTV) and infectious bronchitis virus (IBV) are 
two important avian respiratory viruses, which cause major economic losses in the 
worldwide commercial poultry. ILTV and IBV enter through respiratory and ocular 
routes. The ILTV and IBV invasion strategies at entry sites and subsequent 
pathogenesis mechanisms are poorly understood. Therefore, we aimed to evaluate 
replication characteristics of ILTV and IBV under in vitro and in vivo conditions. 
In Chapter 1, an overview of the current knowledge of ILTV and IBV were given. In 
this chapter, historical background, classification, virus structure, replication, 
pathogenesis, clinical signs and pathology of ILTV and IBV were discussed. 
In Chapter 2, the aims of this study were presented. The first aim was to study the 
replication kinetics of ILTV under in vitro respiratory and conjunctival mucosa 
explant models. The second aim was to understand if there is any change of mucin 
secretion in ILTV infected animals leading to the mucoid plugs/casts in the lumen of 
the respiratory tract. The third aim was to characterize the complete genome of the 
nephropathogenic B1648 strain to understand its epidemiological relationship with 
other IBV strains and genetic factors that may be associated with 
nephropathogenicity. The fourth and last aim was to elucidate how NIBV (B1648) has 
a strong tropism for the kidneys. 
In Chapter 3.1, the first aim was addressed. In vitro tracheal and conjunctival mucosa 
explant models were developed of three chickens. Light microscopy and a fluorescent 
terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) 
staining were used to evaluate the viability of the mucosal explants. In vitro chicken 
tracheal and conjunctival mucosa explant models were maintained up to 96h without 
significant changes in cell viability. These mucosal models were inoculated with 
ILTV and collected at 0, 24, 48 and 72h post inoculation (pi). ILTV was found to 
spread in a plaquewise manner in the mucosa. The three-dimensional changes of an 
ILTV plaque were quantitatively analysed. Plaque latitude increased over time up to 
72h pi. ILTV showed a restricted penetration through the basement membrane (BM) 
(31% of the plaques in the trachea and 43% of the plaques in the conjunctiva at 48h 
pi). Further, the effect of ILTV on the cell viability of tracheal and conjunctival 
mucosae indicated that ILTV blocks apoptosis in infected cells but induces apoptosis 
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in neighboring uninfected cells. Overall, tracheal and conjunctival mucosal explant 
models were valuable and reproducible tools to study the early events of ILTV 
infection under in vitro conditions. 
In Chapter 3.2, the second aim was addressed. First, we examined the expression of 
MUC5AC and MUC5B in the mucosa of larynx, trachea and bronchi of normal and 
ILTV infected chickens. Second, the mucoid plugs/casts present inside the trachea 
were stained for mucins (MUC5AC and MUC5B) and nuclear DNA fibrous structures 
(extracellular traps). The results showed that MUC5AC and MUC5B were 
extensively produced in the epithelium of the respiratory mucosa of normal chickens. 
Interestingly, the MUC5AC and MUC5B mucins were only present at the dorsal 
tracheal region (thinner) of the cranial and middle part of tracheal mucosa of normal 
chickens. The tracheal mucosal thickness was nearly 6.5 times higher in ILTV 
infected chickens compared to control chickens, and which is the main reason for 
almost 40% reduced diameter of the lumen in infected trachea. MUC5AC and 
MUC5B mucins were hardly observed in the mucosa of the respiratory tract and in the 
mucoid plugs/casts of the ILTV infected chickens. Surprisingly, DNA fibrous 
structures were present in 10.0 ± 7.3% nuclei of the cells from ILTV infected mucoid 
plugs/casts. Upon inoculation of isolated blood heterophils with ILTV, DNA fibrous 
structures were observed in 2.0 ± 0.1% nuclei of heterophils at 24 hours post 
inoculation (hpi). In summary, ILTV infected mucoid plugs/casts are not associated 
with MUC5AC and MUC5B mucins but with DNA fibrous structures, and are 
contributing to tracheal obstruction, and finally asphyxiation in chickens. 
In Chapter 4.1, the third aim was addressed. The complete genome of Belgian NIBV 
reference B1648 strain was characterized to understand its evolutionary relationship 
with other IBV strains, and to identify the genetic factors, which may be associated 
with the nephropathogenic nature of this strain. Thirteen open reading frames (ORFs) 
were predicted in the B1648 strain (5’UTR-1a-1ab-S-3a-3b-E-M-4b-4c-5a-5b-N-6b-
3’UTR). ORFs 4b, 4c and 6b were present in B1648 and most of the other IBV 
complete genomes. Based on the phylogenetic analysis of the full-length genome, 
replicase transcriptase complex, spike protein, partial S1 gene and M protein, B1648 
strain was grouped with non-Massachusetts type strains (NGA/A116E7/2006, UKr 
27-11, QX-like ITA/90254/2005, QX-like CK/SWE/0658946/10, TN20/00, IBV-
27/99, RF/06/2007 and SLO/266/05). According to the partial S1 fragment, strains 
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TN20/00, IBV-27/99, RF/06/2007 and SLO/266/05 were grouped with B1648 and 
further, designated as B1648 genotype. The full-length genome of the B1648 strain 
shares the highest sequence homology with UKr 27-11, Gray, JMK, and 
NGA/A116E7/2006 (91.2 to 91.6%), but was less related with reference Beaudette 
and Massachusetts type strains (89.7%). Nucleotide and amino acid sequence analyses 
have revealed that the B1648 strain may have played an important role in the recent 
evolution of IBV in Europe and North Africa. The possible pathogenicity 
determinants of B1648 strain might be located on the 1a, spike, M and accessory 
proteins (3a, 3b, 4b, 4c, 5a and 5b). Overall, B1648 is a distinct strain setting it apart 
from all strains reported so far in Europe and other parts of the world. 
In Chapter 4.2, the fourth aim was addressed. Nephropathogenic (B1648) and 
respiratory (M41) IBV infection kinetics were elucidated in vitro in respiratory 
mucosa explants and blood monocytes (KUL01+ cells) by a reproducible quantitative 
analysis system using confocal microscopy. A new real time quantitative polymerase 
chain reaction (5’ RT-qPCR) was validated and used to evaluate B1648 and M41 
infection kinetics in vivo in chickens. B1648 strain was replicating slightly better in 
the epithelium of the respiratory mucosa explants than M41 strain and used more 
KUL01+ cells (monocytes/macrophages) as carriers to transport the deeper layers of 
the respiratory tract in contrast to M41. Nephropathogenic B1648 virus productively 
infected KUL01+ blood monocytic cells whereas the infection with respiratory M41 
virus was abortive. In vivo, IBV respiratory shedding was similar for both strains. 
Viral RNA copies were detected in plasma and mononuclear cells of B1648 
inoculated chickens. In M41 inoculated chickens, viral RNA copies were not 
observed in plasma and mononuclear cells (except at one time point for plasma and 
mononuclear cells of one chicken at 6 dpi). Based on virus isolation, plasma and 
mononuclear cell samples of B1648 inoculated chickens were positive for infectious 
virus in contrast with M41 inoculated chickens. In addition, viral antigen KUL01+ 
cells were identified in mononuclear cells of only B1648 inoculated chickens. Viral 
RNA copies and antigen positive cells were observed in kidneys, spleen, lungs and 
liver of chickens infected with B1648 but not with M41, at 12 dpi (euthanasia). In 
summary, both B1648 and M41 replicate extensively in the epithelium of the tracheal 
mucosa, after which only B1648 can disseminate to internal organs through cell 
associated viremia in mononuclear leukocytes and cell free virus in plasma. This 
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study clearly demonstrated that the tissue tropism differences between IBV B1648 
and M41 can be explained by the susceptibility of KUL01+ monocytic cells. 
In Chapter 5, all data obtained in this study were reviewed and discussed. In vitro 
tracheal and conjunctival mucosal explant models were successfully established for 
chickens. These in vitro explants were susceptible to ILTV. ILTV spreads in a 
plaquewise manner in the mucosa and penetrates underlying layers in a restricted 
manner. The ILTV infected mucoid plugs/casts are associated with DNA fibrous 
structures but not with mucins (MUC5AC and MUC5B). IBV B1648 is distinct from 
all other IBV strains reported so far in Europe and other parts of the world and may 
have played an important role in evolution. IBV B1648 can easily disseminate to 
internal organs via cell-free viremia in plasma and cell-associated viremia in 
mononuclear cells with KUL01+ cells as important carrier cells.  
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Samenvatting 
Infectieuze laryngotracheïtis virus (ILTV) en infectieuze bronchitis virus (IBV) zijn 
twee belangrijke aviaire respiratoire virussen die wereldwijd enorme economische 
verliezen veroorzaken bij nutspluimvee. ILTV en IBV dringen binnen via respiratoire 
en oculaire route. De ILTV en IBV invasiestrategieën op deze plaatsen en de ermee 
gepaarde pathogenesemechanismen zijn onvoldoende gekend. Daarom hebben we tot 
doel de vermeerderingskarakteristieken van ILTV en IBV onder in vitro en in vivo 
omstandigheden te bestuderen. 
Een overzicht van de beschikbare kennis van ILTV en IBV werd gegeven in 
Hoofdstuk 1. De historische achtergrond, indeling, virusstructuur, vermeerdering, 
pathogenese, ziektebeelden en pathologie van ILTV en IBV werden hier besproken. 
In Hoofdstuk 2 werden de beoogde doelstellingen beschreven. De eerste doelstelling 
was de vermeerderingskinetiek van ILTV met behulp van in vitro respiratoire en 
conjunctivale mucosa explantmodellen te bestuderen. De tweede doelstelling bestond 
uit het onderzoeken van een mogelijke verandering in mucine secretie in ILTV-
geïnfecteerde dieren dat aanleiding geeft tot mucoïede plugs/casts in het lumen van 
het ademhalingsstelsel. De derde doelstelling was de karakterisatie van het volledig 
genoom van de nefropathogene stam B1648 zodat de epidemiologische relatie met 
andere IBV stammen en genetische factoren die mogelijks geassocieerd zijn met 
nefropathogeniciteit beter begrepen kunnen worden. De vierde en laatste doelstelling 
was het ophelderen van hoe NIBV (B1648) een sterk tropisme voor de nieren heeft 
verworven. 
Hoofdstuk 3.1 geeft een antwoord op de eerste doelstelling. Er werden in vitro 
tracheale en conjunctivale mucosa explanten gemaakt van drie verschillende kippen. 
De viabiliteit van de mucosale explanten werd beoordeeld door middel van 
lichtmicroscopie en een fluorescente terminal deoxynucleotidyl transferase mediated 
dUTP nick end labeling (TUNEL) kleuring. De in vitro kippen tracheale en 
conjunctivale mucosa explantmodellen werden tot 96 uur lang gehouden zonder dat er 
significante verschillen gezien werden in de levensvatbaarheid van de cellen. De 
explanten werden geïnfecteerd met ILTV en verzameld op 0, 24, 48 en 72 uur na 
inoculatie (post inoculatie, pi). ILTV bleek van cel-tot-cel te spreiden in de mucosa 
met de vorming van een plaque als gevolg. De drie-dimensionele veranderingen van 
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een plaque werden kwantitatief geanalyseerd. De breedte (latitude) van de plaques 
nam toe tot 72 uren pi. ILTV vertoonde een beperkte penetratie door de basaal 
membraan (BM) (31% van de plaques in de trachea en 43% van de plaques in de 
conjunctiva op 48 uur pi). Het effect van ILTV op de levensvatbaarheid van de cellen 
werd nagegaan in tracheale en conjunctivale mucosa. ILTV blokkeerde apoptose in 
geïnfecteerde cellen maar induceerde apoptose in naburige niet-geïnfecteerde cellen. 
Algemeen genomen kunnen tracheale en conjunctivale mucosale explantmodellen 
beschouwd worden als waardevolle en reproduceerbare tools om de eerste 
gebeurtenissen in een ILTV-infectie onder in vitro omstandigheden te kunnen 
bestuderen. 
De tweede doelstelling werd behandeld in Hoofdstuk 3.2. Ten eerste werd de 
expressie van MUC5AC en MUC5B ter hoogte van de mucosa van de larynx, trachea 
en bronchen bij gezonde en ILTV-geïnfecteerde kippen nagegaan. Ten tweede werden 
de mucoïde plugs/casts die aanwezig waren in de trachea gekleurd voor mucines 
(MUC5AC en MUC5B) en DNA fibreuze structuren (extracellulaire traps). MUC5AC 
en MUC5B werd sterk geproduceerd door het epitheel in de respiratoire mucosa bij 
gezonde kippen. MUC5AC en MUC5B waren enkel aanwezig in het dorsale tracheale 
gebied (dunner) van het proximale en middelste deel van de tracheale mucosa bij 
gezonde kippen. De dikte van de tracheale mucosa was bijna 6,5 keer toegenomen in 
ILTV-geïnfecteerde kippen vergeleken met gezonde kippen, wat dus de hoofdreden is 
voor de vernauwing van de diameter van het lumen van om en bij de 40% bij 
geïnfecteerde dieren. De MUC5AC en MUC5B mucines werden nauwelijks 
waargenomen in de mucosa van het ademhalingsstelsel noch in de mucoïde 
plugs/casts bij ILTV-geïnfecteerde dieren. Verrassend genoeg waren DNA fibreuze 
structuren aanwezig bij 10.0 ± 7.3% van de kernen van cellen in ILTV-geïnfecteerde 
mucoïde plugs/casts. Na inoculatie van geïsoleerde bloedheterofielen met ILTV 
werden deze structuren 24 uur pi waargenomen in 2.0 ± 0.1% van de kernen. 
Samengevat, ILTV-geïnfecteerde mucoïde plugs/casts worden niet geassocieerd met 
MUC5AC en MUC5B mucines maar met DNA fibreuze structuren en dragen bij tot 
de obstructie van de luchtpijp met verstikking tot gevolg. 
In Hoofdstuk 4.1 werd de derde doelstelling besproken. Het volledige genoom van de 
Belgische NIBV referentiestam B1648 werd gekarakteriseerd om zijn evolutionaire 
relatie met andere IBV stammen te kunnen begrijpen, en om genetische factoren te 
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identificeren die mogelijks geassocieerd zijn met de nefropathogene natuur van deze 
stam. Dertien “open reading frames” (ORFs) werden voorspeld in de B1648 stam 
(5’UTR-1a-1ab-S-3a-3b-E-M-4b-4c-5a-5b-N-6b-3’UTR). ORFs 4b, 4c en 6c waren 
aanwezig in B1648, alsook in de meeste andere IBV volledige genomen. Gebaseerd 
op de fylogenetische analyse van het full-length genoom werden het replicase 
transcriptase complex, het spike eiwit, een gedeeltelijk S1 gen en het M-eiwit van 
B1648 gegroepeerd met die van niet-Massachusetts type stammen 
(NGA/A116E7/2006, UKr 27-11, QX-like ITA/90254/2005, QX-like 
CK/SWE/0658946/10, TN20/00, IBV-27/99, RF/06/2007 and SLO/266/05). Als 
gevolg van het gedeeltelijk S1 fragment werden de TN20/20, IBV-27/99, RF/06/2007 
en SLO/266/05 stammen gegroepeerd met B1648 en werden ze verder vernoemd als 
B1648 genotype. Het full-length genoom van de B1648 stam vertoonde een erg hoge 
sequentie homologie met UKr 27-11, Gray, JMK en NGA/A116E7/2006 (91.2 tot 
91.6%), maar was minder gerelateerd met de Beaudette en Massachusetts type 
referentie stammen (89.7%). Nucleotide en aminozuursequentie analyses brachten aan 
het licht dat de B1648 stam mogelijks een belangrijke rol gespeeld heeft in de recente 
evolutie van IBV in Europa en Noord-Afrika. De mogelijke pathogeniciteitsbepalende 
factoren van B1648 kunnen zich bevinden in de 1a, spike, M en accessoire eiwitten 
(3a, 3b, 4b, 4c, 5a en 5b). Algemeen genomen is de B1648 stam een stam die zich 
onderscheidt van alle stammen die tot nu toe in Europa en andere werelddelen werden 
gerapporteerd. 
In Hoofdstuk 4.2 werd de vierde doelstelling behandeld. Nefropathogene (B1648) en 
respiratoire (M41) IBV-infectiekinetieken werden opgesteld in in vitro respiratoire 
mucosa explanten en bloedmonocyten (KUL01+ cellen) door middel van een 
reproduceerbaar kwantitatief analysesysteem en confocale microscopie. Een nieuwe 
real time quantitative polymerase chain reaction (5’ RT-qPCR) werd gevalideerd en 
gebruikt om de infectiekinetiek van B1648 en M41 bij levende kippen te bestuderen. 
De B1648 stam vermeerderde iets meer, vergeleken met de M41 stam, in het epitheel 
van respiratoire mucosa explanten en gebruikte meer KUL01+ cellen 
(monocyten/macrofagen) als carrier om zo dieper in de lagen van het respiratoire 
stelsel te geraken. De nefropathogene stam B1648 infecteerde succesvol KUL01+ 
cellen, terwijl een infectie met de respiratoire M41 stam mislukte. In vivo bleek de 
IBV uitscheiding vergelijkbaar met beide stammen. Bij B1648-geïnfecteerde kippen 
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werden er virale RNA kopijen teruggevonden in plasma en mononucleaire cellen. Bij 
M41-geïnfecteerde kippen werden er geen RNA kopijen gevonden in deze cellen of 
plasma (behalve in plasma en in mononucleaire cellen van één kip op 6 dagen na 
inoculatie). Volgens de virusisolatie waren stalen met plasma en mononucleaire cellen 
afkomstig van B1648-geïnfecteerde dieren positief voor infectieus virus in 
tegenstelling tot M41-geïnfecteerde dieren. Bovendien werden viraal antigeen- 
positieve KUL01+ cellen enkel geïdentificeerd in mononucleaire cellen van B1648-
geïnfecteerde kippen. Op 12 dagen na inoculatie (euthanasie) werden virale RNA 
kopijen en antigen positieve cellen gevonden in de nieren, de milt, de longen en de 
lever van kippen geïnfecteerd met B1648, maar niet bij dieren geïnfecteerd met M41. 
Samengevat, zowel B1648 als M41 vermeerderen in het epitheel van de tracheale 
mucosa, waarna enkel B1648 verder kan spreiden naar interne organen via een 
celgeassocieerde viremie in mononucleaire leukocyten en celvrij in plasma. Deze 
studie demonstreerde duidelijk dat de weefselvoorkeuren tussen IBV B1648 en M41 
kunnen verklaard worden door de gevoeligheid van de KUL01+ monocytische cellen 
voor een IBV infectie. 
Alle gegevens worden kort aangekaart en grondig bediscussieerd in Hoofdstuk 5. In 
vitro tracheale en conjunctivale mucosale explantmodellen voor kippen werden 
succesvol ontwikkeld. Deze in vitro explanten waren gevoelig voor ILTV-infectie. 
ILTV spreidt van cel tot cel in de mucosa met de vorming van een plaque als gevolg 
en penetreert de onderliggende lagen op een beperkte manier. De ILTV-geïnfecteerde 
mucoïede plugs/casts werden in verband gebracht met DNA fibreuze structuren maar 
niet met mucines (MUC5AC en MUC5B). IBV B1648 kan gemakkelijk spreiden naar 
interne organen via een celvrije viremie in plasma en via een celgeassocieerde viremie 
in mononucleaire cellen met KUL01+cellen als belangrijke carriercellen. 
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